Tuesday, November 19, 2013
Print Entire 2013 Program:
|
|
SESSION 1 SCHEDULE | |
Tuesday
SESSION 1:
ENDOVENOUS TREATMENT OF VARICOSE VEINS AND OTHER VENOUS TOPICS - PART 1
|
|
x | |
8:00 AM - 8:06 AM | Welcome: Endovascular Tour Of C1 - C6 Venous Disease |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
8:07 AM - 8:12 AM | Anatomy And Nomenclature Of The Venous System |
Presenter(s):Mark A. Adelman, MD | |
8:13 AM - 8:18 AM | Venous Mapping And Reflux Study |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
8:19 AM - 8:24 AM | Proper Clinical Evaluation |
Presenter(s):Fedor Lurie, MD, PhD | |
8:25 AM - 8:30 AM | Epidemiology Of Chronic Venous Disease |
Presenter(s):Peter Gloviczki, MD | |
8:31 AM - 8:36 AM | How To Use CEAP And VCSS In Clinical Practice |
Presenter(s):Robert B. McLafferty, MD | |
8:37 AM - 8:42 AM | Step-By-Step Endovenous Thermal Ablation Of The GSV |
Presenter(s):Edward G. Mackay, MD | |
8:43 AM - 8:48 AM | Step-By-Step Endovenous Thermal Ablation Of The SSV |
Presenter(s):Julianne Stoughton, MD, FACS | |
8:49 AM - 8:54 AM | Step-By-Step: Ambulatory Phlebectomy |
Presenter(s):Sylvain Chastanet, MD | |
8:55 AM - 9:00 AM | Should We Treat Truncal Reflux And Varicose Veins All In One Session |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
9:01 AM - 9:06 AM | The Affordable Care Act Will Replace Volume-Based Medicine With A Value-Based System: How Will This Affect Chronic Venous Disease |
Presenter(s):Mark H. Meissner, MD | |
9:07 AM - 9:12 AM | DEBATE: C2 Venous Disease Is Stable, Should Not Be A Covered Insurance Benefit |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
9:13 AM - 9:18 AM | DEBATE: C2 Venous Disease Is Progressive, Should Be A Covered Insurance Benefit |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
9:19 AM - 9:24 AM | Review Of Randomized Controlled Trials Comparing Endovenous Thermal And Chemical Ablation |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
9:25 AM - 9:30 AM | Does Multiple Axial Vein Incompetence Increase The Clinical Severity Of Venous Disease |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
9:31 AM - 9:36 AM | Venous Disease Pathophysiology: What We Know And What We Do Not Know |
Presenter(s):Peter J. Pappas, MD | |
9:37 AM - 9:42 AM | What Is New In DVT Treatment |
Presenter(s):John Blebea, MD, MBA | |
9:43 AM - 9:48 AM | Venous Ulcers: Contemporary Management |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
9:49 AM - 9:54 AM | Saphenous Reflux Correction Does Not Aid Ulcer Healing . . . Really: Is The ESCHAR Trial Bogus |
Presenter(s):William A. Marston, MD | |
9:55 AM - 10:00 AM | DEBATE: Preemptive Strike On Perforators Reduces Recurrences |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
10:01 AM - 10:06 AM | DEBATE: Preemptive Strike On Perforators Does Not Reduce Recurrences |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
10:07 AM - 10:12 AM | Perforator Ablation For CEAP 5/6: UCLA Experience |
Presenter(s):Peter F. Lawrence, MD | |
10:13 AM - 10:18 AM | Hurt Locker: Complications Of Foam And Liquid Sclerotherapy |
Presenter(s):Edward G. Mackay, MD | |
10:19 AM - 10:24 AM | Hurt Locker: Steps To Avoid Endothermal Heat Induced Thrombosis |
Presenter(s):Mikel Sadek, MD | |
10:25 AM - 10:30 AM | Hurt Locker: Steps To Avoid Saphenous And Sural Nerve Paresthesia |
Presenter(s):Jean Luc Gerard, MD | |
10:31 AM - 10:36 AM | Improving Sensitivity And Splecificity For Imaging Iliac Vein Compression With MR Or CT |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
10:37 AM - 10:42 AM | Step-By-Step Diagnostic Evaluation For Patients With Suspected May-Thurner Syndrome |
Presenter(s):Brian G. DeRubertis, MD | |
10:43 AM - 10:48 AM | Are The NICE 2013 UK Guidelines On The Management Of Venous Disease The Same As The SVS/AVF |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
10:49 AM - 10:54 AM | Optimal C1 Venous Disease Treatment: My Pearls |
Presenter(s):Julianne Stoughton, MD, FACS | |
10:55 AM - 11:00 AM | Does Saphenous Ablation Ever Help C3 Patients Who Do Not Have Varicose Veins |
Presenter(s):Edward G. Mackay, MD | |
11:01 AM - 11:06 AM | Potential Advantages Of A New Patient Based Quality Of Life Measure (VVsymQ): Is It A Practical Metric To Aid In Payor Approval |
Presenter(s):Mark A. Adelman, MD | |
11:07 AM - 11:12 AM | RF Segmental Ablation: 5-Year Data |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
11:13 AM - 11:18 AM | Mechanochemical Ablation: 17K Cases |
Presenter(s):Steve Elias, MD | |
11:19 AM - 11:24 AM | Vein Diameter Is A Poor Determinate By Which To Ration Varicose Vein Treatment |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:25 AM - 11:30 AM | The Incidence Of Contralateral Iliac Venous Thrombosis After Stenting Across The Iliocaval Confluence |
Presenter(s):David L. Gillespie, MD | |
11:31 AM - 11:36 AM | Endovascular Treatment Of Venous CTO Above The Inguinal Ligament |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
11:37 AM - 11:42 AM | Endovascular Treatment Of Venous CTO Below The Inguinal Ligament |
Presenter(s):Mark J. Garcia, MD | |
11:43 AM - 12:00 PM | Panel Discussion |
Panelist(s): Mark A. Adelman, MD / Jose I. Almeida, MD, RVT, FACS / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh / Mark J. Garcia, MD / Peter Gloviczki, MD / Lowell S. Kabnick, MD, FACS, FACPh / Peter F. Lawrence, MD / Thomas F. O'Donnell, Jr., MD / Mark S. Whiteley, MS, FRCS | |
12:00 PM - 12:55 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Tuesday
SESSION 2:
ENDOVENOUS TREATMENT OF VARICOSE VEINS AND OTHER VENOUS TOPICS – PART 2
|
|
x | |
12:55 PM - 1:00 PM | A Novel Approach To Closing The Great Saphenous Vein: V-Block Trial |
Presenter(s):Ralf R. Kolvenbach, MD | |
1:01 PM - 1:06 PM | Best Current Device For Ablation Of Saphenous Veins And Why |
Presenter(s):Peter F. Lawrence, MD | |
1:07 PM - 1:12 PM | TAHOE I And II: Immediate Outcomes With A Biodegradable Implant For Refluxing GSV |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
1:13 PM - 1:18 PM | Pros And Cons Of Stenting For May-Thurner Syndrome: Do We Need A RCT |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
1:19 PM - 1:24 PM | Association Of Deep Vein Reflux And Obstruction In PTS: Which Is The Culprit |
Presenter(s):Seshadri Raju, MD | |
1:25 PM - 1:30 PM | Deep Venous Valvular Reconstruction: Indications, How And Results |
Presenter(s):Michael C. Dalsing, MD | |
View Abstract | |
1:31 PM - 1:36 PM | The Brooklyn Venous Stent Experience: Similar Or Different Than Mississippi |
Presenter(s):Enrico Ascher, MD | |
1:37 PM - 1:42 PM | Economics Of IVUS/Iliac Stent For Office-Based Endovascular Interventions |
Presenter(s):Paul J. Gagne, MD | |
1:43 PM - 1:48 PM | What’s On The Horizon In Venous Thrombosis Research |
Presenter(s):Peter Henke, MD | |
1:49 PM - 1:54 PM | New Drugs: Ready For Primetime DVT Prophylaxis Treatment |
Presenter(s):Joseph A. Caprini, MD | |
View Abstract | |
1:55 PM - 2:00 PM | D-Dimer And/Or Duplex Findings To Manage DVT |
Presenter(s):Timothy K. Liem, MD | |
2:01 PM - 2:06 PM | Update: Accreditation Of Vein Centers-IAC Vein Center |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
2:07 PM - 2:12 PM | Lymphedema: When Manual Lymphatic Drainage Is Not Enough . . . |
Presenter(s):Peter Gloviczki, MD | |
2:13 PM - 2:18 PM | How To Differentiate Venous Ulcers From Others |
Presenter(s):Raghu Kolluri, MD | |
2:19 PM - 2:24 PM | Detecting Iliac, IVC, Ovarian Vessels By Duplex |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
2:25 PM - 2:30 PM | DEBATE: Preemptive Strike On Incompetent Ovarian Veins Does Not Reduce Recurrences |
Presenter(s):Mark H. Meissner, MD | |
2:31 PM - 2:36 PM | DEBATE: Preemptive Strike On Incompetent Ovarian Veins Reduces Recurrences |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Abstract | |
2:37 PM - 2:42 PM | Novel Embolization Device: 10 Cases Of Pelvic Congestion Syndrome Secondary To Ovarian Vein Incompetence |
Presenter(s):Dennis J. Griffin, MD | |
2:43 PM - 2:48 PM | Nutcracker Syndrome: Laparotomy Or Stent |
Presenter(s):Marc A. Passman, MD | |
2:49 PM - 2:54 PM | Acute Saphenous Vein Thrombosis: Anticoagulate, Strip Or Burn |
Presenter(s):Joseph D. Raffetto, MD | |
2:55 PM - 3:00 PM | Transition Of AVF Registry To The SVS-VQI |
Presenter(s):Brajesh K. Lal, MD | |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Tuesday
SESSION 3:
ENDOVENOUS TREATMENT OF VARICOSE VEINS - PART 3
CASE PRESENTATIONS, LITERATURE REVIEW, QUESTIONS AND ANSWERS |
|
x | |
3:00 PM - 3:20 PM | 10 Years Of ASVAL: Lessons Learned |
Presenter(s):Paul Pittaluga, MD | |
3:20 PM - 3:40 PM | Complex Superficial Venous Disease |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
3:40 PM - 4:00 PM | Infrapopliteal Deep Vein Thrombosis |
Presenter(s):Joann Lohr, MD | |
4:00 PM - 4:20 PM | Endothermal Heat Induced Thrombosis |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
4:20 PM - 4:40 PM | Pelvic Congestion/Varicose Veins |
Presenter(s):Melvin Rosenblatt, MD | |
4:40 PM - 5:00 PM | Central Venous Obstruction And Concomitant Superficial Venous Reflux |
Presenter(s):Seshadri Raju, MD | |
5:00 PM - 5:00 PM | Adjourn |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
x | |
7:50 AM - 7:59 AM | Introduction |
Presenter(s):Larry A. Scher, MD / Thomas M. Vesely, MD | |
8:00 AM - 8:10 AM | Individualizing Vascular Access Care: Myth Or Reality? |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
8:11 AM - 8:21 AM | Coordination Of Vascular Access Care |
Presenter(s):William D. Paulson, MD | |
8:22 AM - 8:32 AM | Reevaluation Of The Fistula First Breakthrough Initiative |
Presenter(s):David L. Cull, MD, FACS | |
8:33 AM - 8:43 AM | Cumulative Patency Of Fistulas vs. Grafts: 2000 – 2010 |
Presenter(s):Charmaine Lok, MD | |
8:44 AM - 8:54 AM | Bioengineered Vascular Access Grafts: Ready For Prime Time? |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
8:55 AM - 9:05 AM | Buttonhole Cannulation: 10 Years’ Experience North Of The 49th Parallel |
Presenter(s):Sandra M. Donnelly, MDCM, MSc, FRCP(C) | |
9:06 AM - 9:16 AM | In Vitro Performance Of Long-Term Hemodialysis Catheters |
Presenter(s):Thomas M. Vesely, MD | |
9:17 AM - 9:27 AM | Algorithm To Minimize Use Of Hemodialysis Catheters |
Presenter(s):Eric Chemla, MD | |
View Abstract | |
9:28 AM - 9:50 AM | Panel Discussion |
9:50 AM - 10:10 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Tuesday
SESSION 5:
PERCUTANEOUS MANAGEMENT OF FISTULAS AND GRAFTS
Moderators:Theodore F. Saad, MD / Aris Q. Urbanes, MD
|
|
x | |
10:10 AM - 10:20 AM | Simplifying Difficult Access Management Decisions |
Presenter(s):Jacob Cynamon, MD | |
10:21 AM - 10:31 AM | Transradial Access |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
10:32 AM - 10:42 AM | Mechanical Thrombectomy Of Hemodialysis Fistulas And Grafts: Results Of The PEARL Registry |
Presenter(s):Eugene J. Simoni, MD | |
View Abstract | |
10:43 AM - 10:53 AM | Results Of RENOVA Trial |
Presenter(s):Theodore F. Saad, MD | |
10:54 AM - 11:04 AM | Endovascular Ligation Of Venous Side Branches In Non-Maturing Fistulas |
Presenter(s):Jerry Matteo, MD | |
View Abstract | |
11:05 AM - 11:15 AM | Overlapping Stents |
Presenter(s):Micah R. Chan, MD, MPH | |
View Abstract | |
11:16 AM - 11:26 AM | Percutaneous Creation Of Autogenous Fistula |
Presenter(s):William E. Cohn, MD | |
View Abstract | |
11:27 AM - 11:45 AM | Panel Discussion |
11:45 AM - 12:30 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Tuesday
SESSION 6:
VASCULAR STUDIES FOR DIALYSIS VASCULAR ACCESS
Moderators:William D. Paulson, MD / Arif Asif, MD
|
|
x | |
12:30 PM - 12:40 PM | Ultrasound Vein Mapping: AIUM Guidelines |
Presenter(s):Michelle L. Robbin, MD | |
12:41 PM - 12:51 PM | Ultrasound Venous Mapping vs. Upper Extremity Venography |
Presenter(s):Arif Asif, MD | |
12:52 PM - 1:02 PM | Longitudinal Ultrasound Assessment Of Fistula Maturation |
Presenter(s):Sandra M. Donnelly, MDCM, MSc, FRCP(C) | |
1:03 PM - 1:13 PM | Measurement Of Intra-Access Pressure |
Presenter(s):Dirk M. Hentschel, MD | |
1:14 PM - 1:24 PM | Arterial Inflow Stenosis |
Presenter(s):Steven Wu, MD | |
1:25 PM - 1:35 PM | Influence Of Arterial Elasticity On Fistula Maturation |
Presenter(s):William D. Paulson, MD | |
1:36 PM - 1:46 PM | Recombinant Human Elastase To Promote Hemodialysis Access Patency |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
1:47 PM - 2:00 PM | Panel Discussion |
2:00 PM - 2:20 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Tuesday
SESSION 7:
SURGICAL MANAGEMENT OF FISTULAS AND GRAFTS
Moderators:Larry A. Scher, MD / Jeffrey H. Lawson, MD, PhD
|
|
x | |
2:20 PM - 2:30 PM | Early Cannulation Graft: Results Of Acuseal Clinical Trial |
Presenter(s):Marc H. Glickman, MD | |
2:31 PM - 2:41 PM | Heparin Bonded Grafts For Hemodialysis Access |
Presenter(s):David Shemesh, MD, RVT | |
View Abstract | |
2:42 PM - 2:52 PM | Removal Of Non-Functional Grafts To Reduce Systemic Inflammation |
Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN | |
2:53 PM - 3:03 PM | 18-Year Experience With The DRIL Procedure |
Presenter(s):Steven G. Katz, MD | |
View Abstract | |
3:04 PM - 3:14 PM | Surgical Reconstruction Of Cephalic Arch |
Presenter(s):Karl A. Illig, MD | |
3:15 PM - 3:25 PM | Surgical Salvage Of Thrombosed Fistulas |
Presenter(s):David L. Cull, MD, FACS | |
3:26 PM - 3:36 PM | Experience With The HeRO Device: Mistakes Made, Lessons Learned |
Presenter(s):Jeffrey H. Lawson, MD, PhD | |
3:37 PM - 3:45 AM | Panel Discussion |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Tuesday
SESSION 8:
CLINICAL PRACTICE IN OUTPATIENT FACILITIES
Moderators:Aris Q. Urbanes, MD / Dirk M. Hentschel, MD
|
|
x | |
3:45 PM - 3:55 PM | How To Assess Dialysis Access Maturation In <5 Minutes In The Office |
Presenter(s):Dennis F. Bandyk, MD | |
3:56 PM - 4:06 PM | Conscious Sedation In The Outpatient Setting |
Presenter(s):Aris Q. Urbanes, MD | |
View Abstract | |
4:07 PM - 4:17 PM | Management Of Blood Pressure In The Outpatient Setting |
Presenter(s):Arif Asif, MD | |
4:18 PM - 4:28 PM | Cardiopulmonary Arrest During Interventional Procedures |
Presenter(s):John F. Angle, MD | |
4:29 PM - 4:39 PM | Infection Control In Outpatient Setting |
Presenter(s):Kevin Graham, CHDN, CASC, FACMPE | |
View Abstract | |
4:40 PM - 5:00 PM | Panel Discussion |
5:00 PM - 5:00 PM | Adjourn |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Tuesday
SESSION 9:
CLASSIFICATION AND IMAGING OF VASCULAR ANOMALIES
|
|
x | |
6:55 AM - 7:00 AM | Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
7:00 AM - 7:10 AM | Current Classification And Nomenclature Of Vascular Malformations |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
7:10 AM - 7:20 AM | Venous Embryology: Key To Understanding Truncular Venous Malformations |
Presenter(s):Byung-Boong Lee, MD | |
7:20 AM - 7:30 AM | The Hamburg Classification For Vascular Malformations |
Presenter(s):Iris Baumgartner, MD | |
7:30 AM - 7:40 AM | The International Society for the Study of Vascular Anomalies (ISSVA) Classification System For Vascular Malformations And Vascular Tumors: A Cellular Based System |
Presenter(s):Patricia E. Burrows, MD | |
View Abstract | |
7:40 AM - 7:50 AM | Vascular Tumors Confused With Vascular Malformations: Defining Pediatric Hemangioma, RICH, NICH, Kaposiform-Hemangioendothelioma (KPH) Of The Trunk With The Kasabach-Merritt Syndrome, And KPH Of The Liver With CHF In The Neonate |
Presenter(s):Francine Blei, MD | |
7:50 AM - 8:00 AM | New Imaging Modalities Essential For Accurate Diagnosis Of Low-Flow And High-Flow Vascular Malformations |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
8:00 AM - 8:10 AM | Classification Of AVMs: The Houdart Classification, The Do Classification, And The Yakes Classification |
Presenter(s):Wayne F. Yakes, MD | |
8:10 AM - 8:15 AM | DEBATE: Why The Hamburg Classification Should Only Be Used |
Presenter(s):Byung-Boong Lee, MD | |
8:15 AM - 8:20 AM | DEBATE: Why The ISSVA Classification Should Only Be Used |
Presenter(s):Patricia E. Burrows, MD | |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Tuesday
SESSION 10:
EMBOLIC AGENTS UTILIZED IN ENDOVASCULAR VASCULAR MALFORMATION
|
|
x | |
8:20 AM - 8:30 AM | Tips And Tricks For Using Liquid Embolic Agents For AVMs |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
8:30 AM - 8:40 AM | Current Embolic Agents de Jour To Treat Venous And Lymphatic Malformations |
Presenter(s):Patricia E. Burrows, MD | |
View Abstract | |
8:40 AM - 8:50 AM | ONYX AVM Embolotherapy: The Histologic Tissue Changes, Tissue Inflammatory Response, And Fluoroscopy Issues With Its Use |
Presenter(s):Mollie Meek, MD | |
8:50 AM - 9:00 AM | Tips And Tricks Using ONYX To Minimize Complications And Procedure Times |
Presenter(s):Furuzan Numan, MD | |
9:00 AM - 9:10 AM | Sclerogel: A New Ethanol-Based Embolic Agent To Treat Low—Flow Vascular Malformations |
Presenter(s):Iris Baumgartner, MD | |
9:10 AM - 9:20 AM | Ethanol: The Gold Standard For Embolization Of Extra-Truncular Vascular Malformations |
Presenter(s):Iris Baumgartner, MD | |
9:20 AM - 9:30 AM | Current Use Of Ethanol And Coils To Treat High-Flow Vascular Malformations |
Presenter(s):Krassi Ivancev, MD, PhD | |
9:30 AM - 10:00 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 10 | |
SESSION 11 SCHEDULE | |
Tuesday
SESSION 11:
MANAGEMENT OF HEAD AND NECK VASCULAR ANOMALIES
|
|
x | |
10:00 AM - 10:05 AM | DEBATE: Polymerizing Embolic Agents Are The Best To Treat AVMs |
Presenter(s):Robert J. Rosen, MD | |
10:05 AM - 10:10 AM | DEBATE: Ethanol Is The Best Embolic Agent To Treat AVMs |
Presenter(s):Wayne F. Yakes, MD | |
10:10 AM - 10:20 AM | Role Of The Beta Blockers And Combined Therapies To Treat Pediatric Hemangioma |
Presenter(s):Francine Blei, MD | |
10:20 AM - 10:30 AM | Treatment Of Head And Neck Pediatric Hemangioma In Children: UAMS Experience |
Presenter(s):Gresham T. Richter, MD | |
10:30 AM - 10:40 AM | Dangerous Arterial Connections In The Head And Neck: Avoiding Neurological Complications And The Judicious Use Of Embolic Agents |
Presenter(s):Guilherme Dabus, MD | |
10:40 AM - 10:50 AM | Surgical Options In The Management Of Head And Neck Low-Flow Vascular Malformations |
Presenter(s):Milton Waner, MD | |
10:50 AM - 11:00 AM | Liquid Embolic Agents In The Treatment Of Cranio-Facial AVMs And AVF: Techniques And Results |
Presenter(s):Guilherme Dabus, MD | |
11:00 AM - 11:10 AM | Neucrylate AVM And Neucrylate AN: New Head And Neck AVM And Aneurysm Polymerizing Embolic Agents |
Presenter(s):R. Sean Pakbaz, MD | |
11:10 AM - 11:20 AM | Treatment Of Pediatric Head And Neck Vascular Malformations: UAMS Experience |
Presenter(s):Gresham T. Richter, MD | |
11:20 AM - 11:30 AM | Ethanol Endovascular Curative Repair Of Tongue, Pharyngeal, Facial, And Scalp Low-Flow Vascular Malformations |
Presenter(s):Wayne F. Yakes, MD | |
11:30 AM - 11:40 AM | Surgical Options In The Management Of High-Flow Vascular Malformations |
Presenter(s):Milton Waner, MD | |
11:40 AM - 11:50 AM | Endovascular Management Strategies Of Difficult Auricular And Facial AVMs In Sensitive Neurological Areas: The Colorado Vascular Malformation Experience |
Presenter(s):Wayne F. Yakes, MD | |
11:50 AM - 12:00 PM | Endovascular Bailout Of A Mismanaged And Tragic Facial Infiltrative AVM |
Presenter(s):Krassi Ivancev, MD, PhD | |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Tuesday
SESSION 12:
UPPER AND LOWER EXTREMITY VASCULAR MALFORMATION MANAGEMENT
|
|
x | |
1:00 PM - 1:10 PM | Management Of Complex Upper Extremity Vascular Malformations |
Presenter(s):Furuzan Numan, MD | |
1:10 PM - 1:20 PM | Treatment Of AVMs Head To Toe: The BCVI Experience |
Presenter(s):Guilherme Dabus, MD | |
1:20 PM - 1:30 PM | Techniques For Treating Vascular Malformations Of The Extremities |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
1:30 PM - 1:40 PM | Treatment Of Intramuscular Venous Malformations Of The Extremities |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
1:40 PM - 1:50 PM | Surgical Concepts To Treat The Lower Extremity Lateral Marginal Vein (Vein of Servelle) |
Presenter(s):Byung-Boong Lee, MD | |
1:50 PM - 2:00 PM | The Personal Psychodynamics Of Complications In Vascular Malformation Treatment: What I Learned About Myself |
Presenter(s):Robert L. Vogelzang, MD | |
2:00 PM - 2:10 PM | Clinical Emergencies In Patients With Vascular Anomalies |
Presenter(s):Francine Blei, MD | |
2:10 PM - 2:20 PM | Common Femoral And Iliac Arterial Sparing Endovascular Techniques In Neonates |
Presenter(s):Patricia E. Burrows, MD | |
View Abstract | |
2:20 PM - 2:30 PM | Endovascular Treatment Strategies For Complex Soft Tissue And Bone AVMs |
Presenter(s):Wayne F. Yakes, MD | |
2:30 PM - 3:00 PM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Tuesday
SESSION 13:
CHEST, ABDOMEN, AND PELVIS VASCULAR MALFORMATION MANAGEMENT
|
|
x | |
3:00 PM - 3:10 PM | Pre-Operative AVM Embolization Strategies |
Presenter(s):Byung-Boong Lee, MD | |
3:10 PM - 3:20 PM | Difficult Pelvic AVMs: What Embolic Agent And How To Use It |
Presenter(s):Furuzan Numan, MD | |
3:20 PM - 3:30 PM | Staged Management Of Pelvic AVMs With nBCA |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
3:30 PM - 3:40 PM | Large Complex Pelvic AVMs: Curative Experience With Single-Stage Coil Embolization |
Presenter(s):Robert L. Vogelzang, MD | |
3:40 PM - 3:50 PM | Endovascular Management Of Renal AVMs |
Presenter(s):Robert J. Rosen, MD | |
View Abstract | |
3:50 PM - 4:00 PM | Uterine AVMs: Clinical Experience And Results |
Presenter(s):Robert L. Vogelzang, MD | |
4:00 PM - 4:10 PM | Endovascular Ethanol Treatment Of Hepatic Venous Malformations (Hepatic Hemangioma) |
Presenter(s):Wayne F. Yakes, MD | |
4:10 PM - 4:20 PM | Vascular Malformation Treatment Strategies: The UCSD Experience |
Presenter(s):R. Sean Pakbaz, MD | |
4:20 PM - 4:30 PM | Endovascular Management Of Mesenteric, Small Bowel, And Colo-Rectal Vascular Malformations |
Presenter(s):Wayne F. Yakes, MD | |
4:30 PM - 4:40 PM | The Long-Term Outcomes For The Treatment Of Vascular Malformation: The Northwestern Experience |
Presenter(s):Robert L. Vogelzang, MD | |
4:40 PM - 4:50 PM | The Multi-Disciplinary Team Approach For The Management Of Vascular Malformations: The Duke Experience |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
4:50 PM - 5:00 PM | Endovascular Management Strategies Of Inoperable Thoracic And Shoulder AVMs |
Presenter(s):Wayne F. Yakes, MD | |
Moderator(s): Wayne F. Yakes, MD | |
5:00 PM - 5:15 PM | Expert Panel Discussion: Q & A From The Audience |
Panelist(s): Iris Baumgartner, MD / Francine Blei, MD / Patricia E. Burrows, MD / Guilherme Dabus, MD / Ziv J. Haskal, MD, FACR, FAHA, FSIR / Krassi Ivancev, MD, PhD / Byung-Boong Lee, MD / Mollie Meek, MD / Furuzan Numan, MD / R. Sean Pakbaz, MD / Gresham T. Richter, MD / Robert J. Rosen, MD / Cynthia K. Shortell, MD / Robert L. Vogelzang, MD / Milton Waner, MD | |
5:15 PM - 5:15 PM | Adjourn |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
x | |
9:00 AM - 9:10 AM | Opening Remarks |
Presenter(s):Dieter O. Mayer, MD | |
9:10 AM - 9:20 AM | A Combination Of Neem Oil And Hypericum Oil In The Treatment Of Acute And Chronic Wounds |
Presenter(s):Severin Laeuchli, MD | |
View Abstract | |
9:20 AM - 9:30 AM | Discussion |
9:30 AM - 9:40 AM | Doxycycline As A Modulator Of Chronic Wounds |
Presenter(s):James R. Wilcox, BSN | |
View Abstract | |
9:40 AM - 9:50 AM | Discussion |
9:50 AM - 10:00 AM | Ultraportable Negative Pressure Treatment In Vascular Ulcers |
Presenter(s):Marco Romanelli, MD, PhD | |
View Abstract | |
10:00 AM - 10:10 AM | Discussion |
10:10 AM - 10:20 AM | Wound Diagnostics: Facts And Fiction |
Presenter(s):Robert J. Snyder, DPM | |
View Abstract | |
10:20 AM - 10:30 AM | Discussion |
10:30 AM - 11:00 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
x | |
11:00 AM - 11:07 AM | Livedoid Vasculopathy: Transatlantic Consensus |
Presenter(s):Afsaneh Alavi, MD, FRCPC | |
View Abstract | |
11:07 AM - 11:12 AM | Discussion |
11:12 AM - 11:19 AM | Topical Oxygen: An Update |
Presenter(s):Giacomo Clerici, MD | |
11:19 AM - 11:24 AM | Discussion |
11:24 AM - 11:31 AM | Enzymatic Debridement Of Wounds |
Presenter(s):Michael A. Maier, DPM | |
View Abstract | |
11:31 AM - 11:36 AM | Discussion |
11:36 AM - 11:43 AM | Amnion Regenerative Tissue Therapies |
Presenter(s):Julie R. O'Connell, PhD | |
View Abstract | |
11:43 AM - 11:48 AM | Discussion |
11:48 AM - 11:55 AM | Early Biological Wound Care After Lower Extremity Revascularization |
Presenter(s):Nicholas J. Morrissey, MD | |
View Abstract | |
11:55 AM - 12:00 PM | Discussion |
12:00 PM - 12:30 PM | Lunch Break – Rhinelander Gallery (2nd Floor)Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
x | |
12:30 PM - 12:45 PM | Measuring Evidence-Based Behavior In Clinical Practice |
Presenter(s):Hester Vermeulen, PhD | |
View Abstract | |
12:45 PM - 12:50 PM | Discussion |
12:50 PM - 1:05 PM | Evidence For Hyperbaric Oxygen Therapy For Acute And Chronic Wounds |
Presenter(s):Mark J.W. Koelemay, MD, PhD | |
View Abstract | |
1:05 PM - 1:10 PM | Discussion |
1:10 PM - 1:25 PM | Evidence-Based Decision Aids For Surgical Interventions |
Presenter(s):Dirk T. Ubbink, MD, PhD | |
View Abstract | |
1:25 PM - 1:30 PM | Discussion |
1:30 PM - 1:45 PM | A Randomized Controlled Trial To Evaluate An Antimicrobial Dressing With Silver Alginate Powder For The Management Of Chronic Wounds Exhibiting Signs Of Critical Colonization |
Presenter(s):R. Gary Sibbald, MD | |
View Abstract | |
1:45 PM - 1:50 PM | Discussion |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
x | |
1:50 PM - 2:10 PM | Improvement In Revascularization Techniques, Good Awareness In Offloading The Foot, Amazing New Antibiotics: Why Do We Still Amputate? |
Presenter(s):Michael E. Edmonds, MD | |
View Abstract | |
2:10 PM - 2:20 PM | Discussion |
2:20 PM - 2:40 PM | How To Choose An Offloading Method: The Importance Of Patients’ Compliance And Physicians’ Knowledge |
Presenter(s):Thomas Boeni, MD | |
2:40 PM - 2:50 PM | Discussion |
2:50 PM - 3:00 PM | Dermal Substitutes: Is There An Indication For Patients With Diabetic Foot Ulcers? |
Presenter(s):Lee C. Rogers, DPM | |
3:00 PM - 3:10 PM | Discussion |
3:10 PM - 3:20 PM | Achilles Tendon Complete Tenotomy: Complete Or Partial? |
Presenter(s):Wayne J. Caputo, DPM | |
View Abstract | |
3:20 PM - 3:30 PM | Discussion |
3:30 PM - 4:00 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
x | |
4:00 PM - 4:10 PM | Following Revascularization For Toe Gangrene: Await Auto-Amputation Or Chop It? |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
4:10 PM - 4:20 PM | Discussion |
4:20 PM - 4:30 PM | Angiosome Revascularization And Wound Healing; Fact Or Fiction? |
Presenter(s):Hisham Rashid, FRCS, FRCS (Gen) | |
View Abstract | |
4:30 PM - 4:40 PM | Discussion |
4:40 PM - 4:50 PM | The Importance Of Blood Flow For The Podiatric Physician |
Presenter(s):Marc A. Brenner, DPM | |
View Abstract | |
4:50 PM - 5:00 PM | Discussion |
5:00 PM - 5:10 PM | Do Drug Eluting Balloons And Stents Promise Anything Extra Compared To Plain Old Balloon Angioplasty For Wound Patients? |
Presenter(s):Robert J. Hinchliffe, MD | |
View Abstract | |
5:10 PM - 5:20 PM | Discussion |
5:20 PM - 5:30 PM | Alloplastic Bypass Material Below The Knee: Actual Rationale In Patients With Wounds |
Presenter(s):Sebastian E. Debus, MD, PhD | |
View Abstract | |
5:30 PM - 5:40 PM | Discussion |
5:40 PM - 5:50 PM | Potential Predictors For Success Of Open Or Endo Revascularization For Wound Patients |
Presenter(s):Joseph L. Mills, MD | |
View Abstract | |
5:50 PM - 6:00 PM | Discussion |
6:00 PM - 6:05 PM | Closing Remarks |
Presenter(s):Dieter O. Mayer, MD | |
6:05 PM - 6:05 PM | Adjourn |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Tuesday
SESSION 19:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
Moderators:TBD
|
|
x | |
PART 1A: IN THE BEGINNING . . . WHERE THE STROKE CASCADE EVOLVES | |
Moderator(s): Allan L. Brook, MD / Joshua A. Hirsch, MD | |
8:00 AM - 8:07 AM | Anatomic Moment: Intracranial Vertebral Artery And Its Implications |
Presenter(s):Lou Caplan, MD | |
View Abstract | |
8:08 AM - 8:15 AM | EMS And Cooperation Makes A Difference |
Presenter(s):Bradley Kaufman, MD, MPH | |
View Abstract | |
8:16 AM - 8:23 AM | Emergency Room Stroke Triage Issues |
Presenter(s):David Esses, MD | |
View Abstract | |
8:24 AM - 8:31 AM | TIAs: Rapid Diagnosis And Therapy |
Presenter(s):David S. Liebeskind, MD | |
View Abstract | |
8:32 AM - 8:39 AM | IV vs. IA: Priorities For Revascularization In Acute Ischemic Stroke |
Presenter(s):David S. Liebeskind, MD | |
View Abstract | |
8:40 AM - 8:47 AM | The Next Big Thing In Stroke |
Presenter(s):Joseph P. Broderick, MD | |
View Abstract | |
8:48 AM - 8:55 AM | Door To Revascularization Time: Optimization And How We Mimic Cardiology’s Excellence |
Presenter(s):Mayank Goyal, MD, FRCPC | |
View Abstract | |
8:56 AM - 9:00 AM | Questions And Answers |
PART B: IMAGING: THE BEST IS STILL TO COME… EXCITING FUTURE: A LOOK INTO 21ST CENTURY RESEARCH | |
Moderator(s): Don Frei, MD / R. Gilberto Gonzalez, MD, PhD | |
9:01 AM - 9:08 AM | What Have We Learned From The Stroke Latest Trials – SYNTHESIS, MR RESCUE, et al. |
Presenter(s):Lawrence Wechsler, MD | |
View Abstract | |
9:09 AM - 9:16 AM | Optimizing Imaging In Acute Stroke: Balancing Time vs. Information |
Presenter(s):Mayank Goyal, MD, FRCPC | |
View Abstract | |
9:17 AM - 9:24 AM | My Quick Stroke Protocol And Why |
Presenter(s):Howard A. Rowley, MD | |
View Abstract | |
9:25 AM - 9:32 AM | Perfusion Parameters That Matter Most For Triage And Outcomes |
Presenter(s):Colin P. Derdeyn, MD | |
View Abstract | |
9:33 AM - 9:40 AM | Imaging Of Collaterals And Implications For Safe Revascularization |
Presenter(s):Don Frei, MD | |
View Abstract | |
9:41 AM - 9:48 AM | Stroke Genomics: Part 1 |
Presenter(s):Mark F. Mehler, MD | |
View Abstract | |
9:49 AM - 9:56 AM | Stroke Genomics: Part II |
Presenter(s):Mark F. Mehler, MD | |
9:57 AM - 10:04 AM | Stroke Imaging: Where Do We Stand Today |
Presenter(s): R. Gilberto Gonzalez, MD, PhD | |
View Abstract | |
10:05 AM - 10:12 AM | Application Of Nanotechnology To Stroke Imaging And Therapy |
Presenter(s):James Provenzale, MD, FACR | |
View Abstract | |
10:13 AM - 10:20 AM | Stem Cell Therapy For Stroke |
Presenter(s):Sean I. Savitz, MD | |
View Abstract | |
10:20 AM - 10:30 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1C: PRACTICE BUILDING, PLANNING AND THE QUALITY TEAM APPROACH | |
Moderator(s): Lawrence Wechsler, MD / David Gordon, MD | |
10:31 AM - 10:38 AM | Building Blocks For A Stroke Center Of Excellence: How And Why |
Presenter(s):Peter A. Rasmussen, MD | |
View Abstract | |
10:39 AM - 10:46 AM | Intricacies In Developing A Comprehensive Stroke Center |
Presenter(s):Steven H. Rudolph, MD | |
View Abstract | |
10:47 AM - 10:54 AM | Stroke Units Benefits: Is There Evidence |
Presenter(s):Daniel L. Labovitz, MD | |
View Abstract | |
10:55 AM - 11:02 AM | Anesthetic Management Of Endovascular Treatment Of Acute Ischemic Stroke |
Presenter(s):Zirka H. Anastasian, MD | |
View Abstract | |
11:03 AM - 11:10 AM | Major Trial Futility And Implications For Payment And Care Paradigm Shifts |
Presenter(s):Peter A. Rasmussen, MD | |
View Abstract | |
11:11 AM - 11:20 AM | Endovascular Simulation: A Necessary Evil Or A Teaching Tool And Team Building Exercise That Pays Dividends |
Presenter(s):Allan L. Brook, MD | |
View Abstract | |
11:21 AM - 11:28 AM | Endovascular vs. Conventional Neurosurgery: An ACO’s Perspective |
Presenter(s):Todd S. Miller, MD | |
View Abstract | |
11:29 AM - 11:36 AM | Neurology As The Forefront To Success In Stroke Treatment: My Opinion |
Presenter(s):Osama O. Zaidat, MD | |
View Abstract | |
11:37 AM - 11:44 AM | Neuro Anesthesia In The Endovascular World: General vs. Local – When And Why |
Presenter(s):Apolonia E. Abramowicz, MD | |
View Abstract | |
11:45 AM - 11:52 AM | Is It Stent-Retrievers, Or The Next Generation Device, Or Is It Treating 0-3 Hours That Will Make The Difference And Why |
Presenter(s):Colin P. Derdeyn, MD | |
View Abstract | |
11:52 AM - 12:00 PM | Critical Care, Quality Improvement And Patient Outcomes |
Presenter(s):Howard A. Riina, MD | |
View Abstract | |
12:01 PM - 12:15 PM | IMS III: Lessons Learned |
Presenter(s):Joseph P. Broderick, MD | |
View Abstract | |
12:15 PM - 1:14 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Tuesday
SESSION 20:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 2
Moderators:TBD
|
|
x | |
PART 2A: IMS, ARUBA, SAMMPRIS, CREST IS THE BEST, BUT. . . | |
Moderator(s): Joshua A. Hirsch, MD / Don Frei, MD | |
1:15 PM - 1:22 PM | The Future Of Stroke Trials And Practical Points Given Recent Trial Outcomes |
Presenter(s):Marc I. Chimowitz, MBChB | |
View Abstract | |
1:23 PM - 1:30 PM | Carotid Artery Treatment: My Pearls And Summary After Attending Every Conference On Every Continent |
Presenter(s):Frank J. Veith, MD | |
View Abstract | |
1:31 PM - 1:38 PM | CREST: What Have We Learned And What Is Next |
Presenter(s):Thomas G. Brott, MD | |
View Abstract | |
1:39 PM - 1:46 PM | The Cervical Approach To CAS: A Game Changer |
Presenter(s):Patrice F. Bergeron, MD | |
View Abstract | |
1:47 PM - 1:54 PM | Acute Carotid Stenting Combined With Embolectomy |
Presenter(s):Don Heck, MD | |
View Abstract | |
1:55 PM - 2:02 PM | ARUBA Endovascular: Lessons Not Learned And Why |
Presenter(s):Aman B. Patel, MD | |
View Abstract | |
2:03 PM - 2:10 PM | Neurosurgical Opinion On Treatment Of Arteriovenous Malformations |
Presenter(s):Aman B. Patel, MD | |
2:11 PM - 2:21 PM | Questions And Answers |
PART 2B: HEMORRHAGIC STROKE ISSUES OF THE 21ST CENTURY | |
Moderator(s): Philip M. Meyers, MD / Allan L. Brook, MD | |
2:22 PM - 2:29 PM | Venous Hypertension, Sinus Thrombosis Diagnosis And Treatment Paradigms |
Presenter(s):Ilan Shelef, MD | |
View Abstract | |
2:30 PM - 2:37 PM | Pitfalls In The ICU Management Of Aneurysmal SAH |
Presenter(s):Rishi Malhotra, MD | |
View Abstract | |
2:38 PM - 2:45 PM | Spinal Dural Arterial Venous Fistulas: Presentations And Treatment Options |
Presenter(s):Athos Patsalides, MD, MPH | |
View Abstract | |
2:46 PM - 2:53 PM | Multidisciplinary Teams In The OR, Endovascular Suite, And HYBRID Arena: My Experience |
Presenter(s):Peter A. Rasmussen, MD | |
View Abstract | |
2:54 PM - 3:01 PM | Carotid Blow Out: Indications For Treatment And Technical Pearls |
Presenter(s):Gregg H. Zoarski, MD | |
View Abstract | |
3:02 PM - 3:09 PM | Unruptured Aneurysms: When I Recommend Treatment And Why |
Presenter(s):Philip M. Meyers, MD | |
View Abstract | |
3:10 PM - 3:17 PM | Neurosurgical Bypass: Indications And Techniques: What The Angiographer Needs To Identify |
Presenter(s):David J. Langer, MD | |
3:18 PM - 3:25 PM | Medical Legal Issues In The Stroke World And How They Have Evolved |
Presenter(s):Michael I. Weintraub, MD | |
View Abstract | |
3:26 PM - 3:33 PM | Balloons vs. Stent And Coils For Wide Necked Aneurysms Not Meeting Flow Diversion Criteria: My Approach |
Presenter(s):Peter K. Nelson, MD | |
View Abstract | |
3:34 PM - 3:41 PM | Managing Complications In The Endovascular Suite |
Presenter(s):J Mocco, MD, MS | |
View Abstract | |
3:42 PM - 3:49 PM | A Cost Effective Evaluation Analysis Of IV And Thrombolysis |
Presenter(s):Ansaar Rai, MD | |
View Abstract | |
3:50 PM - 3:57 PM | Pipeline European Experience And Avoiding Complications |
Presenter(s):Peter K. Nelson, MD | |
View Abstract | |
3:58 PM - 4:05 PM | Endovascular Treatment Strategies For Small Aneurysms: Is Flow Diverting The Final Step |
Presenter(s):David Fiorella, MD | |
View Abstract | |
4:06 PM - 4:13 PM | Radial Artery Access: Pros, Cons And Practical Points |
Presenter(s):David D. Pasquale, MD | |
View Abstract | |
4:14 PM - 4:21 PM | Latest Technology In Flow Diversion |
Presenter(s):Pedro Lylyk, MD | |
View Abstract | |
4:22 PM - 4:29 PM | The Hoover Maneuver: Sucking Clot Out vs. Stent Retrievers – Pros And Cons |
Presenter(s):Jeffrey Farkas, MD | |
View Abstract | |
4:30 PM - 4:50 PM | Questions And Answers |
END OF SESSION 20 | |
Wednesday, November 20, 2013
Print Entire 2013 Program:
|
|
SESSION 21 SCHEDULE | |
Wednesday
SESSION 21:
PROGRESS IN TRANSCATHETER HEART VALVES AND NEW APPROACHES TO THE ASCENDING AORTA
|
|
x | |
6:45 AM - 6:49 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:49 AM - 6:54 AM | Update On New Endovascular Techniques For Mitral Valve Repair: Status Of The MitraClip, Its Trials (EVEREST II And COAPT) And With The FDA |
Presenter(s):Ted Feldman, MD | |
View Abstract | |
6:55 AM - 7:00 AM | Vascular Access Complications Are A Major Determinant Of Outcomes After TAVR: What Can Be Done To Decrease These Complications |
Presenter(s):Patrice B. Mwipatayi, FRACS | |
7:01 AM - 7:06 AM | DEBATE:Update On Transcatheter Aortic Valve Replacement (TAVR): Results, Device Improvement And Future Outlook: An Interventional Cardiologist’s View |
Presenter(s):Ted Feldman, MD | |
7:07 AM - 7:12 AM | DEBATE:Update On Transcatheter Aortic Valve Replacement (TAVR): A Cardiac Surgeon’s View Of Its Role In 2013 And The Future |
Presenter(s):Erno Remsey-Semmelweis, MD, PhD | |
View Abstract | |
7:13 AM - 7:18 AM | Valve-In-Valve Procedures For Failed Aortic Valve Repairs |
Presenter(s):Ron Waksman, MD | |
7:19 AM - 7:24 AM | Valve-In-Valve Procedures After Failed Mitral Valve Repairs |
Presenter(s):Dietmar H. Koschyk, MD | |
View Abstract | |
7:25 AM - 7:30 AM | Second Generation Devices For TAVR: What Are The Improvements And Will They Help Outcomes |
Presenter(s):Ted Feldman, MD | |
7:31 AM - 7:36 AM | Why And How Stent-Grafts Will Replace Open Surgery For Ascending Aortic Lesions |
Presenter(s):Matt M. Thompson, MD | |
7:37 AM - 7:42 AM | Endovascular Treatment Of Ischemic Complications After Surgical Treatment Of Type A Aortic Dissections |
Presenter(s):Burkhart Zipfel, MD | |
7:43 AM - 7:48 AM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Wednesday
SESSION 22:
NEW DEVELOPMENTS IN TREATMENT OF THE AORTIC ARCH AND AORTIC DISSECTIONS
Moderators:Juan C. Parodi, MD / Matt M. Thompson, MD
|
|
x | |
7:48 AM - 7:53 AM | Results Of Aortic Arch Repair By TEVAR With The Cook Internally Branched Device |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
7:54 AM - 7:59 AM | Total Arch Repair With A Novel Branched Endograft: Promising Results With Complicated Arch Dissections Involving Arch Branches: How Does The Graft Work |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
8:00 AM - 8:05 AM | Bolton Branched Endograft Device For Aortic Arch Repair: Early And Mid-Term Results |
Presenter(s):Toru Kuratani, MD, PhD | |
8:06 AM - 8:11 AM | A New Branched Arch Endograft Introduced Antegrade Via A Transapical Access Without Direct Branch Access: How Does It Work |
Presenter(s):Tilo Koelbel, MD, PhD | |
8:12 AM - 8:17 AM | Adjunctive Techniques For Treating Arch Disease: Precurved Fenestrated Graft With Branches And Buffalo Horn Chimney Stents |
Presenter(s):Yoshihiko Yokoi, MD | |
View Abstract | |
8:18 AM - 8:23 AM | Endovascular Techniques For Treating Aortic Arch Lesions |
Presenter(s):Piotr M. Kasprzak, MD | |
8:24 AM - 8:29 AM | Adjunctive Techniques To Facilitate Endovascular Repair Of Aortic Dissection With A Tear And Involvement Of The Arch And Its Branches: Hybrid Repairs And Chimneys |
Presenter(s):Chang Shu, MD | |
8:30 AM - 8:35 AM | Prevention, Diagnosis And Treatment Of Retrograde Dissection After TEVAR |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
8:36 AM - 8:41 AM | How To Improve Endograft Conformability In The Aortic Arch With TEVAR |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
8:42 AM - 8:47 AM | Reinterventions For Late Endograft Migration After TEVAR In The Aortic Arch |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
8:48 AM - 8:54 AM | Panel Discussion |
END OF SESSION 22 | |
SESSION 23 SCHEDULE | |
Wednesday
SESSION 23:
PROGRESS IN TREATING DISEASES OF THE THORACIC AORTA, INCLUDING TYPE B AORTIC DISSECTIONS (TBADs)
Moderators:Michael D. Dake, MD / Rodney A. White, MD
|
|
x | |
8:55 AM - 9:01 AM | DEBATE: Value Of Medical Therapy For Uncomplicated TBAD: It Is Best For Most |
Presenter(s):Dittmar Boeckler, MD | |
9:02 AM - 9:07 AM | DEBATE: Value Of Medical Therapy For Uncomplicated TBAD: It Is Best For Few: TEVAR Is Best For Most |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
9:08 AM - 9:13 AM | Which Uncomplicated TBAD Should Be Treated By TEVAR And Which By Best Medical Therapy (BMT) |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
9:14 AM - 9:19 AM | Treatment Of Uncomplicated TBADs: 25% Develop Problems: Factors Predicting Which Patients Will Develop Complication So They Can Get Early TEVAR |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
9:20 AM - 9:25 AM | The Surgical Standard For TBADs: When Is Open Surgery The Best Treatment |
Presenter(s):Hazim J. Safi, MD | |
9:26 AM - 9:31 AM | TEVAR Can Be Effective Treatment For Chronic TBADs: For How Long After The Initial Dissection |
Presenter(s):Toru Kuratani, MD, PhD | |
9:32 AM - 9:37 AM | With Acute Complicated TBADs Late Aortic False Lumen Remodeling Persists In The Stented Segment But Not In The Aorta Below That: TEVAR Does Not Prevent Aneurysmal Degeneration |
Presenter(s):Mark Conrad, MD / Richard P. Cambria, MD | |
9:38 AM - 9:43 AM | Endovascular Options In Aortic Dissection When TEVAR Coverage Of The Primary Tear Fails To Obliterate The False Lumen |
Presenter(s):Peter J. Mossop, MBBS | |
9:44 AM - 9:49 AM | Two New Techniques To Occlude Distal False Lumen Back Flow In Chronic TBADs: Plugging Can Work Even With Rupture |
Presenter(s):Tilo Koelbel, MD, PhD / Sebastian E. Debus, MD, PhD | |
9:50 AM - 9:55 AM | Next Frontier For TEVAR And Aortic Dissection Treatment Using An Onlay Aortic Patch |
Presenter(s):Hans Krankenberg, MD | |
9:56 AM - 10:03 AM | Panel Discussion |
10:03 AM - 10:20 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN TEVAR AND EVAR
Moderators:Edward B. Diethrich, MD / Ronald M. Fairman, MD
|
|
x | |
10:20 AM - 10:25 AM | Optimizing TEVAR Outcomes By Applying The Results Of The MOTHER Registry To Clinical Practice |
Presenter(s):Matt M. Thompson, MD | |
10:26 AM - 10:31 AM | New Insights From The INSTEAD Trial And The IRAD Registry: How Do They Change Our Understanding Of TBADs And Their Treatment |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
10:32 AM - 10:37 AM | Progress In The Treatment Of Visceral Ischemia From Acute TBAD |
Presenter(s):Timur P. Sarac, MD | |
10:38 AM - 10:43 AM | Endovascular Repair For Acute TBAD With Visceral Ischemia Is Successful And Durable |
Presenter(s):Chang Shu, MD | |
10:44 AM - 10:49 AM | What Are The Risk Factors For Paraplegia After TEVAR And What Can Be Done To Offset Them |
Presenter(s):Wei Guo Fu, MD | |
View Abstract | |
10:50 AM - 10:55 AM | What Causes Death In Patients With Uncomplicated TBAD: How Should That Influence Our Treatment |
Presenter(s):Rodney A. White, MD | |
10:56 AM - 11:01 AM | When Does LSA Revascularization Matter: A Selective Approach Is Best Even Though The SVS Guidelines Don’t Agree |
Presenter(s):Matt M. Thompson, MD | |
11:02 AM - 11:07 AM | LSA Transposition And Bypass In Association With TEVAR Are Not Benign Procedures Although They Have Durable Patency |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
11:08 AM - 11:13 AM | Routine Revascularization Of The Left Subclavian Artery (LSA) For All Zone 2 TEVARs Is Both Unnecessary And Harmful |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
11:14 AM - 11:19 AM | Aortic Arch Debranching Is Not A Simple Procedure: Tips And Tricks For Doing It Right |
Presenter(s):William J. Quinones-Baldrich, MD | |
11:20 AM - 11:25 AM | Challenges And Solutions For Multiple Arch Pathologies |
Presenter(s):Dittmar Boeckler, MD | |
11:26 AM - 11:31 AM | In The Ongoing Transition From Open Repair To EVAR With Thoracoabdominal Aneurysms (TAAAs): What Situations And Lesions Still Are Best Treated By Open Surgery |
Presenter(s):Michael J. Jacobs, MD | |
11:32 AM - 11:37 AM | How To Pick Patients With Uncomplicated Acute Type B Aortic Dissection Who Are Best Treated By TEVAR |
Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS | |
View Abstract | |
11:38 AM - 11:43 AM | With EVAR And TEVAR Does The Choice Of Graft Affect Arterial Stiffness And Post-Implantation Syndrome: Is There Any Clinical Significance |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
11:44 AM - 11:49 AM | EVAR Durability: Should It Be An Issue With Newer Endografts For AAA Repair |
Presenter(s):Giovanni Pratesi, MD | |
11:50 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Wednesday
SESSION 25:
MORE TOPICS RELATING TO ABDOMINAL AND THORACIC AORTIC LESIONS
Moderators:Timur P. Sarac, MD / Michel Makaroun, MD
|
|
x | |
1:00 PM - 1:05 PM | DEBATE: AAA Repair Is Justified In Patients With Chronic Renal Insufficiency: Which Is Better, EVAR Or Open Repair (OR) |
Presenter(s):Anton N. Sidawy, MD, MPH | |
1:06 PM - 1:11 PM | DEBATE: AAA Repair Is Not Justified In Dialysis (ESRD) Patients: Outcomes Of EVAR And OR Don’t Justify It |
Presenter(s):Rabih A. Chaer, MD | |
1:12 PM - 1:17 PM | AAAs Are A Systemic Disease And Therefore Progressive By Nature: What Are The Clinical Implications |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
1:18 PM - 1:23 PM | Is There Still A Role For Abdominal Debranching Procedures: What Is It |
Presenter(s):Ronald M. Fairman, MD | |
1:24 PM - 1:29 PM | TEVAR For Acute TBAD Patients Should Be Restricted To Symptomatic Patients And Those With Complications: Based On The Updated ADSORB Trial And Other Data |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
1:30 PM - 1:35 PM | DEBATE: Adventa V 12 Covered Stents (Atrium) Is Best For Treating Aortic Coarctations: Can They Be Used In All Settings |
Presenter(s):Elchanan Bruckheimer, MBBS | |
1:36 PM - 1:41 PM | DEBATE: Bare Stent Protected PTA Is Better For Most Aortic Coarctations And Produce Good Long-Term Results |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
1:42 PM - 1:47 PM | DEBATE: Open Surgical Treatment Is Best For Patients With Aortic Coarctations: Which Ones |
Presenter(s):Joseph S. Coselli, MD | |
1:48 PM - 1:53 PM | Panel Discussion |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Wednesday
SESSION 26:
CRITICAL EVALUATION OF CAROTID TREATMENT – ACUTE STROKES AND CAROTID ARTERY STENTING (CAS) AS OF NOVEMBER 2013: WHERE ARE THEY GOING
Moderators:Thomas S. Riles, MD / Frank J. Veith, MD
|
|
x | |
STATUS OF ACUTE STROKE TREATMENT | |
1:54 PM - 1:59 PM | How Well Are The New Endovascular Devices Working For Treatment Of Acute Strokes: Why The Negative Results Of The Recent Trials (MR RESCUE, IMS And SYNTHESIS XP) With The Solitaire, Trevo, Merci And Penumbra Devices May Not Be The Last Word |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
2:00 PM - 2:05 PM | Who Could (And Should) Perform Acute Stroke Interventions |
Presenter(s):Horst Sievert, MD | |
2:06 PM - 2:11 PM | Update On Endovascular Techniques And Results Of Carotid And Cerebral Artery Thrombectomy For Acute Strokes: How It Can Be Done Safely And Effectively And What Is The Risk: Experience In >150 Patients |
Presenter(s):Klaus D. Mathias, MD | |
STATUS OF CAROTID ARTERY STENTING (CAS) | |
2:12 PM - 2:17 PM | Improved Technology For CAS Will Improve CAS Outcomes: Why Membrane/Mesh Covered Stents And Flow Reversal Will Make A Difference: What Is Their Status |
Presenter(s):Claudio J. Schonholz, MD | |
2:18 PM - 2:23 PM | DEBATE: CREST Justifies Increased Usage Of CAS For Symptomatic And Asymptomatic Patients With Carotid Stenosis |
Presenter(s):William A. Gray, MD | |
2:24 PM - 2:29 PM | DEBATE: Nonsense: CREST Does Not Justify Increased Usage Of CAS For Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Michel Makaroun, MD | |
2:30 PM - 2:35 PM | What Is The Real Meaning Of Minor Strokes As Defined In CREST: Do They Matter More Than A Minor MI |
Presenter(s):Emmanuel M. Houdart, MD | |
2:36 PM - 2:41 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CEA Is Best And Does Not Increase Procedural Risk |
Presenter(s):A. Ross Naylor, MD, FRCS | |
2:42 PM - 2:47 PM | DEBATE: How Should Recently Symptomatic Patients Be Treated: Urgent CAS Is Best And Can Be Done Safely |
Presenter(s):Barry T. Katzen, MD | |
2:48 PM - 2:53 PM | What Is The Best Current Treatment For Recently Symptomatic Carotid Stenosis: CAS Or CEA: Based On Combined Data From RCTs |
Presenter(s):Gustav Fraedrich, MD | |
ASYMPTOMATIC CAROTID STENOSIS | |
2:54 PM - 2:59 PM | DEBATE: Few If Any Patients Benefit From CEA Or CAS For Asymptomatic Carotid Stenosis In The Properly Used Statin Era |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
3:00 PM - 3:05 PM | DEBATE: Not So! Many Asymptomatic Carotid Stenosis Patients Benefit From CAS And CEA: Which Ones |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
3:06 PM - 3:11 PM | Asymptomatic Carotid Stenosis Can Progress And Become Symptomatic In A Substantial Proportion Of Patients |
Presenter(s):Richard P. Cambria, MD / Glenn M. LaMuraglia, MD / Mark Conrad, MD | |
3:12 PM - 3:17 PM | New Insights Into Selecting Asymptomatic Carotid Stenosis Patients At High Stroke Risk Who Should Have CAS Or CEA: The Importance Of Juxtaluminal Black Areas (JBAs) |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Abstract | |
3:18 PM - 3:23 PM | How To Pick High Risk Asymptomatic Carotid Stenosis Patients For CAS Or CEA: The Importance Of Transcranial Doppler Hits |
Presenter(s):J. David Spence, MD | |
View Abstract | |
3:24 PM - 3:29 PM | How To Pick Asymptomatic Carotid Stenosis Patients For CAS: What Percentage Of All Asymptomatic High Grade Lesions Should Be Treated |
Presenter(s):Sriram S. Iyer, MD | |
3:30 PM - 3:40 PM | Panel Discussion |
3:40 PM - 4:00 PM | Break - 40th Anniversary Celebration (Cocktails Will Be Served)Rhinelander Gallery (2nd Floor) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Wednesday
SESSION 27:
NEW INFORMATION ON RENAL DENERVATION AND INTERVENTIONAL
Moderators:Bruce A. Perler, MD, MBA / Frank J. Veith, MD
|
|
x | |
RENAL DENERVATION | |
4:00 PM - 4:05 PM | How Does Sympathetic Denervation By Endovascular Renal Artery Radiofrequency Ablation Work |
Presenter(s):John W. Osborn, PhD | |
View Abstract | |
4:06 PM - 4:11 PM | What Does Renal Denervation Do For Drug Resistant Hypertension And Other Conditions: Diabetes, Heart Disease And Arrhythmias |
Presenter(s):Michael R. Jaff, DO | |
4:12 PM - 4:17 PM | Innovative Approaches To Renal Denervation: What Are The Old And New Devices: Are There Differences |
Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD | |
4:18 PM - 4:23 PM | What Is The Target In Renal Denervation: Why Is The Artery Not Damaged Or Is It |
Presenter(s):Renu Virmani, MD | |
4:24 PM - 4:29 PM | Surgical Denervation Of The Renal Arteries Treats Resistant Hypertension Effectively: Surgeons Should Perform Renal Denervation Procedures – Endovascular And Open |
Presenter(s):Juan C. Parodi, MD | |
4:30 PM - 4:35 PM | Panel Discussion |
THE CCSVI AND MS CONTROVERSY | |
Moderator(s): L. Nelson Hopkins, MD / Frank J. Veith, MD | |
4:35 PM - 4:40 PM | What New Information Supports The Effectiveness Of Treating CCSVI In MS Patients |
Presenter(s):Paolo Zamboni, MD / Francesco Mascoli, MD | |
4:41 PM - 4:46 PM | CCSVI Treatment Helps Some MS Patients: What We Know And What We Do Not Know: Is A Randomized Trial In The Works |
Presenter(s):Michael D. Dake, MD | |
4:47 PM - 4:52 PM | What Is The Evidence That Balloon Venoplasty Is Effective Treatment In Patients With CCSVI And MS |
Presenter(s):Donald B. Reid, MD | |
4:53 PM - 4:58 PM | DEBATE: Clinical Experience Supports The Value Of Venous Balloon Angioplasty For Many MS Patients: RCTs Will Be Impossible |
Presenter(s):Ivo Petrov, MD, PhD | |
4:59 PM - 5:04 PM | DEBATE: Skepticism Is Healthy In This Area: The Evidence To Date Is Weak And Unconvincing |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
5:05 PM - 5:10 PM | Venous Balloon Angioplasty For MS Makes No Sense: Any Benefit Is Due To A Placebo Effect And The Nature Of The Disease |
Presenter(s):Emmanuel M. Houdart, MD | |
5:11 PM - 5:16 PM | Another Negative View On The Value Of Interventional Treatment For MS: The Supporting Evidence Is Too Weak |
Presenter(s):Jean-Baptiste Ricco, MD, PhD / Jim Reekers, MD, PhD | |
5:17 PM - 5:22 PM | Does Venous Balloon Angioplasty Help Patients With CSVI: Early Results Of A RCT Cast Doubt: When Will We Know |
Presenter(s):Robert Zivadinov, MD, PhD, FAAN | |
View Abstract | |
5:23 PM - 5:28 PM | Panel Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Wednesday
SESSION 28:
MORE CAROTID TOPICS
Moderators:Daniel G. Clair, MD / Jean-Baptiste Ricco, MD, PhD
|
|
x | |
5:28 PM - 5:33 PM | Asymptomatic Lesions In Diffusion Weighted (DW) And Flair MRI: What Are The Real Implications |
Presenter(s):Jörn O. Balzer, MD, PhD | |
5:34 PM - 5:39 PM | Management Of Complications During And After CAS: How Important Is It And Tips And Tricks For Doing It |
Presenter(s):Klaus D. Mathias, MD | |
5:40 PM - 5:45 PM | Reversal Of A Longstanding Major Neurological Deficit By Improving Carotid Flow With CAS |
Presenter(s):Robert M. Bersin, MD | |
5:46 PM - 5:51 PM | Emergency CEA For Patients With Stroke In Evolution: When Is It Indicated And How Should It Be Performed |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
5:52 PM - 5:57 PM | How Can Computerized Duplex Ultrasound Identify Unstable Risky Plaques In Asymptomatic Carotid Stenosis Patients |
Presenter(s):A. Ross Naylor, MD, FRCS | |
5:58 PM - 6:03 PM | What Is Current Best Medical Therapy: What Does It Do To Carotid Plaques And Do Patients Accept It And Comply With It |
Presenter(s):J. David Spence, MD | |
View Abstract | |
6:04 PM - 6:09 PM | How Bad And Persistent Were The Cranial Nerve Deficits In CREST |
Presenter(s):Robert J. Hye, MD / Ariane Mackey, MD / Thomas G. Brott, MD | |
6:10 PM - 6:15 PM | For Radiation Induced Symptomatic Carotid Stenosis, What Is The Best Treatment: CAS Or CEA |
Presenter(s):Frans L. Moll, MD, PhD | |
6:16 PM - 6:25 PM | Panel Discussion End of Program A |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Wednesday
SESSION 29:
LOWER EXTREMITY OCCLUSIVE DISEASE – HOT TOPICS I
Moderators:Enrico Ascher, MD / Keith D. Calligaro, MD
|
|
x | |
6:50 AM - 6:54 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:54 AM - 6:59 AM | Status Of Tibial Interventions In The US: Role Of Balloons, Bare Metal Stents (BMS) And Drug Eluting Stents (DES) |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
7:00 AM - 7:05 AM | In The US, For CLI Endovascular First Is Not Cost Effective And For Long SFA Lesions Open Bypass Is Best |
Presenter(s):Firas F. Mussa, MD | |
7:06 AM - 7:11 AM | New Recent Advances And Adjuncts To Prevent Radiocontrast Nephropathy After Endovascular Treatments Under Fluoroscopic Guidance |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
7:12 AM - 7:17 AM | Efficacy Of Atherectomy And Drug Eluting Balloons (DEBs): Where Is This Best: Based On The DEFINITIVE AR Trial |
Presenter(s):Gunnar Tepe, MD | |
7:18 AM - 7:23 AM | New Techniques For Below-The-Knee (BTK) Endo Procedures Including The OFFROAD Device To Facilitate Re-Entry After Subintimal Wire Passage |
Presenter(s):Andrej Schmidt, MD | |
7:24 AM - 7:29 AM | Less Invasive Interventions With 4 French Systems Like The Astron Pulsar Stent: The 4 EVER Trial Final Results: Closure Devices Are Not Needed |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
7:30 AM - 7:35 AM | DEBATE: For BTK Occlusive Lesions Subintimal Wire Passage Works And Is Best |
Presenter(s):Amman Bolia, MD | |
View Abstract | |
7:36 AM - 7:41 AM | DEBATE: For BTK Occlusive Lesions Subintimal Wire Passage Has Pros And Cons |
Presenter(s):Roberto Ferraresi, MD | |
7:42 AM - 7:47 AM | Interventions In The Pedal Arch: When And How, Including Retrograde Digital Artery Puncture: Limitations And Results |
Presenter(s):Mariano Palena, MD / Marco G. Manzi, MD | |
7:48 AM - 7:53 AM | How To Make Transtibial And Transpedal Access Work In The US |
Presenter(s):Brian G. DeRubertis, MD | |
7:54 AM - 7:59 AM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Wednesday
SESSION 30:
LOWER EXTREMITY OCCLUSIVE DISEASE – HOT TOPICS II
Moderators:Mark H. Wholey, MD / Joseph L. Mills, MD
|
|
x | |
8:00 AM - 8:05 AM | DEBATE: With CLI, Bypasses Are Never Indicated First: Are They Ever Needed |
Presenter(s):Craig M. Walker, MD | |
8:06 AM - 8:11 AM | DEBATE: There Are CLI Patients Who Cannot Or Should Not Be Treated Endovascularly: Who Are They |
Presenter(s):George H. Meier III, MD | |
8:12 AM - 8:17 AM | There Is A Major Role For Open Distal Bypass Operations To Salvage CLI Limbs After Failed Endovascular Interventions |
Presenter(s):Frank B. Pomposelli, MD | |
8:18 AM - 8:23 AM | Value And Effectiveness Of The In.Pact Drug Eluting Balloon (DEB) In Treating BTK Arteries For CLI |
Presenter(s):Andrej Schmidt, MD | |
8:24 AM - 8:29 AM | DEBATE: DEBs And DESs (Zilver PTX) Are Equally Good For Long Fem-Pop Lesions But DES Are Better For Long Infrapopliteal Lesions |
Presenter(s):Thomas Zeller, MD | |
8:30 AM - 8:35 AM | DEBATE: DEBs Are As Good As DES: How To Choose Based On Lesion Length, Location, Etc: Results Of The REAL Trial |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
8:36 AM - 8:41 AM | Value Of DEBs (Paclitaxil) vs. Uncoated Balloons After SFA Nitinol Stenting – The FREEWAY Multicenter RCT: What Are The Cost Implications |
Presenter(s):Stefan Mueller-Huelsbeck, MD | |
View Abstract | |
8:42 AM - 8:47 AM | Plain Old Balloon Angioplasty (POBA) Is Best For CLI For Infrapopliteal Disease: Do It Right And Don’t Replace It With Other Techniques Like DEBs Or DESs Which May Be Unsuitable And More Costly |
Presenter(s):Iris Baumgartner, MD | |
8:48 AM - 8:53 AM | Are There Negative Consequences To Extreme Or Overly Persistent Endovascular Treatments For CLI |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
8:54 AM - 9:00 AM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Wednesday
SESSION 31:
LOWER EXTREMITY OCCLUSIVE DISEASE - HOT TOPICS III
Moderators:Giancarlo Biamino, MD, PhD / Michael S. Conte, MD
|
|
x | |
9:00 AM - 9:05 AM | Long-Term Results With Drug Eluting Balloons (DEBs) Are Favorable And Show That DEBs Can Eliminate The Need For Stents – Even When PTA Causes Substantial Dissection |
Presenter(s):Gunnar Tepe, MD | |
9:06 AM - 9:11 AM | Final Results Of The DEBATE Randomized Trials (BK And SFA) Of DEBs In Diabetics With CLI: DEBs Are Effective But Are All DEBs Equal |
Presenter(s):Francesco Liistro, MD | |
9:12 AM - 9:17 AM | Extreme Below-The-Knee (BTK) Interventions: When To Dare And When To Stop: What Techniques Help |
Presenter(s):Mariano Palena, MD / Marco G. Manzi, MD | |
9:18 AM - 9:23 AM | In Lower Limb Ischemia Patients The Presenting Symptom Makes A Difference: Patients With Claudication, Rest Pain And Major Gangrene Should Be Managed Differently |
Presenter(s):Roberto Ferraresi, MD | |
9:24 AM - 9:29 AM | New Tools And Tricks For Treating Tibial CTOs Including Transcollateral Crossing Of Total Occlusions |
Presenter(s):Craig M. Walker, MD | |
9:30 AM - 9:35 AM | Long-Term Results Of The SUPERA Stent For Femoral And Popliteal Lesions: Advantages And Limitations |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
9:36 AM - 9:41 AM | DEBATE: DESs Will Be The New Gold Standard For Treating Difficult SFA Lesions |
Presenter(s):Gary M. Ansel, MD | |
9:42 AM - 9:47 AM | DEBATE: Not True: DEBs Will Be The Gold Standard For Treating SFA Lesions |
Presenter(s):Giancarlo Biamino, MD, PhD | |
9:48 AM - 9:53 AM | Failed SFA Endovascular Interventions For Advanced Infrainguinal Disease Have An Important Negative Impact On Limb Salvage |
Presenter(s):Ross Milner, MD | |
9:54 AM - 10:00 AM | Panel Discussion And Break |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Wednesday
SESSION 32:
NEW DEVELOPMENTS IN TREATING CRITICAL LOWER EXTREMITY ISCHEMIA (CLI) IN STENT RESTENOSIS (ISR), ATHERECTOMY AND MORE ON DESs
Moderators:Barry T. Katzen, MD / Frank J. Veith, MD
|
|
x | |
10:00 AM - 10:05 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: An Interventionalist’s View |
Presenter(s):Thomas Zeller, MD | |
10:06 AM - 10:11 AM | DEBATE: Importance Of Maintaining Revascularization Patency In CLI Patients: A Surgeon’s View |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
10:12 AM - 10:17 AM | Pedal Bypass With Deep Vein Arterialization Is Especially Applicable In Certain Specific Critical Ischemic Situations: Late Results |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Abstract | |
IN STENT RESTENOSIS (ISR) | |
10:18 AM - 10:23 AM | Insights Into The Pathogenesis Of ISR |
Presenter(s):Renu Virmani, MD | |
10:24 AM - 10:29 AM | DEBATE: DEBs Are The Best Treatment For ISR |
Presenter(s):Francesco Liistro, MD | |
10:30 AM - 10:35 AM | DEBATE: Covered Stents (Viabahn) Are The Best Treatment For ISR: Based On The RELINE Randomized Controlled Trial Comparing Them To Balloon PTA |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
10:36 AM - 10:41 AM | DEBATE: Atherectomy Or Laser And DEBs Are The Best Treatment For ISR: Good Results Are Durable |
Presenter(s):Jos C. van den Berg, MD, PhD | |
10:42 AM - 10:47 AM | Optimal Treatment Of ISR: A US Perspective |
Presenter(s):Craig M. Walker, MD | |
ATHERECTOMY | |
10:48 AM - 10:53 AM | DEBATE: Atherectomy Will Not Become First Line Treatment Even Though The New Devices Are Better Than The Old |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
10:54 AM - 10:59 AM | DEBATE: Atherectomy Is Effective And Durable Treatment For Lower Extremity Occlusive Disease: Which Device Is Best |
Presenter(s):James F. McKinsey, MD | |
11:00 AM - 11:05 AM | Atherectomy Has Value In Association With DEBs For Fem-Pop Lesions: What Is The Value Of Cilostazol In Preventing Restenosis |
Presenter(s):Thomas Zeller, MD | |
11:06 AM - 11:11 AM | What Is The Future For Atherectomy After Past Failures And Conflicting Data |
Presenter(s):Sean P. Lyden, MD | |
11:12 AM - 11:17 AM | Atherectomy Is Of Little Value For Tibial Lesions |
Presenter(s):Jean M. Panneton, MD | |
MORE ON DRUG ELUTING STENTS (DES) ETC. | |
11:18 AM - 11:23 AM | DEBATE: New Findings From The ZILVER PTX Trial: Are The Benefits Of This DES Durable: Do The Good Results (3 Years And Beyond) Justify The Costs |
Presenter(s):Michael D. Dake, MD | |
11:24 AM - 11:29 AM | DEBATE: DEBs And Latest Generation Bare Metal Stents (BMS): Do They Obviate The Need For DESs |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
11:30 AM - 11:35 AM | What I Learned From European Vascular Specialists About Treating BTK Lesions |
Presenter(s):Peter A. Schneider, MD | |
11:36 AM - 11:41 AM | Overview Of The Newer And Old CTO Crossing Devices: What Are They And When Are They Useful |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
11:42 AM - 11:47 AM | Decreasing Access Site Complications With Routine Ultrasound Guidance And Micropuncture Technique |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
11:48 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Wednesday
SESSION 33:
MORE INTERESTING TOPICS RELATED TO LOWER EXTREMITY VASCULAR DISEASE
Moderators:Lindsay Machan, MD / Albrecht H. Kramer, MD
|
|
x | |
1:00 PM - 1:05 PM | Biodegradable DESs To Treat Iliac And Femoral Lesions: Are They Promising: Results From The ESPRIT Trial |
Presenter(s):Johannes Lammer, MD | |
1:06 PM - 1:11 PM | Results Of A Bioabsorbable REMEDY Stent To Treat SFA Disease: Advantages And Limitations |
Presenter(s):Peter C.J. Goverde, MD / Frank E.G. Vermassen, MD, PhD | |
1:12 PM - 1:17 PM | How To Deal With Complex CTOs In Tortuous Anatomy: Best Guidewire Selection And Step-By-Step Technique For Retrograde Fem-Pop Access And Recanalization Via Tibial Punctures |
Presenter(s):Andrej Schmidt, MD | |
1:18 PM - 1:23 PM | Which Is Worse For Diseased Arteries: Metal (Stents) Or Toxic Drugs (On DEBs And DESs): What Will The Long-Term Effects Be |
Presenter(s):Renu Virmani, MD | |
1:24 PM - 1:29 PM | DEBs: How Well Do They Really Work For SFA And BTK Lesions: Based On RCTs And Real World Data: Does Debulking Help |
Presenter(s):Giancarlo Biamino, MD, PhD | |
1:30 PM - 1:35 PM | Tack Optimized Plain Balloon Angioplasty: Will It Replace Stenting-The-Tack-It Device: How Does It Work And The TOBA Trial |
Presenter(s):Koen Deloose, MD | |
1:36 PM - 1:41 PM | Can OCT (Optical Coherence Tomography) Be Used To Help Decide When A Post PTA Dissection Needs To Be Fixed With A Tack-It Device Or Stent |
Presenter(s):Marianne Brodmann, MD | |
1:42 PM - 1:47 PM | Pedal Access And Pedal Loop Interventions: When Should They Be Done And How Durable Are They |
Presenter(s):Roberto Ferraresi, MD | |
1:48 PM - 1:53 PM | Tibial Artery Endovascular Treatments In The US Are Not Durable: Will New Technology Change That |
Presenter(s):Rabih A. Chaer, MD | |
1:54 PM - 1:59 PM | DEBATE: When Should CLI Patients Be Treated With A Bypass: An Endovascularly Oriented Surgeon’s View |
Presenter(s):Koen Deloose, MD | |
2:00 PM - 2:05 PM | DEBATE: When Should CLI Patients Be Treated By A Bypass: An Interventionalist’s View |
Presenter(s):Gary M. Ansel, MD | |
2:06 PM - 2:11 PM | Why Open Surgery Is An Important Part Of Limb Salvage With CLI: Will We Ever Have A Novel Prospective Multicenter Registry Comparing Bypass Surgery To Modern Endovascular Treatment |
Presenter(s):Nobuyoshi Azuma, MD / Osamu Iida, MD | |
2:12 PM - 2:19 PM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Wednesday
SESSION 34:
NEW INFORMATION ABOUT STENT-GRAFTS ESPECIALLY IN THE LOWER
Moderators:Gary Giangola, MD / Dennis R. Gable, MD, FACS
|
|
x | |
2:20 PM - 2:25 PM | New Concepts About Biodegradable Stent-Grafts And Stents |
Presenter(s):Timur P. Sarac, MD | |
2:26 PM - 2:31 PM | Role Of Covered Stents To Treat Obesity By Modulating Visceral Blood Flow |
Presenter(s):Timothy P. Murphy, MD | |
2:32 PM - 2:37 PM | Stent-Grafts vs. Bare Metal Stents For SFA Disease: Lessons Learned From The VIPER And VIASTAR Trials: When Are Stent-Grafts Better |
Presenter(s):Johannes Lammer, MD | |
2:38 PM - 2:43 PM | Top 10 Technical Considerations To Maximize Outcomes Of Viabahn Stent-Grafts In The SFA |
Presenter(s):Michael B. Silva, Jr., MD | |
2:44 PM - 2:49 PM | Technical Steps To Performing Aorto-Iliac Stent-Grafting With Balloon Expandable Stent Grafts (Atrium) For Distal Aortic And Iliac Disease And When The Aortic Occlusion Is Juxtarenal: The CERAB Technique For Protecting The Renal Arteries |
Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD | |
2:50 PM - 2:55 PM | DEBATE: Advantages To Balloon Expandable Stent-Grafts (Atrium) For Aorto-Iliac Occlusive Disease: Why Is It Better Than Stenting And Open Surgery |
Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
View Abstract | |
2:56 PM - 3:01 PM | DEBATE: Open Surgical Repair For Juxtarenal Aortic Occlusive Disease Is Simpler, Safer And Better Than Endovascular Approaches: Technical Tips |
Presenter(s):Roberto Chiesa, MD | |
View Abstract | |
3:02 PM - 3:07 PM | Stent-Graft And Stent Treatment Of Juxtarenal Aortic Occlusions: How Can It Be Done Safely, What Are The Pitfalls And How Durable Is It |
Presenter(s):Martin Malina, MD, PhD | |
3:08 PM - 3:15 PM | Panel Discussion |
3:15 PM - 3:45 PM | Break - 40th Anniversary Celebration (Cocktails Will Be Served)Rhinelander Gallery (2nd Floor) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Wednesday
SESSION 35:
MORE LOWER EXTREMITY AND RELATED HOT TOPICS
Moderators:Mark A. Adelman, MD / Peter F. Lawrence, MD
|
|
x | |
3:45 PM - 3:50 PM | Ultrasound Is A New And Critical Adjunct In The Diagnosis And Treatment Of Popliteal Entrapment Syndromes |
Presenter(s):Niten Singh, MD | |
3:51 PM - 3:56 PM | Where Is The Solid Data To Show That Outcomes Of Endovascular Lower Extremity Interventions Are Better Than Open Surgery |
Presenter(s):Scott L. Stevens, MD | |
3:57 PM - 4:02 PM | Blue Toe Syndrome – An Under-Recognized Entity: Tips And Current Advances In Diagnosis And Treatment |
Presenter(s):Afshin Assadian, MD | |
4:03 PM - 4:08 PM | Unusual Causes Of Blue Toe Syndrome That Are Treatable By Thrombolysis |
Presenter(s):Thomas O. McNamara, MD | |
4:09 PM - 4:14 PM | Atherectomy For Calcified Lesions: Which Device Works Best For Which Lesions |
Presenter(s):Lawrence A. Garcia, MD | |
4:15 PM - 4:20 PM | Retrograde Popliteal Access Is Safe And Effective: When And How To Do It |
Presenter(s):Mark G. Davies, MD | |
4:21 PM - 4:26 PM | New Findings From The ZILVER PTX Trial After 3 Years Of Observation: Do DESs Work As Well In Diabetics, For In Stent Restenosis And TASC C And D Lesions As For Standard Patients And Lesions |
Presenter(s):Michael D. Dake, MD | |
4:27 PM - 4:32 PM | Does Zilver PTX Drug Eluting Stenting Yield Better Results Than An Open Bypass |
Presenter(s):Marc Bosiers, MD | |
4:33 PM - 4:38 PM | Early Patency Results Of A Multicenter RCT Comparing In.Pact DEBs With Uncoated Balloons In SFA, Popliteal And BTK Lesions |
Presenter(s):Erik E. Debing, MD, PhD | |
4:39 PM - 4:44 PM | For Popliteal Lesions Is Stenting Better Than PTA: The ETAP Trial 1-Year Results |
Presenter(s):Thomas Zeller, MD | |
4:45 PM - 4:51 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Wednesday
SESSION 36:
UPDATE ON NEW INFORMATION ABOUT ENDOLEAKS AND THEIR MANAGEMENT
Moderators:Alan B. Lumsden, MD, FACS / Claudio J. Schonholz, MD
|
|
x | |
4:51 PM - 4:56 PM | Recurrent Endoleaks: How Should They Be Treated And How Successful Is The Treatment |
Presenter(s):Götz M. Richter, MD, PhD | |
4:57 PM - 5:02 AM | Many (> 1/3) Patients With Unstable AAA Sacs And “Endotension” After EVAR Really Have Positional-Dependent Endoleaks: How To Diagnose And Treat This Problem |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Abstract | |
5:03 PM - 5:08 PM | Is Perigraft Hygroma Without Endoleak A Real Cause Of Endotension And Sac Enlargement: How Should It Be Treated |
Presenter(s):John Blebea, MD, MBA | |
5:09 PM - 5:14 PM | Defining Endotension: An Experimental Model Explaining Why It is Really An Unrecognized Type I Endoleak |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
5:15 PM - 5:20 AM | Translumbar Glue Embolization For Type II Endoleaks: Guidance With 3D Imaging Using Siemens Software And The Zeego System Make This Safer, More Reliable And Quicker |
Presenter(s):Neal S. Cayne, MD | |
5:21 PM - 5:26 PM | Trans IVC Approach To Treat Type II Endoleaks: When And How |
Presenter(s):Patrice F. Bergeron, MD | |
5:27 PM - 5:32 PM | Chronic Type II Endoleaks Contribute To Late Endograft Fixation Failures After EVAR And Should Be Fixed |
Presenter(s):Martin R. Back, MD | |
5:33 PM - 5:38 PM | What Is The Best Way To Treat Type II Endoleaks: Aggressive vs. Conservative, Route Of Treatment And Agent |
Presenter(s):Robert A. Morgan, MD | |
5:39 PM - 5:44 PM | Partial Conversion With Endograft Salvage For Endotension And Persistent Type II Endoleak After EVAR: When And How To Use This Simpler Way |
Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD | |
View Abstract | |
5:45 PM - 5:50 PM | DEBATE: Most Type II Endoleaks After EVAR Are Benign: For The Motion |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
5:51 PM - 5:56 PM | DEBATE: Most Type II Endoleaks After EVAR Are Benign: Against The Motion |
Presenter(s):Frans L. Moll, MD, PhD | |
5:57 PM - 6:02 PM | Most Type II Endoleaks After EVAR Should Be Taken Seriously |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
6:03 PM - 6:08 PM | Laser-Assisted Transarterial Endograft Puncture Into The AAA Sac For Type 2 Endoleak Treatment With Onyx: A New Approach: Technique And Results |
Presenter(s):Mark W. Mewissen, MD | |
6:09 PM - 6:20 PM | Panel Discussion End of Program B |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Wednesday
SESSION 37:
NEW DEVELOPMENTS IN VENOUS DISEASE: TREATMENT OF LARGE VEIN DISEASE AND HOT TOPICS ON IVC FILTERS
Moderators:Plinio Rossi, MD / Lowell S. Kabnick, MD, FACS, FACPh
|
|
x | |
7:10 AM - 7:14 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
7:15 AM - 7:20 AM | Improved Treatment Of Klippel-Trenaunay Syndrome With Steam Venous Sclerosis And Foam |
Presenter(s):Samy S. Nitecki, MD | |
View Abstract | |
7:21 AM - 7:26 AM | Avoiding Pitfalls Of The Nutcracker Syndrome: Is Stenting Of The Left Renal Vein The Best Treatment |
Presenter(s):J. Leonel Villavicencio, MD | |
View Abstract | |
7:27 AM - 7:32 AM | DEBATE: Embolization Has A Major Role In Treatment Of Varicocele And Pelvic Congestion Syndrome |
Presenter(s):Lindsay Machan, MD | |
View Abstract | |
7:33 AM - 7:38 AM | DEBATE: Left Renal Vein Stenting Is The Best Treatment For The Nutcracker Syndrome And Pelvic Congestion |
Presenter(s):Michael D. Dake, MD | |
7:39 AM - 7:44 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
7:45 AM - 7:52 AM | Panel Discussion |
IVC FILTER RELATED TOPICS | |
Moderator(s): Fedor Lurie, MD, PhD / Seshadri Raju, MD | |
7:53 AM - 7:58 AM | GI Complications Of IVC Filters And Endovascular Treatment Of Filters With GI Tract Complications |
Presenter(s):Rabih A. Chaer, MD | |
7:59 AM - 8:04 AM | Tips And Tricks To Help Remove IVC Filters (Retrievable And Permanent) That Resist Removal |
Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
8:05 AM - 8:10 AM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter: Early Clinical Results And Why It Is A New Horizon |
Presenter(s):David Rosenthal, MD / Albrecht H. Kramer, MD | |
View Abstract | |
8:11 AM - 8:16 AM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
8:17 AM - 8:22 AM | Symptomatic Duodenal Perforation By IVC Filters: Incidence, Prevention And Treatment |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
8:23 AM - 8:28 AM | Why Are Retrievable IVC Filters Hard To Remove: Tips And Tricks To Do It |
Presenter(s):Brian G. DeRubertis, MD | |
8:29 AM - 8:34 AM | Prolonged Radiation Exposure During IVC Filter Removal And How To Avoid It |
Presenter(s):Mark D. Iafrati, MD | |
8:35 AM - 8:40 AM | Which Patients Should Have A Prophylactic IVC Filter Placed During Catheter Based Treatment Of Large Vein Clots: Based On A RCT – The Filter PEVI Study |
Presenter(s):Mohsen Sharifi, MD | |
View Abstract | |
8:41 AM - 8:46 AM | Correlation Of IVUS And CT Scan Measurements For Placement Of IVUS-Guided IVC Filters |
Presenter(s):David L. Gillespie, MD | |
8:47 AM - 8:52 AM | IVC Filter Usage In The US: Do The Benefits Outweigh The Risks And How Should Filter Removal Decrease The Risks While Preserving The Benefits |
Presenter(s):J. Pablo Morales, MD / Kenneth J. Cavanaugh, Jr., PhD | |
8:53 AM - 9:02 AM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Wednesday
SESSION 38:
VENOUS HOT TOPICS RELATED TO CHRONIC OCCLUSIVE DISEASE, POST-PHLEBITIC SYNDROME AND VENOUS STENTS
Moderators:Mark H. Meissner, MD / Jose I. Almeida, MD, RVT, FACS
|
|
x | |
9:03 AM - 9:08 AM | Best Medical Management Of Post-Thrombotic Syndrome: How Good Or Bad Is It |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
9:09 AM - 9:14 AM | Can The Post-Thrombotic Syndrome Be Avoided |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
9:15 AM - 9:20 AM | Deep Venous Stenting: Which Patients Need It, How Can One Tell, What Is The Benefit |
Presenter(s):Todd Berland, MD / Lowell S. Kabnick, MD, FACS, FACPh | |
9:21 AM - 9:26 AM | Ballooning And Stenting Are Not Enough For Iliac Vein Obstruction And Reflux: What Else Must Be Done |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
9:27 AM - 9:32 AM | Long-Term Outcomes Of May-Thurner Syndrome Treatment |
Presenter(s):Rabih A. Chaer, MD | |
9:33 AM - 9:38 AM | With Venous Stents In The IVC And Iliac Veins, Do Late Problems Develop Or Do They Provide An Effective Durable Treatment |
Presenter(s):Seshadri Raju, MD | |
9:39 AM - 9:45 AM | Can Venous Stents Safely Be Placed Across The Junction Of The Common Iliac Veins And The IVC: Will It Cause Thrombosis And Problems |
Presenter(s):David L. Gillespie, MD | |
9:46 AM - 9:51 AM | Bilateral Iliac Vein Stenting: Improving The Raju-Neglen Fenestration Technique |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
9:52 AM - 9:57 AM | Venous Stents Below The Inguinal Ligament, Through Occluded IVC Filters And Into The Profunda Vein: Technique And Results |
Presenter(s):Seshadri Raju, MD | |
9:58 AM - 10:08 AM | Panel Discussion |
10:09 AM - 10:40 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Wednesday
SESSION 39:
TREATMENT OF ACUTE AND SUBACUTE LARGE VEIN THROMBOSIS AND OTHER NEW DEVELOPMENTS IN VENOUS DISEASE
Moderators:Bo G. Eklof, MD, PhD / Peter Gloviczki, MD
|
|
x | |
10:40 AM - 10:45 AM | When Is Open Thrombectomy Or Other Open Surgical Treatment Best For The Post-Thrombotic Syndrome |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
10:46 AM - 10:51 AM | Optimal Strategy For Treatment Of Symptomatic Iliofemoral DVT With Lysis, Mechanical Clot Removal And What Else |
Presenter(s):Mark W. Mewissen, MD | |
10:52 AM - 10:57 AM | Overview Of Current Role Of Lysis, Mechanical Thrombectomy And Stents For Acute And Subacute Iliofemoral And Caval DVT: What Is The Evidence In Support |
Presenter(s):Mark H. Meissner, MD | |
10:58 AM - 11:03 AM | Free Floating Thrombus In The IVC Or Iliac Veins: What Is The Risk And How Should It Be Treated |
Presenter(s):Michael C. Dalsing, MD | |
View Abstract | |
11:04 AM - 11:09 AM | Successful Treatment Of Acute Or Subacute Venous Obstructive Disease With The Rotarex/Aspirex Device |
Presenter(s):Andrej Schmidt, MD | |
11:10 AM - 11:15 AM | Are Oral Factor 10 And 2 Inhibitors (Rivaroxaban, Apixaban, Dabigatran) Here To Stay Or Not: Advantages And Limitations |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
11:16 AM - 11:21 AM | How To Use Coumadin And Newer Antithrombotic Agents After An Intervention; After Open Non-Vascular And Vascular Surgery |
Presenter(s):Fedor Lurie, MD, PhD | |
11:22 AM - 11:27 AM | Genetic And Other Factors Promoting DVT: How Can They Be Detected And Treated |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
11:28 AM - 11:33 AM | Aspirin Therapy For Recurrent Venous Thromboprophylaxis Has Now Been Proven Effective |
Presenter(s):Mark H. Meissner, MD | |
11:34 AM - 11:39 AM | Percutaneous Foam Sclerotherapy For Venous Ulcers |
Presenter(s):Ronald G. Bush, MD / Peggy Bush, MSN, APN | |
11:40 AM - 11:50 AM | Panel Discussion |
11:50 AM - 1:00 PM | Lunch Break - Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Wednesday
SESSION 40:
OTHER NEW DEVELOPMENTS IN THE MANAGEMENT OF VENOUS DISEASE
Moderators:William A. Marston, MD / Thomas W. Wakefield, MD
|
|
x | |
1:00 PM - 1:05 PM | Tips And Tricks For Improving Treatment Of Venous Ulcers |
Presenter(s):Albeir Y. Mousa, MD | |
1:06 PM - 1:11 PM | SVS/AVF Guidelines For Venous Ulcer Management: How Can Costs Be Minimized |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
1:12 PM - 1:17 PM | A Workable Plan For The Endovenous Treatment Of Leg Ulcers: How Effective Is It And How Many Patients Are Eligible: A New Horizon For Vascular Specialists |
Presenter(s):Seshadri Raju, MD | |
1:18 PM - 1:23 PM | Important Vascular Changes During Pregnancy And Their Implications For The Vascular Surgeon And Vascular Specialist |
Presenter(s):Joann Lohr, MD | |
1:24 PM - 1:29 PM | When Should Acute DVT Be Treated Aggressively By Endovascular Means And When Is Conservative Treatment Best: What Is The Optimal Treatment |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
1:30 PM - 1:35 PM | What The Vascular Specialist Needs To Know About The Newer Oral Anticoagulants, Their Pitfalls And How To Use Them |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
1:36 PM - 1:41 PM | New Techniques For Treating Central Vein Occlusions And SVC Syndrome Which Minimize The Use Of Stents: Why It Is Worthwhile |
Presenter(s):Thomas O. McNamara, MD | |
1:42 PM - 1:47 PM | Aggressive Treatment Of Central Vein Stenoses In Patients With Threatened A-V Dialysis Access |
Presenter(s):Karl A. Illig, MD | |
1:48 PM - 1:53 PM | FDA Perspective On Evaluating Procedures And Devices For Treating Venous Disease – Including CCSVI |
Presenter(s):Kenneth J. Cavanaugh, Jr., PhD / J. Pablo Morales, MD | |
1:54 PM - 2:04 PM | Panel Discussion |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Wednesday
SESSION 41:
CALF DEEP VEIN THROMBOSIS (DVT) AND SUPERFICIAL VEIN THROMBOSIS
Moderators:J. Leonel Villavicencio, MD / Cees H.A. Wittens, MD, PhD
|
|
x | |
2:05 PM - 2:10 PM | Acute Saphenous Vein Thrombosis: Anticoagulate, Ligate, Strip Or Burn |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
2:11 PM - 2:16 PM | DEBATE: Infrapopliteal DVT Should Not Be Treated Aggressively |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
2:17 PM - 2:22 AM | DEBATE: Infrapopliteal DVT Is Dangerous And Should Be Treated |
Presenter(s):Joann Lohr, MD | |
2:23 PM - 2:28 PM | All Calf DVTs Are Not The Same: A Case For SELECTIVE Treatment |
Presenter(s):Elna M. Masuda, MD | |
2:29 PM - 2:34 PM | A United States Survey On The Management Of Below Knee DVT |
Presenter(s):Ross Milner, MD | |
2:35 PM - 2:40 PM | Should You Treat Outpatient Intramuscular DVT: With What And For How Long |
Presenter(s):Robert B. McLafferty, MD | |
2:41 PM - 2:46 PM | Mechanism Of Venous Valve Closure And The Role Of The Valves In The Venous Circulation |
Presenter(s):Fedor Lurie, MD, PhD | |
2:47 PM - 2:52 PM | Why Did Venous Valve Repair Disappear In The US |
Presenter(s):Seshadri Raju, MD | |
2:53 PM - 2:58 PM | Deep Venous Valvular Reconstruction: How To Do It And Results |
Presenter(s):Marzia Lugli, MD | |
2:59 PM - 3:04 PM | Deep Venous Valve Reconstruction Is Underutilized |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
3:05 PM - 3:10 PM | Deep Venous Valves: Why Are They Important And When And How Should They Be Treated |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
3:11 PM - 3:16 PM | Why And How To Treat Popliteal Vein Aneurysms: The Lateral Approach May Help |
Presenter(s):Charles Strom, MD / Frank B. Pomposelli, MD | |
3:17 PM - 3:32 PM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Wednesday
SESSION 42:
INTERESTING TOPICS, CASES AND LITERATURE REVIEWS (10-MINUTE TALKS)
|
|
x | |
3:33 PM - 3:43 PM | What We Learned From The Boston Marathon Civilian Injuries |
Presenter(s):Glenn M. LaMuraglia, MD | |
3:44 PM - 3:54 PM | Major Venous Injuries: Lessons Learned From Iraq And Afghanistan |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
3:55 PM - 4:05 PM | Common Femoral Vein Endovenectomy With Endoluminal Iliac Vein Recanalization For Post-Thrombotic Syndrome: Indications And Tips And Tricks |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
4:06 PM - 4:16 PM | Iliocaval IVUS And Stenting: Tips And Tricks |
Presenter(s):Jose I. Almeida, MD, RVT, FACS | |
4:17 PM - 4:27 PM | Crossing Ilio-Femoral CTOs: What Approach, Tips And Tricks |
Presenter(s):Gerard J. O'Sullivan, MD | |
4:28 PM - 4:38 PM | For Near Fatal PE And Possibly Central DVT: A New Device, Tips And Tricks |
Presenter(s):Christopher J. Kwolek, MD | |
4:39 PM - 4:49 PM | Resection Of IVC For Renal Cell Cancer: Tips And Tricks |
Presenter(s):R. Clement Darling III, MD | |
4:50 PM - 5:00 PM | Deep Venous Reconstruction: Tips And Tricks – A Pictorial Video Demonstration |
Presenter(s):Peter Gloviczki, MD | |
5:00 PM - 5:15 PM | Panel Discussion End of Program C |
END OF SESSION 42 | |
Thursday, November 21, 2013
Print Entire 2013 Program:
|
|
SESSION 43 SCHEDULE | |
Thursday
SESSION 43:
NEW OR IMPROVED TECHNOLOGIES FOR VASCULAR TREATMENT
Moderators:Anton N. Sidawy, MD, MPH / Dhiraj M. Shah, MD
|
|
x | |
6:55 AM - 7:00 AM | Advantages Of A Fully Self-Expanding Bioabsorbable Stent Scaffold In The Treatment Of SFA Disease: Results Of The STANCE Study |
Presenter(s):Andrew Holden, MBChB | |
7:01 AM - 7:06 AM | Results With The Next Generation Dual Component (Nitinol And PTFE) Stent (Tigris Stent From Gore): Concept And Early Results |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
7:07 AM - 7:12 AM | Diagnosis Of Flow-Limiting Stenosis And Plaque Vulnerability In One Non-Invasive Test: It Will Be Possible And Clinically Useful For Evaluating Peripheral Arterial Stenoses |
Presenter(s):Christopher K. Zarins, MD | |
7:13 AM - 7:18 AM | Update On Biodegradable Stents In The Coronary Position And Elsewhere: Impact Of Fractures On Thrombosis And Restenosis: Why They May Be Important |
Presenter(s):Ron Waksman, MD | |
7:19 AM - 7:24 AM | System For Reducing Radiation Exposure While Maintaining Image Quality During Interventional Procedures |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
7:25 AM - 7:30 AM | What’s New In Drug Eluting Stent (DES) Technology And What Difference Will It Make |
Presenter(s):Ron Waksman, MD | |
7:31 AM - 7:36 AM | Reentry Jugular Access Device |
Presenter(s):Mark H. Wholey, MD / Kumar Pilai, MD | |
7:37 AM - 7:43 AM | Panel Discussion |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Thursday
SESSION 44:
THORACOABDOMINAL ANEURYSMS (TAAAs) AND TECHNIQUES TO
Moderators:Frank J. Veith, MD / Eric L.G. Verhoeven, MD, PhD
|
|
x | |
7:43 AM - 7:48 AM | DEBATE: Branched And Fenestrated Endografts Are The Way To Go For Most TAAAs And Pararenal AAAs: CHIMPS Are Almost Always Second Best |
Presenter(s):Stephan Haulon, MD | |
7:49 AM - 7:55 AM | DEBATE: CHIMPS Are The Best Option In Many TAAA And Pararenal AAAs For Many Reasons |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
7:55 AM - 8:00 AM | Chimney And Sandwich Grafts Work As Well As Branched Grafts If Planning Measurements And Case Selection Are Good: What Pitfalls Must Be Avoided |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:01 AM - 8:06 AM | Multiple Parallel Grafts (Chimneys And Periscopes) Are Safe, Effective And Durable For Treating Elective And Ruptured TAAAs And Pararenal AAAs: An Experience With 169 Grafts In 77 Patients Followed Up To 5 Years |
Presenter(s):Mario Lachat, MD | |
8:07 AM - 8:12 AM | Experience With More Than 100 Cases Illuminates The Fog Surrounding Chimney Grafts: When Do They Work And When Don’t They |
Presenter(s):Giovanni Torsello, MD / Konstantinos Donas, MD | |
View Abstract | |
8:13 AM - 8:18 AM | DEBATE: Why The Sandwich Technique Is Better Than Branched Grafts For Repairing TAAAs: What Are The Pitfalls To Avoid |
Presenter(s):Armando C. Lobato, MD, PhD | |
8:19 AM - 8:24 AM | DEBATE: Why Branched Grafts Are Better Than CHIMPS For Repairing TAAAs And Pararenal AAAs |
Presenter(s):Timothy A.M. Chuter, DM | |
8:25 AM - 8:30 AM | Well Done Snorkel Or Chimney Grafts Make Fenestrated Grafts Unnecessary For Juxtarenal AAAs: Tips And Tricks For Doing Them |
Presenter(s):Jason T. Lee, MD / Ronald L. Dalman, MD | |
8:31 AM - 8:36 AM | How To Perform EVAR With Renal Chimneys (Video): What Are The Key Technical Steps |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
8:37 AM - 8:42 AM | Addressing Gutters In CHIMP Procedures Using Endoanchors (Aptus HeliFx) And The Nellix Endograft (Endologix) |
Presenter(s):Jan D. Blankensteijn, MD | |
8:43 AM - 8:48 AM | Tips And Tricks With Chimney Grafts For Renal Revascularization And How To Make Them Work Even Without Brachial Access |
Presenter(s):David J. Minion, MD | |
8:49 AM - 8:54 AM | Off-The-Shelf Branched And Fenestrated Devices For Complex AAAs |
Presenter(s):Mark A. Farber, MD | |
8:55 AM - 9:00 AM | Outcomes With Branched And Fenestrated Endografts For TAAAs And Pararenal AAAs In The Real World: How Do They Compare With Open Repair Performed By Well Trained Vascular Surgeons |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
9:01 AM - 9:09 AM | Panel Discussion |
9:10 AM - 9:24 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Thursday
SESSION 45:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA, CLI, THE ANGIOSOME CONCEPT AND ACUTE LIMB ISCHEMIA
Moderators:Enrico Ascher, MD / Gregg S. Landis, MD
|
|
x | |
9:24 AM - 9:29 AM | What Is The Role For Hybrid Approaches To Aorto-Iliac And Iliofemoral Arterial Occlusive Disease |
Presenter(s):Evan C. Lipsitz, MD | |
9:30 AM - 9:35 AM | When Is Tibial Angioplasty For Limb Salvage Worthwhile In Patients With ESRD |
Presenter(s):Werner Lang, MD | |
9:36 AM - 9:41 AM | Endovascular Treatment Can Be Vital To Limb Salvage After Multiple Failed Bypasses |
Presenter(s):Florian Dick, MD / Nicolas A. Diehm, MD | |
View Abstract | |
9:42 AM - 9:47 AM | Open Treatments (Bypasses) Can Be Vital To Limb Salvage After Multiple Failed Endovascular Treatments |
Presenter(s):Michael S. Conte, MD | |
VIEWS ON THE ANGIOSOME CONCEPT | |
9:48 AM - 9:53 AM | The Role Of The Angiosome Concept In Distal Bypass Surgery For CLI |
Presenter(s):Gregory L. Moneta, MD | |
9:54 AM - 9:59 AM | Angiosomes: Do They Really Matter For Limb Salvage With Endovascular Treatments And With Open Bypasses |
Presenter(s):Robert J. Hinchliffe, MD | |
10:00 AM - 10:05 AM | The Angiosome Concept Is Over-Rated: Collaterals Will Usually Heal The Foot If The Revascularization Is Effective |
Presenter(s):Iris Baumgartner, MD | |
10:06 AM - 10:11 AM | Is Angiosome Directed Tibial Revascularization Needed For Successful Limb Salvage With Endovascular Treatment: With Open Bypasses: When Does It Not Matter |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
10:12 AM - 10:18 AM | Impact Of The Quality Of The Pedal Arch On Infrapopliteal Bypass Patency And Limb Salvage: It Is Not What You Think: What About The Angiosome Concept |
Presenter(s):Hisham Rashid, FRCS, FRCS (Gen) | |
10:19 AM - 10:24 AM | DEBATE: Endovascular First Is The Best Strategy For Treating Acute Limb Ischemia (ALI) |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
10:25 AM - 10:30 AM | DEBATE: Endovascular Treatments Are All One Needs To Treat ALI |
Presenter(s):Gary M. Ansel, MD | |
10:31 AM - 10:36 AM | DEBATE: Nonsense: Open Treatments Are Often Necessary To Treat ALI |
Presenter(s):Joseph L. Mills, MD | |
10:37 AM - 10:42 AM | EndoRepair Of Small Popliteal Aneurysms With Ultrasound Guidance Alone: Is It Safe And Durable |
Presenter(s):Enrico Ascher, MD | |
10:43 AM - 10:48 AM | The Angiojet Device Works Well In ALI |
Presenter(s):Fabrizio Fanelli, MD | |
10:49 AM - 10:55 AM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Thursday
SESSION 46:
ADVANCES IN MEDICAL THERAPY OR TREATMENT OF MEDICAL PROBLEMS
|
|
x | |
10:55 AM - 11:00 AM | Controlling Lipids In Patients With PAD: How Doing So Can Improve A Vascular Surgeon’s Practice: What Steps Are Needed |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS | |
View Abstract | |
11:01 AM - 11:06 AM | When Does Good Medical Treatment With Optimal Statin Use Result In Carotid Plaque Modification And Regression: How Does It Correlate With Decreased Stroke Risk |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
11:07 AM - 11:12 AM | Tricks To Allow Statin Administration In Allegedly Statin Intolerant Patients |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
11:13 AM - 11:18 AM | What’s New In Raising HDL: How Can It Be Done And Will It Help Patients |
Presenter(s):Ron Waksman, MD | |
11:19 AM - 11:24 AM | Statins Decrease Emboli During CAS: Why Does This Occur |
Presenter(s):Peter L. Faries, MD, FACS | |
11:25 AM - 11:30 AM | Perioperative Administration Of Clopidogrel Is Safe In Patients Undergoing Major Open Vascular Surgery On Carotid And Leg Arteries And The Aorta |
Presenter(s):Carlos Saadeh, MD, FRCSC, FACS | |
View Abstract | |
11:31 AM - 11:36 AM | Optimal Antiplatelet Treatment In PAD Patients Undergoing Vascular Surgery: Is Aspirin Enough |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
11:37 AM - 11:42 AM | Does An Anti-Inflammatory Drug Halt The Growth Of Small AAAs: Other Interesting Facts About Small AAA Growth: The AORTA RCT Trial vs. Placebo |
Presenter(s):Henrik Sillesen, MD, DMSc | |
11:43 AM - 11:48 AM | DEBATE: Vasoactive Drugs (Pletal, Trental) Are Helpful In Patients With Intermittent Claudication |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
11:49 AM - 11:54 AM | DEBATE: Nonsense: Red Wine Is Better |
Presenter(s):Erich Minar, MD | |
11:55 AM - 12:00 PM | Panel Discussion End Of Program D |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Thursday
SESSION 47:
NEW, REVISITED OR INTERESTING LOWER EXTREMITY TOPICS
Moderators:Daniel G. Clair, MD / Herbert Dardik, MD
|
|
x | |
6:55 AM - 7:00 AM | BTK Interventions For Dummies: How To Make Them Easy |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
7:01 AM - 7:06 AM | Resorbable Scaffold (Stents) In The SFA: The ESPRIT Trial Experience |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
7:07 AM - 7:12 AM | Preventing Restenosis After PTA By Subintimal Injection Of Dexamethasone |
Presenter(s):Patrice F. Bergeron, MD | |
7:13 AM - 7:18 AM | There Is Still A Role For Hybrid Procedures In The Endovascular Era: What Is It In The Lower Extremity |
Presenter(s):Oscar L. Ojeda, MD | |
View Abstract | |
7:19 AM - 7:24 AM | Combined SFA Endovascular Treatment With Distal Vein Bypass: Advantages And Limitations |
Presenter(s):Giustino Marcucci, MD | |
View Abstract | |
7:25 AM - 7:30 AM | Alternative Access Techniques When The Common Femoral Artery Is Too Diseased, Infected Or Calcified To Be Used |
Presenter(s):Thomas O. McNamara, MD | |
7:31 AM - 7:36 AM | Long-Term Outcomes After Major Femoral Artery Complications Of Vascular Closure Devices: Results Of A 7-Year Danish Study |
Presenter(s):Lars Lonn, MD, PhD | |
View Abstract | |
7:37 AM - 7:42 AM | Role Of Lower Extremity Bypass In The Endovascular Era: It Saves Limbs |
Presenter(s):Gregory L. Moneta, MD | |
7:43 AM - 7:48 AM | Value Of LeGoo In Distal Bypass Operations: How To Use It And How Does It Help |
Presenter(s):Hany Zayed, MD | |
7:49 AM - 8:02 AM | Panel Discussion |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Thursday
SESSION 48:
NEW AND INTERESTING AORTA RELATED TOPICS
Moderators:Timur P. Sarac, MD / Clifford J. Buckley, MD
|
|
x | |
8:02 AM - 8:07 AM | Use Of Atrial Septal Defect Closure Device To Treat A Saccular Aneurysm Of The Visceral Segment Of The Aorta |
Presenter(s):Ross Milner, MD | |
8:08 AM - 8:13 AM | Reintervention Rates For Elective And Emergency EVAR Are Surprisingly Similar: Why |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
8:14 AM - 8:19 AM | 22% Of AAAs Have A Familial Basis: What Is Its Significance After EVAR |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
8:20 AM - 8:25 AM | Mesenteric Trash From A Shaggy Aorta In Patients Undergoing Fenestrated EVAR: Is It A Contraindication And How To Avoid The Problem |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
8:26 AM - 8:31 AM | How Often Is Reintervention Needed After TEVAR For Aortic Transection: Implications For Surveillance |
Presenter(s):Anders Wanhainen, MD, PhD / Martin Bjorck, MD, PhD | |
8:32 AM - 8:37 AM | PET CT Scanning To Help In The Follow-up Of Patients After EVAR: Which Patients With Endoleaks Need Reintervention And Which Do Not: Can It Decrease The Burden Of Unnecessary Imaging |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
8:38 AM - 8:43 AM | Top 10 Tips For Treating Aortic Aneurysms After Chronic Type B Dissections: Pitfalls To Avoid |
Presenter(s):Giovanni Torsello, MD | |
8:44 AM - 8:49 AM | Novel Fenestration Template For Physician Modified Stent-Grafts For Pararenal AAAs |
Presenter(s):Benjamin W. Starnes, MD | |
8:50 AM - 8:55 AM | In Situ Fenestration For Total Arch Exclusion And Endograft Reconstruction: How Can Brain Perfusion Be Sustained: First In Man Experience |
Presenter(s):Bjõrn Sonesson, MD, PhD | |
View Abstract | |
8:56 AM - 9:01 AM | Laser Fenestration Is A Safe Way To Revascularize Left Subclavian Arteries Covered During TEVAR: How To Do It |
Presenter(s):Jean M. Panneton, MD | |
9:02 AM - 9:07 AM | What Distinguishes Acute And Chronic Type B Aortic Dissections: Is There A Subacute Phase: Implications For TEVAR |
Presenter(s):Martin Bjorck, MD, PhD | |
9:08 AM - 9:13 AM | Two-Year Clinical Follow-Up After Successful Drug Eluting Stent Implantation For The Treatment Of Vasculogenic Erectile Dysfunction: Where Does The Procedure Stand |
Presenter(s):Krishna J. Rocha-Singh, MD | |
9:14 AM - 9:19 AM | Percutaneous Transgluteal Access To The Hypogastrics For Embolization, Etc.: How To Do It And When |
Presenter(s):Darren B. Schneider, MD | |
9:20 AM - 9:30 AM | Panel Discussion |
9:30 AM - 9:50 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Thursday
SESSION 49:
PROGRESS IN TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs) AND
Moderators:Mark A. Adelman, MD / Jacques Busquet, MD
|
|
x | |
THORACIC OUTLET SYNDROMES | |
9:50 AM - 9:55 AM | Thoracic Outlet Syndromes: Role Of Lysis, Stenting, Surgery |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
9:56 AM - 10:01 AM | What’s New In TOS Treatment And Reporting Standards: When If Ever Should Neurologic TOS Be Treated |
Presenter(s):Karl A. Illig, MD | |
10:02 AM - 10:07 AM | A New Test For TOS With Venous Obstruction: External Jugular Vein Distension With Arm Abduction And External Rotation |
Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
10:08 AM - 10:13 AM | Paraclavicular Open Decompression For Venous TOS: Indications, Technique And Results |
Presenter(s):Ali Azizzadeh, MD | |
10:14 AM - 10:19 AM | Robot Assisted Transthoracic First Rib Resection For Venous TOS |
Presenter(s):Hans M.E. Coveliers, MD | |
MISCELLANEOUS HOT TOPICS | |
10:20 AM - 10:25 AM | Value Of Cutting Balloon Angioplasty For Treating Restenosis |
Presenter(s):Thomas O. McNamara, MD | |
10:26 AM - 10:31 AM | Are DEBs And DESs Worth The Cost In BTK Interventions |
Presenter(s):Thomas Zeller, MD | |
10:32 AM - 10:37 AM | Tips And Tricks For Radial Approach For All Endovascular Interventions: What Equipment Is Needed |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
10:38 AM - 10:43 AM | Update On Role Of Viatorr Covered Stent For TIPS Procedures For Variceal Bleeding: Patient Survival Is Much Improved Over Esophageal Banding In A RCT |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
10:44 AM - 10:50 AM | Panel Discussion |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Thursday
SESSION 50:
NEW DEVELOPMENTS IN PROSTHETIC VASCULAR GRAFTS AND OTHER
Moderators:Larry H. Hollier, MD / Palma M. Shaw, MD
|
|
x | |
PROGRESS IN PROSTHETIC VASCULAR GRAFTS | |
10:51 AM - 10:55 AM | 4-Year Results Of A Randomized Trial Comparing Heparin Bonded PTFE Grafts (Propaten) To Standard PTFE Grafts In The Fem-Pop Position |
Presenter(s):Jes S. Lindholt, MD | |
View Abstract | |
10:56 AM - 11:00 AM | 4-Year Results Of Heparin Bonded PTFE Grafts Are Better Than Standard PTFE Grafts And May Be As Good As Saphenous Vein Grafts |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:01 AM - 11:05 AM | Long-Term Propaten Heparin Bonded PTFE Graft Patency Approaches Those Of Vein Grafts In Lower Extremity Bypass Procedures: When Is Vein Superior |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
11:06 AM - 11:10 AM | Standard Grafts, Heparin Bonded Grafts, Hybrid Grafts: Role And Indications For Each In Lower Extremity Occlusive Disease |
Presenter(s):Edward Y. Woo, MD | |
11:11 AM - 11:15 AM | Economic Value Of Heparin Bonded Vascular Grafts (Propaten) For Lower Extremity Bypasses |
Presenter(s):Manish Mehta, MD, MPH | |
11:16 AM - 11:20 AM | Techniques And Advantages Of Sutureless Endoluminal Anastomoses In Lower Extremity Revascularizations: A Solution For Difficult Settings |
Presenter(s):Jean Bismuth, MD | |
11:21 AM - 11:25 AM | A New Composite (PTFE-Dacron) Heparin Bonded Graft (The FUSION Bioline Graft): It Performs Well In A RCT vs. Standard PTFE Grafts |
Presenter(s):Alan B. Lumsden, MD, FACS | |
11:26 AM - 11:30 AM | How Cost Should Impact Treatment Strategies For Management Of SFA Occlusive Disease |
Presenter(s):Dennis R. Gable, MD, FACS | |
11:31 AM - 11:36 AM | The ENDOMAX Trial: A RCT Comparing Bivalirudin vs. Heparin In CLI, PTRA, CAS And EVAR Procedures: Why Bivalirudin May Be Better |
Presenter(s):Barry T. Katzen, MD | |
11:37 AM - 11:42 AM | Upper Extremity Thromboembolectomy Using Duplex Ultrasound As The Sole Imaging Method For Diagnosis And Treatment |
Presenter(s):Anil P. Hingorani, MD | |
11:43 AM - 11:48 AM | Results From The MIMICS Study: Why A 3D Shaped Nitinol Stent May Be Better Than Straight Stents |
Presenter(s):Thomas Zeller, MD | |
11:49 AM - 11:54 AM | Influence Of Smoking On Incidence Of AAAs In Women And After Screening: When Is Rescreening Ever Indicated After A Negative AAA Scan |
Presenter(s):Anders Wanhainen, MD, PhD | |
11:55 AM - 12:00 PM | Panel Discussion End Of Program E |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Thursday
SESSION 51:
MANAGEMENT OF PULMONARY EMBOLISM: FROM ORAL AGENTS TO PARENTERAL LYTICS TO MECHANICAL INTERVENTION AND SURGERY – PART 1
Moderators:Michael R. Jaff, DO
|
|
x | |
7:15 AM - 7:20 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
7:20 AM - 7:30 AM | Welcome And Introduction |
Presenter(s):Michael R. Jaff, DO | |
7:30 AM - 7:45 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Echocardiography And Biomarkers |
Presenter(s):Ido Weinberg, MD, MSc | |
7:45 AM - 8:00 AM | Novel Medical Therapies For PE |
Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
8:00 AM - 8:10 AM | Intravenous Thrombolytic Therapy For PE: What Is The Role |
Presenter(s):Christopher Kabrhel, MD, MPH | |
8:10 AM - 8:20 AM | Catheter-Directed Thrombolysis For PE: A Better Lytic Alternative |
Presenter(s):Nils Kucher, MD | |
8:20 AM - 8:35 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It |
Presenter(s):Gary M. Ansel, MD | |
8:35 AM - 8:45 AM | Percutaneous Pharmacomechanical Intervention For PE: Does This Really Work And What Is The Proof |
Presenter(s):Nils Kucher, MD | |
8:45 AM - 9:15 AM | Case Presentations/Discussion/Questions And Answers |
Panelist(s): Florian Dick, MD / Kim J. Hodgson, MD / Michael R. Jaff, DO / Christopher Kabrhel, MD, MPH / Nils Kucher, MD / Geno J. Merli, MD, MACP, FHM, FSVM / Ido Weinberg, MD, MSc | |
9:15 AM - 9:45 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 51 | |
SESSION 52 SCHEDULE | |
Thursday
SESSION 52:
MANAGEMENT OF PULMONARY EMBOLISM: FROM ORAL AGENTS TO PARENTERAL LYTICS TO MECHANICAL INTERVENTION AND SURGERY - PART 2
Moderators:Michael R. Jaff, DO
|
|
x | |
9:45 AM - 10:00 AM | The SEATTLE Trial: Is It A Breakthrough For PE Treatment |
Presenter(s):Samuel Z. Goldhaber, MD | |
10:00 AM - 10:10 AM | What Will The SEATTLE Trial Not Tell Us |
Presenter(s):Clifford M. Sales, MD, MBA | |
View Abstract | |
10:10 AM - 10:20 AM | Vortex Strategy For Massive PE |
Presenter(s):Christopher J. Kwolek, MD | |
10:20 AM - 10:35 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why |
Presenter(s):Joshua N. Baker, MD | |
10:35 AM - 10:45 AM | Putting It All Together: The Modern Algorithm For Management Of Massive And Submassive PE |
Presenter(s):Tod C. Engelhardt, MD | |
View Abstract | |
10:45 AM - 11:00 AM | Iliac Venous Stenosis: When To Look And When To Stent |
Presenter(s):Barry T. Katzen, MD | |
11:00 AM - 11:15 AM | The Team Approach To PE Management: The Dawn Of PERT |
Presenter(s):Kenneth Rosenfield, MD | |
11:15 AM - 11:40 AM | Questions And Answers |
11:40 AM - 12:00 PM | End of Program F Visit Exhibits and Pavilions (2nd and 3rd Floors) |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Thursday
SESSION 53:
AORTIC ANEURYSMS: JUXTARENAL, PARARENAL, THORACIC, TAAAs AND AAAs: INTRODUCTION TO THE MULTILAYER FLOW MODULATING (MLFM) STENT
Moderators:Larry H. Hollier, MD / Wei Guo Fu, MD
|
|
x | |
1:00 PM - 1:05 PM | Renal Protection Strategies During TAAA Open Repair: A New Perfusion Solution, Open Renal Stenting And Bypass With The Hybrid Graft |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Multicenter Trial Of Fenestrated Grafts In Short Neck AAAs: The COOK-FEN FDA Trial: FEVAR Works In The Real World |
Presenter(s):Luis A. Sanchez, MD | |
1:12 PM - 1:17 PM | DEBATE: Fenestrated EVAR (FEVAR) Is Now The Procedure Of Choice For Juxtarenal AAAs |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
1:18 PM - 1:23 PM | DEBATE: Open Repair Is Still The Procedure Of Choice For Juxtarenal AAAs |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
1:24 PM - 1:29 PM | The Role Of Temporary Perfusion Branches With Endovascular TAAA Repair: How Can They Be Used With Neuromonitoring To Prevent Spinal Cord Ischemia (SCI) |
Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD | |
1:30 PM - 1:35 PM | Petticoat Technique For Aortic Dissections With Visceral Ischemia And How Can Laparoscopy Improve Outcomes In This Setting |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
1:36 PM - 1:41 PM | Update On The Treatment Of Complex Aortic Aneurysms With Multiple Overlapping Bare Stents: Do They Really Work |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
INTRODUCTION TO MULTILAYER STENT FOR ANEURYSM TREATMENT | |
1:42 PM - 1:47 PM | Theoretical Considerations To Explain How The Multilayer Flow Modulating Bare Stent Can Work To Treat Aneurysms |
Presenter(s):Edward B. Diethrich, MD | |
1:48 PM - 1:53 PM | Two-Year Clinical Experience With The MLFM Bare Stent To Treat Complex Aortic Aneurysms With Vital Branch Involvement: The French Registry Results |
Presenter(s):Claude D. Vaislic, MD | |
1:54 PM - 1:59 PM | A Skeptic’s View Of The MLFM Bare Stent As A Treatment For Complex Aortic Aneurysms |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
2:00 PM - 2:06 PM | Panel Discusion |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Thursday
SESSION 54:
NEW DEVELOPMENTS IN IMAGING, ROBOTICS, LAPAROSCOPY AND
Moderators:Alan B. Lumsden, MD, FACS / Jean-Baptiste Ricco, MD, PhD
|
|
x | |
2:07 PM - 2:12 PM | Summary Of Experience With The Hansen Megellan System For Robotic Assisted Complex And Routine Endovascular Procedures: Advantages And Limitations |
Presenter(s):Nicholas J.W. Cheshire, MD | |
2:13 PM - 2:18 PM | Clinical Experience With Vascular Robotics (Hansen) In EVAR, Carotid And Other Vascular Applications |
Presenter(s):Barry T. Katzen, MD | |
2:19 PM - 2:24 PM | Update On New Tools For 3D Navigation In Endovascular Procedures |
Presenter(s):Jos C. van den Berg, MD, PhD | |
2:25 PM - 2:30 PM | The Vessel Navigator From Philips: Is It A Toy Or A Useful Tool For EVAR |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
2:31 PM - 2:36 PM | DEBATE: Fancy Fluoroscopy With 3D Imaging, Fusion And Good Software Are The Best Way To Simplify The Endovascular Treatment Of Complex AAAs And Are The Way To Go |
Presenter(s):Neal S. Cayne, MD | |
2:37 PM - 2:42 PM | DEBATE: IVUS Is Better Than Fancy Fluoroscopy For Complex AAAs |
Presenter(s):Carlos H. Timaran, MD | |
2:43 PM - 2:48 PM | Future Of 3D Ultrasound In Measuring AAAs: Why Is It Important: What Diameter Should Be Used: And Why Old Natural History Studies May Be Misleading |
Presenter(s):Henrik Sillesen, MD, DMSc | |
2:49 PM - 2:54 PM | DEBATE: Laparoscopic Techniques Are Important To Vascular Surgeons And Worth Learning |
Presenter(s):Joseph S. Giglia, MD | |
2:55 PM - 3:00 PM | DEBATE: Not So: An Enthusiast In Laparoscopic Vascular Surgery Has Been Converted To A Non-Believer |
Presenter(s):Willem Wisselink, MD | |
3:01 PM - 3:06 PM | What Is Operator Controlled Imaging (OCI): How Can It Reduce Radiation Exposure To Operators And Patients |
Presenter(s):Robert J. Hinchliffe, MD | |
3:07 PM - 3:30 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 54 | |
SESSION 55 SCHEDULE | |
Thursday
SESSION 55:
ADVANCES IN THE MANAGEMENT OF RUPTURED AAAs
Moderators:Brian R. Hopkinson, ChM, FRCS / Frank J. Veith, MD
|
|
x | |
3:31 PM - 3:36 PM | New Developments In The Diagnosis Of Abdominal Compartment Syndrome With Ruptured AAAs: Tips And Tricks For Management |
Presenter(s):Martin Bjorck, MD, PhD | |
3:37 PM - 3:42 PM | DEBATE: We Do Not Need A RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Has Already Proven To Be Better |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
3:43 PM - 3:48 PM | DEBATE: Of Course We Need Level I Evidence: The IMPROVE Trial Is A Good One: What Are Its Results And What If It Fails To Show Benefit |
Presenter(s):Janet T. Powell, MD, PhD | |
3:49 PM - 3:54 PM | Technique For Supraceliac Balloon Aortic Control During EVAR For Ruptured AAA (Video) |
Presenter(s):Frank J. Veith, MD / Neal S. Cayne, MD / Todd Berland, MD | |
3:55 PM - 4:00 PM | Clinical Experience With A One Shot Occlusion Balloon For Emergency Aortic Control For Ruptured AAAs And Other Large Vessel Bleeding |
Presenter(s):Benjamin W. Starnes, MD | |
4:01 PM - 4:06 PM | Balloon Control For Ruptured AAAs: When And When Not To Use |
Presenter(s):George H. Meier III, MD | |
4:07 PM - 4:12 PM | DEBATE: EVAR Is No Better Than Open Repair (OR) For Ruptured AAAs |
Presenter(s):Michel Makaroun, MD | |
4:13 PM - 4:18 PM | DEBATE: Nonsense: Data Showing Equality Of EVAR And OR For Ruptured AAAs Is Flawed: If Done Right EVAR Is Superior |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
4:19 PM - 4:24 PM | 100% Of Ruptured AAAs Can Be Treated Endovascularly If Chimneys And Periscopes Are Used: Outcomes Are Good And Turn-Down Rates Are Low |
Presenter(s):Dieter O. Mayer, MD / Thomas Larzon, MD, PhD / Mario Lachat, MD | |
4:25 PM - 4:30 PM | EVAR Is A Feasible Option For Ruptured Suprarenal AAAs And TAAAs |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
4:31 PM - 4:36 PM | Treatment Of Ruptured Pararenal AAAs And TAAAs Can Be Treated Successfully With Off-The-Shelf Devices: Is There Any Role For OR |
Presenter(s):Timothy A. Resch, MD, PhD | |
4:37 PM - 4:43 PM | Panel Discussion |
END OF SESSION 55 | |
SESSION 56 SCHEDULE | |
Thursday
SESSION 56:
MORE ON AORTIC ANEURYSMS, CHIMPS AND AORTIC BRANCH ARTERIES
Moderators:Richard P. Cambria, MD / Giovanni Torsello, MD
|
|
x | |
4:43 PM - 4:48 PM | Hybrid Procedures Are The Way To Go For TAAAs In Young Patients With Hereditary Collagen Disorders: Use Of Gore Hybrid Grafts And The VORTEC Technique To Facilitate Branch Anastomoses |
Presenter(s):Sebastian E. Debus, MD, PhD | |
4:49 PM - 4:54 PM | DEBATE:Debranching Works Well For Arch Aneurysms And Is Currently The Procedure Of Choice For Most: Lessons Learned From An Experience With More Than 160 Arch Aneurysms And Dissections |
Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
View Abstract | |
4:55 PM - 5:00 PM | DEBATE:New Data On Double And Triple Chimney Grafts For Arch Lesions: Will They Eliminate The Need For Branched Grafts And Hybrid Procedures |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
5:01 PM - 5:06 PM | How To Make Arch Chimneys Work: They Are The Way To Go |
Presenter(s):Thomas Larzon, MD, PhD | |
5:07 PM - 5:12 PM | Indications And Outcomes For Arch Chimney Grafts - When Do They Work And When Don’t They: How To Avoid Pitfalls |
Presenter(s):Martin Malina, MD, PhD | |
5:13 PM - 5:18 PM | Four-Year Follow-Up On Arch Chimneys: They Are Durable |
Presenter(s):Nicola Mangialardi, MD / Sonia Ronchey, MD, PhD | |
View Abstract | |
5:19 PM - 5:24 PM | A Note Of Caution Regarding Chimney Grafts: They Are Not As Good As Some Claim |
Presenter(s):Willem Wisselink, MD | |
5:25 PM - 5:30 PM | Renal Chimney Grafts Do Work And Can Be Placed From The Groins: The Push-Up Technique |
Presenter(s):Mario Lachat, MD | |
5:31 PM - 5:36 PM | Isolated Renal And Visceral Artery Dissection Should Be Treated Medically |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
5:37 PM - 5:42 PM | Anatomic Feasibility Of Off-The-Shelf Fenestrated Endografts To Treat Juxta And Pararenal AAAs: Comparison Of The P-Branch (Cook) And Ventana (Endologix) Devices: What Proportion Of Patients Are Suitable |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
5:43 PM - 5:50 PM | Panel Discussion End Of Program G |
END OF SESSION 56 | |
SESSION 57 SCHEDULE | |
Thursday
SESSION 57:
MANAGEMENT OF INFECTED GRAFTS AFTER EVAR AND OPEN SURGERY: ROLE OF EVAR FOR MYCOTIC ANEURYSMS
Moderators:Timur P. Sarac, MD / Peter R. Taylor, MA, MChir, FRCS, ARCM
|
|
x | |
1:00 PM - 1:05 AM | Graft Infections After EVAR: How Should They Be Diagnosed And Treated |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Treatment Of Infected Grafts After EVAR: Is There Hope |
Presenter(s):Edward Y. Woo, MD | |
1:12 PM - 1:17 PM | Infection Following EVAR: An Under-Reported Problem With Old Solutions And New Challenges: What Should We Be Doing For This Problem |
Presenter(s):Laura Capoccia, MD, PhD | |
1:18 PM - 1:23 PM | Does Semiconservative Treatment Of Infected Aortic Grafts And Endografts – With Salvage Of The Graft Work: What Are The Requirements To Make It Work |
Presenter(s):Martin Malina, MD, PhD | |
1:24 PM - 1:29 PM | Diagnosis Of Vascular Prosthetic Graft Infection By PET/SPECT Scanning |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
1:30 PM - 1:35 PM | How Well Do Cryopreserved Allografts Used In In-Line Reconstructions Work For Aortic Graft Infection: When Should They Not Be Used |
Presenter(s):Peter F. Lawrence, MD | |
1:36 PM - 1:41 PM | In Situ Reconstruction Is The Preferred Treatment For Aortic Graft Enteric Erosion Or Fistula |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
1:42 PM - 1:47 PM | Endovascular Treatment Of Infected AAAs (Mycotic Aneurysms): Virulence Of The Organism Is Key: Is Surgical Drainage And Debridement Always Necessary |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
1:48 PM - 1:53 PM | EVAR Treatment Of Infected AAAs Can Be Effective Long-Term Without Secondary Treatment: What Are The Requirements |
Presenter(s):Boonprasit Kritpracha, MD | |
1:54 PM - 1:59 PM | Next Generation Antimicrobial Silver-Triclosan Vascular Prosthetic Grafts (Synergy/Maquet): How Good Will They Be And Will They Enable In Situ Repair In Patients With Graft Infections (European Results) |
Presenter(s):Max Zegelman, MD, PhD | |
View Abstract | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 57 | |
SESSION 58 SCHEDULE | |
Thursday
SESSION 58:
INTERESTING NEW LOWER AND UPPER EXTREMITY AND STEM CELL TOPICS
Moderators:John (Jeb) W. Hallett, MD / John B. Chang, MD
|
|
x | |
2:06 PM - 2:11 PM | Updated Strategies To Treat Acute Arterial Complications Of Total Knee And Hip Replacements |
Presenter(s):Maria Antonella Ruffino, MD | |
2:12 PM - 2:17 PM | New Cutting Balloon Technology To Improve The Results Of Endovascular Treatment Of Lower Extremity Ischemia: The Chocolate Balloon |
Presenter(s):Syed M. Hussain, MD | |
2:18 PM - 2:23 PM | DEBATE: Open Bypasses For Severe Upper Extremity Digital Ischemia: There Is A Role |
Presenter(s):R. Clement Darling III, MD | |
2:24 PM - 2:29 PM | DEBATE: With Good Endovascular Techniques There Is No Role For Bypasses In Upper Extremity And Digital Ischemia |
Presenter(s):Roberto Ferraresi, MD | |
2:30 PM - 2:35 PM | Image Sharing Telemedicine Connects PACS Systems Via A VPN Network |
Presenter(s):Jon S. Matsumura, MD | |
2:36 PM - 2:41 PM | A New Simplified Less Invasive And Better Technique For Treating Iliofemoral Aneurysms |
Presenter(s):Zoran Rancic, MD, PhD | |
2:42 PM - 2:47 PM | When Should Femoral Aneurysms Be Treated And How |
Presenter(s):Peter F. Lawrence, MD | |
2:48 PM - 2:53 PM | What Is The Best Treatment For Intermittent Claudication Due To SFA Occlusion Based On All Trial Data |
Presenter(s):Lawrence A. Garcia, MD | |
2:54 PM - 2:59 PM | In.Pact DEB In The SFA For Intermittent Claudication: Is It Justified |
Presenter(s):Peter Gaines, MD | |
3:00 PM - 3:05 PM | Role Of Open Operative And Non-Operative Treatment For Intermittent Claudication: When Is Open Operation Better Than Endovascular Treatment |
Presenter(s):Gregory L. Moneta, MD | |
3:06 PM - 3:11 PM | Critical Review Of Stem Cell Treatment For CLI: False Hope Or True Promise |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
3:12 PM - 3:17 PM | What’s New In The Clinical Trial Of Stem Cells And Angiogenesis: Is There A Role In Treating Lower Extremity Ischemia |
Presenter(s):Richard J. Powell, MD | |
3:18 PM - 3:23 PM | What’s New In Stem Cell Research: Are Positive Results In The Heart Going To Be Reflected In The Leg |
Presenter(s):Alan Dardik, MD, PhD | |
3:24 PM - 3:45 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 58 | |
SESSION 59 SCHEDULE | |
Thursday
SESSION 59:
MORE HOT TOPICS RELATED TO THE THORACIC AORTA
Moderators:Rodney A. White, MD / Wei Guo Fu, MD
|
|
x | |
3:45 PM - 3:50 PM | Errors In Aortic Sizing Can Be Due To Non-Circular Aortas And Systolic-Diastolic Variability: How To Avoid These Errors By EKG Gated CTA And Other Means |
Presenter(s):Juan C. Parodi, MD / Ramon Berguer, MD, PhD | |
3:51 PM - 3:56 PM | Which Uncomplicated Acute Type B Aortic Dissection Should Not Be Treated Medically: The Size Of The Primary Tear, Its Location And False Lumen Flow Matter And Can Mandate TEVAR Treatment |
Presenter(s):Richard G.J. Gibbs, FRCS | |
3:57 PM - 4:02 PM | How To Better Understand Spinal Cord Ischemia (SCI) During TEVAR |
Presenter(s):Germano Melissano, MD | |
View Abstract | |
4:03 PM - 4:08 PM | DEBATE: CSF Drainage Is Not Always Needed During TEVAR: It Can Be Done When Necessary: The Case Against Prophylaxis |
Presenter(s):Burkhart Zipfel, MD | |
4:09 PM - 4:14 PM | DEBATE: SCI Prophylaxis With CSF Drainage Is Better Than Rescue Treatment With EVAR: The Case For Wider Use Of CSF Drainage |
Presenter(s):Charles W. Acher, MD | |
View Abstract | |
4:15 PM - 4:21 PM | Panel Discussion |
END OF SESSION 59 | |
SESSION 60 SCHEDULE | |
Thursday
SESSION 60:
MORE NEW DEVELOPMENTS RELATED TO LOWER EXTREMITY DISEASE AND MISCELLANEOUS TOPICS
Moderators:Wesley S. Moore, MD / Lucien D. Castellani, MD
|
|
x | |
4:21 PM - 4:26 PM | Use Of The Art Assist Device In The Treatment Of CLI: How Does It Work And When Should It Be Used |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
4:27 PM - 4:32 PM | Novel Enodvascular Method For Completely Percutaneous Femoropopliteal Bypass: Experimental And Initial Clinical Experience |
Presenter(s):James D. Joye, DO | |
4:33 PM - 4:38 PM | "Time Is Tissue": A New Systematic Approach To Diabetic Foot Infections: Is It Really New Or Just Newly Recognized |
Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD | |
4:39 PM - 4:44 PM | Tips And Pitfalls For Saving CLI Limbs In Dialysis Patients: They Are Difficult But Limbs Can Be Saved Even With Poor Runoff, Extensive Calcium And Advanced Gangrene |
Presenter(s):Nobuyoshi Azuma, MD | |
4:45 PM - 4:50 PM | Impact Of Age, ESRD, And Diabetes On Mortality After Lower Extremity Bypasses: Diabetes Doesn’t Matter; The Others Do |
Presenter(s):Hisham Rashid, FRCS, FRCS (Gen) | |
4:51 PM - 4:56 PM | Effectiveness Of Statins On Outcomes After SFA Interventions For CLI |
Presenter(s):Mark G. Davies, MD | |
4:57 PM - 5:02 PM | XXS Study: A RCT Of PTA vs. Stents In CLI Patients |
Presenter(s):Gunnar Tepe, MD | |
5:03 PM - 5:08 PM | The Unique Properties Of A 3D Helical Stent |
Presenter(s):Peter Gaines, MD | |
5:09 PM - 5:14 PM | Is There A Role For DEBs In Heavily Calcified Arteries |
Presenter(s):Fabrizio Fanelli, MD | |
MISCELLANEOUS TOPICS | |
5:15 PM - 5:20 PM | Tips And Tricks On How To Use CO2 For Arteriography: When Should It Not Be Used |
Presenter(s):Kyung Cho, MD | |
5:21 PM - 5:26 PM | Pulsatile Venous Tinnitus In Young Women: A Scary But Easily Fixed Symptom: Its Pathogenesis, Diagnosis And Treatment |
Presenter(s):Ramon Berguer, MD, PhD | |
5:27 PM - 5:32 PM | Effect Of A Posture Shirt On Throwing Velocity, Throwing Accuracy And Blood Flow Of Baseball Pitchers |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
5:33 PM - 5:38 PM | Tips And Tricks On How To Reduce Radiation Exposure |
Presenter(s):Mark A. Farber, MD | |
5:39 PM - 5:44 PM | CFA PTA And Stenting: Does It Work And Can It Be Done In An Office Setting |
Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
5:45 PM - 5:55 PM | Panel Discussion End Of Program H |
END OF SESSION 60 | |
SESSION 61 SCHEDULE | |
Thursday
SESSION 61:
LARGE VEIN OCCLUSION: UNMET NEEDS AND OPPORTUNITIES FOR THE FUTURE
|
|
x | |
1:00 PM - 1:05 PM | Venous Disease From The Foot To The Heart: How Large Is The Need And Why Its Treatment Should Be Considered By The Vascular Practitioner |
Presenter(s):Peter Gloviczki, MD | |
1:06 PM - 1:11 PM | Calf Vein DVT: Incidence And Treatment Implications For The Clinician And The Patient |
Presenter(s):Ross Milner, MD | |
1:12 PM - 1:17 PM | Lower Extremity DVT In Women: Is The Disease Any Different Than In Men |
Presenter(s):Joann Lohr, MD | |
1:18 PM - 1:23 PM | Highlights Of The 2013 International Guidelines on the Prevention of Venous Thromboembolism |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
1:24 PM - 1:29 PM | Venous Quality Of Life Indices: What Are They And Are They Of Use Only For Research Or Should We Use Them To Follow Our Patients Clinically |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
1:30 PM - 1:35 PM | Optimal Institutional Program For Venous Thromboembolism And DVT Prevention: Proof That It Works And Is Cost Effective |
Presenter(s):Nicholas J. Morrissey, MD | |
1:36 PM - 1:41 PM | DEBATE: Expanding Treatment To Chronic Iliofemoral Venous Occlusion: Like Arterial Occlusion, They Are Best Managed By Relieving The Obstruction |
Presenter(s):Mark W. Mewissen, MD | |
1:42 PM - 1:47 PM | DEBATE: Chronic Iliofemoral Venous Occlusion Dictates A Medical Solution In Some Patients |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
1:48 PM - 1:54 PM | Panel Discussion |
END OF SESSION 61 | |
SESSION 62 SCHEDULE | |
Thursday
SESSION 62:
OTHER COMMONLY ENCOUNTERED VENOUS OCCLUSIVE PROBLEMS AND THEIR TREATMENT
|
|
x | |
1:55 PM - 2:00 PM | Upper Extremity Venous Disease- Missed Opportunities For Improving Long-Term Patient Outcomes |
Presenter(s):Karl A. Illig, MD | |
2:01 PM - 2:06 PM | Axillo-Subclavian Venous Stenoses: Underdiagnosed And Thus Undertreated |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
2:07 PM - 2:12 PM | DEBATE: Axillo-Subclavian Stenoses Unmasked By Thrombolysis Should Be Treated With Angioplasty And Stenting |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
2:13 PM - 2:18 PM | DEBATE: Axillo-Subclavian Stenoses Unmasked by Thrombolysis Should Be Treated With Surgical Reconstruction And Thoracic Outlet Decompression |
Presenter(s):Ali Azizzadeh, MD | |
2:19 PM - 2:24 PM | The Incidence Of DVT After Saphenous Venous Ablation Is Low But Is Correlated With The Technique |
Presenter(s):Lois A. Killewich, MD, PhD | |
2:25 PM - 2:30 PM | DEBATE: Calf Vein DVTs Are Dangerous And Should Be Treated |
Presenter(s):Anil P. Hingorani, MD | |
2:31 PM - 2:36 PM | DEBATE: All Calf DVTs Are Not The Same: A Case For Selective Treatment |
Presenter(s):Elna M. Masuda, MD | |
2:37 PM - 2:45 PM | Panel Discussion |
2:45 PM - 3:15 PM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 62 | |
SESSION 63 SCHEDULE | |
Thursday
SESSION 63:
TREATMENT OF LOWER EXTREMITY DVT: BALLOONS, STENTS, THROMBOLYSIS, ULTRASOUND, AND MECHANICAL THROMBECTOMY
Moderators:John B. Chang, MD / Kenneth Ouriel, MD, MBA, FACS, FACC
|
|
x | |
3:16 PM - 3:21 PM | Lower Extremity Veins Are Different Than Arteries: Stents Used In Veins Should Be Engineered For Veins |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
3:22 PM - 3:27 PM | DEBATE:Anticoagulation Is Warranted After Venous Stenting Of Chronic Iliofemoral Venous Occlusions: Aspirin Is Not Enough |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
3:28 PM - 3:33 PM | DEBATE:Patency After Stenting Of Chronic Iliofemoral Venous Occlusion Is Not Improved With Angicoagulation: Aspirin Is Adequate |
Presenter(s):Seshadri Raju, MD | |
3:34 PM - 3:39 PM | Stenting Across The Inguinal Ligament: Devices, Technique, And Results |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
3:40 PM - 3:45 PM | Acute DVT Treatment: Anticoagulation vs. Angiojet Assisted Thrombolysis: The Pearl Registry |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
3:46 PM - 3:51 PM | Catheter Directed Thrombolysis Improves Outcomes For Acute DVT: CaVent, ATTRACT And Dutch CAVA Trials |
Presenter(s):Rick De Graaf, MD, PhD | |
3:52 PM - 3:57 PM | Rapid Pharmacomechanical Venous Clot Removal In The High Risk Patient With Ultrasound Accelerated Lysis: Downgrading Contraindications From Absolute To Relative |
Presenter(s):Mark J. Garcia, MD | |
3:58 PM - 4:03 PM | The Ekosonic System For Penetrating Thrombus In Veins |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
4:04 PM - 4:09 PM | Clinical Practice Guidelines For Management Of Acute DVT |
Presenter(s):Mark H. Meissner, MD | |
4:10 PM - 4:15 PM | Panel Discussion |
END OF SESSION 63 | |
SESSION 64 SCHEDULE | |
Thursday
SESSION 64:
INFERIOR VENA CAVAL ISSUES: ENDOVASCULAR AND OPEN SURGICAL MANAGEMENT
Moderators:David Rosenthal, MD / John E. Connolly, MD
|
|
x | |
4:16 PM - 4:21 PM | Why Aren’t Retrievable IVC Filters Retrieved |
Presenter(s):Ronald L. Dalman, MD | |
4:22 PM - 4:27 PM | Ultrasound-Assisted Thrombolysis For DVT Including The IVC And Iliac Veins |
Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD | |
4:28 PM - 4:33 PM | Update On The Trellis Device For Treating Thrombi That Trail Into The IVC |
Presenter(s):Paul J. Gagne, MD | |
4:34 PM - 4:39 PM | Stenting For Chronic IVC Occlusion |
Presenter(s):Seshadri Raju, MD | |
4:40 PM - 4:45 PM | Malignant IVC Stenosis And Occlusion: Is Vascular Reconstruction Necessary At The Time Of Tumor Resection |
Presenter(s):Timur P. Sarac, MD | |
4:46 PM - 4:51 PM | Management Of Iatrogenic IVC Injury: Techniques In The Exsanguinating Patient |
Presenter(s):Peter Gloviczki, MD | |
4:52 PM - 5:00 PM | Panel Discussion End of Program I |
END OF SESSION 64 | |
Friday, November 22, 2013
Print Entire 2013 Program:
|
|
SESSION 65 SCHEDULE | |
Friday
SESSION 65:
NEW DEVELOPMENTS IN TREATMENT OF AAAs
Moderators:Michael L. Marin, MD / Kenneth Ouriel, MD, MBA, FACS, FACC
|
|
x | |
6:55 AM - 7:00 AM | A Way To Simplify FEVAR With Difficult Anatomy: Sequential Catheterizations And Progressive Endograft Deployment: The SCAPED Technique |
Presenter(s):Carlos H. Timaran, MD | |
7:01 AM - 7:06 AM | Can We Reduce Follow-up Protocols After EVAR For Some Patients: How Can It Be Done And In Which Patients |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
7:07 AM - 7:12 AM | PET CT Can Predict Rupture Risk In Small AAAs And Safety In Following Large AAAs |
Presenter(s):Natzi Sakalihasan, MD, PhD | |
7:13 AM - 7:18 AM | What Is The Role For Open AAA Repair In The Endovascular Era: Who Should Be Doing It |
Presenter(s):Karl H. Orend, MD | |
7:19 AM - 7:24 AM | Are All Inflammatory AAAs Best Treated By EVAR |
Presenter(s):Manju Kalra, MBBS | |
View Abstract | |
7:25 AM - 7:30 AM | Operative Management Of AAAs In Infants And Early Childhood: What Are They Due To And What Are The Long-Term Results |
Presenter(s):James C. Stanley, MD | |
View Abstract | |
7:31 AM - 7:36 AM | How To Do EVAR As An Outpatient Procedure: Experience In >100 Patients Show There Is No Downside And Many Advantages |
Presenter(s):Mario Lachat, MD / Jacques Bleyn, MD | |
7:37 AM - 7:42 AM | Changes In EVAR Outcomes Over The Last 10 Years: Comparison Of EUROSTAR And ENGAGE Registry Results: Why Is There A Difference |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
7:43 AM - 7:48 AM | Towards The Prevention Of Secondary Sac Rupture After EVAR |
Presenter(s):Roger M. Greenhalgh, MD | |
7:49 AM - 7:54 AM | DEBATE: Late Results Of The OVER And EVAR Trials Show That EVAR Is No Better Than Open Repair |
Presenter(s):Frank A. Lederle, MD | |
7:55 AM - 8:00 AM | DEBATE: Nonsense: The Late Results Of OVER And EVAR Prove EVAR Is Better |
Presenter(s):Juan C. Parodi, MD / Benjamin W. Starnes, MD / Christopher J. Kwolek, MD / Frank J. Veith, MD | |
8:01 AM - 8:06 AM | EVAR Does Make A Difference And Improves Overall Outcomes Of Elective And Ruptured AAAs Despite The Trials: Based On Information From The US Medicare Database |
Presenter(s):Marc L. Schermerhorn, MD | |
8:07 AM - 8:14 AM | Panel Discussion |
END OF SESSION 65 | |
SESSION 66 SCHEDULE | |
Friday
SESSION 66:
NEW DEVELOPMENTS IN DISEASES OF MAJOR AORTIC BRANCHES
|
|
x | |
8:14 AM - 8:19 AM | Technique For Laparoscopic Treatment Of Arculate Ligament Syndrome And Celiac Compression: Is It A Better Way |
Presenter(s):Yves Alimi, MD | |
8:20 AM - 8:25 AM | Tips And Tricks For Minimal Touch Techniques To Avoid Atheroembolization During Renal And Visceral PTA And Stenting |
Presenter(s):Kim J. Hodgson, MD | |
8:26 AM - 8:31 AM | Renal And Visceral Artery Stenoses: When And How Are They Best Treated |
Presenter(s):Sebastian E. Debus, MD, PhD | |
8:32 AM - 8:37 AM | Late Breaking Results From The CORAL Trial And Other Information: What Is The Current Role For Renal Artery Stenting (RAS) |
Presenter(s):Thomas A. Sos, MD | |
8:38 AM - 8:43 AM | The Need For Distal Protection During RAS: When And How To Do It |
Presenter(s):Max Amor, MD | |
8:44 AM - 8:49 AM | Role For Covered Stents In Renal And Visceral Lesions: Technical Tips |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:50 AM - 8:55 AM | Viabahn And Gore Hybrid Grafts To Decrease Renal And Mesenteric Ischemia In Visceral Segment Debranching Procedures (Using The Lachat Concept) |
Presenter(s):Michael C. Stoner, MD | |
8:56 AM - 9:01 AM | Endovascular Treatment Of Acute Mesenteric Ischemia: Role Of First Look Laparoscopy |
Presenter(s):Joseph S. Giglia, MD | |
9:02 AM - 9:07 AM | Endovascular Treatment Of 3 Mesenteric Arteries: When Is It Indicated And Needed |
Presenter(s):Furuzan Numan, MD | |
HYPOGASTRIC ARTERIES DURING EVAR | |
9:08 AM - 9:13 AM | Tips And Tricks For Coil Occlusion Of Hypogastric Arteries Using A New Large Volume Detachable Coil: The Penumbra RUBY Coil |
Presenter(s):Frank R. Arko, MD | |
9:14 AM - 9:19 AM | Technique And Long-Term Results Of The Trifurcated Endograft Method For Hypogastric Revascularization During EVAR With Iliac Aneurysms |
Presenter(s):David J. Minion, MD | |
9:20 AM - 9:25 AM | Long-Term Results Of Sandwich Techniques For Complex Aorto-Iliac And Common Iliac Aneurysms: The Brazilian Registry Shows Them To Be Better Than Hypogastric Exclusion By Coil Embolization And Bell Bottom Techniques |
Presenter(s):Armando C. Lobato, MD, PhD | |
9:26 AM - 9:31 AM | New Off-The-Shelf Gore Branched Internal Iliac Device For Hypogastric Revascularization: Technique And Early Clinical Experience |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
9:32 AM - 9:39 AM | Panel Discussion |
9:39 AM - 9:54 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 66 | |
SESSION 67 SCHEDULE | |
Friday
SESSION 67:
ISSUES RELATED TO BUSINESS, GOVERNMENT, HEALTH CARE REFORM, INDUSTRY AND ETHICS
|
|
x | |
9:54 AM - 9:59 AM | Unintentional Consequences Of Disruptive Technology |
Presenter(s):Edward B. Diethrich, MD | |
10:00 AM - 10:05 AM | Is It Time For Physicians To Unionize And Why |
Presenter(s):Timothy M. Sullivan, MD | |
10:06 AM - 10:11 AM | Will Vascular Surgeons Continue To Lead Vascular Surgery Within Vascular Centers Or Will Other Specialists Become Dominant As They Have In Many Important Institutions |
Presenter(s):Ramon Berguer, MD, PhD | |
10:12 AM - 10:17 AM | Differences In The Independent Or Monospecialty Status Of Vascular Surgery In Europe And The US: How Has Independence Helped Vascular Surgery In Europe |
Presenter(s):Florian Dick, MD | |
10:18 AM - 10:23 AM | Are There Storm Clouds On The Horizon For Vascular Surgery: What Are They And What Can We Do About Them |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
10:24 AM - 10:29 AM | Impact Of Obamacare (ACA) On Vascular Surgeons/Specialists: How Will It Impact On The Way We Practice And Use Advanced Technology |
Presenter(s):Glenn Jacobowitz, MD | |
10:30 AM - 10:35 AM | Impact Of Obamacare (ACA) On American Medicine: An Industry Point Of View |
Presenter(s):Kem Hawkins, MBA | |
10:36 AM - 10:41 AM | Impact Of Obamacare (ACA) On American Medicine: Will it Be As Bad As We Fear: An Academic And Clinical Leader’s Point Of View |
Presenter(s):Clifford J. Buckley, MD | |
10:42 AM - 10:47 AM | Impact Of Obamacare On Vascular Surgery: An SVS And Government Relations Leader’s Point Of View |
Presenter(s):Robert M. Zwolak, MD, PhD | |
10:48 AM - 10:53 AM | ABC Of ACOs/Shared Demonstration Project: Understanding The Program And The Reimbursement Impact: Will Vascular Surgeons Be Poor |
Presenter(s):Sean P. Roddy, MD | |
10:54 AM - 10:59 AM | Health Care And Physician Organization Models To Help Us Survive In The Next Decade |
Presenter(s):Barry T. Katzen, MD | |
OFFICE-BASED PRACTICE | |
11:00 AM - 11:05 AM | Office Based PAD Labs: How Can They Help Your Practice And What Equipment Is Needed |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:06 AM - 11:11 AM | Advantages Of An Office Based Angiosuite For An Academic Vascular Practice: Hurricane Sandy Did Us A Favor |
Presenter(s):Mark A. Adelman, MD | |
11:12 AM - 11:17 AM | Economic Advantages To Setting Up An Office Practice For Venous Procedures, Angiography And PTA: What Are The Pitfalls To Avoid And Is Duplex Essential |
Presenter(s):Enrico Ascher, MD | |
11:18 AM - 11:23 AM | Risks And Benefits Of Employment Contracts For Vascular Surgeons/Specialists |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
11:24 AM - 11:29 AM | What To Do When A Jehovah’s Witness Requires A Blood Transfusion During Emergency Surgery |
Presenter(s):James W. Jones, MD, PhD, MHA | |
View Abstract | |
11:30 AM - 11:36 AM | Panel Discussion |
END OF SESSION 67 | |
SESSION 68 SCHEDULE | |
Friday
SESSION 68:
A TRIBUTE TO OUR MILITARY (8 AND 10-MINUTE TALKS)
|
|
x | |
11:36 AM - 11:44 AM | How Has The Treatment Of Battle Casualties Advanced Between Vietnam And Iraq And Afghanistan: A New Emergency Response Aortic Occlusion System (ER-AOS) For Hemorrhagic Shock Is On The Horizon |
Presenter(s):Todd E. Rasmussen, MD, FACS / Norman M. Rich, MD, FACS, DMCC | |
11:45 AM - 11:55 AM | Experiences Of A Surgeon Astronaut And His Comments About Today’s World |
Presenter(s):Lee M. Morin, MD, PhD | |
View Abstract | |
11:55 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 68 | |
SESSION 69 SCHEDULE | |
Friday
SESSION 69:
INTERESTING HOT TOPICS AND UPDATES
Moderators:Krassi Ivancev, MD, PhD / Anatoly V. Pokrovsky, MD
|
|
x | |
7:00 AM - 7:05 AM | Treatment Of Hematomas Following Arterial Punctures: How To Avoid Malpractice Claims |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
7:06 AM - 7:11 AM | Technical Tips For Cracking And Paving With Bad Iliacs And Other Options For Patients With Poor Access |
Presenter(s):Timothy A. Resch, MD, PhD / Martin Malina, MD, PhD | |
7:12 AM - 7:17 AM | Prevention And Treatment Of A-V Fistulas After Fogarty Embolectomy And PTA |
Presenter(s):Jos C. van den Berg, MD, PhD | |
7:18 AM - 7:23 AM | Duplex Ultrasound As The Sole Imaging Technique For Treating CLI |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
7:24 AM - 7:29 AM | Advantages Of The Proteus Angioslide Embolic Capture Device For Treating Fem-Pop Disease: When Is It Indicated |
Presenter(s):Peter C.J. Goverde, MD | |
7:30 AM - 7:35 AM | With EVAR Its Not Just Anatomy: Race, Ethnicity And Gender Influence Outcomes And Cost |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
7:36 AM - 7:41 AM | What’s New In DES For Fem-Pop And BTK Lesions: Results Of The DESTINY 2 And PES BTK-70 Trials With Paclitaxil And Everolimus Eluting Stents |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
7:42 AM - 7:47 AM | Two-Year Results Of The Protégé-Everflex Stent (EV-3) To Treat Popliteal Lesions: The DURABILITY-POP Trial |
Presenter(s):Patrick Peeters, MD | |
7:48 AM - 7:53 AM | Role And Importance Of The Anesthesiologist In Minimally Invasive Procedures |
Presenter(s):Carlo Setacci, MD | |
7:54 AM - 7:59 AM | What Is The Effect Of Smoking On The Prevalence Of AAA And Does Smoking Influence EVAR Outcome |
Presenter(s):Frans L. Moll, MD, PhD | |
8:00 AM - 8:05 AM | MMP-9 Is An Excellent Marker For Detecting Endoleaks After EVAR: How Should It Be Used |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
8:06 AM - 8:12 AM | Panel Discussion |
END OF SESSION 69 | |
SESSION 70 SCHEDULE | |
Friday
SESSION 70:
EXCITING NEW DEVELOPMENTS WITH ENDOVASCULAR GRAFTS AND DEVICES FOR EVAR AND FENESTRATED AND BRANCHED EVAR
Moderators:Stephan Haulon, MD / James F. McKinsey, MD
|
|
x | |
8:13 AM - 8:18 AM | Fate Of Visceral And Renal Stents And Covered Stents In Fenestrated And Branched Endovascular Repairs: They Are Not Perfect: How To Make Them Near Perfect |
Presenter(s):Piotr M. Kasprzak, MD | |
8:19 AM - 8:24 AM | DEBATE: 10-Year Experience With Fenestrated And Branched Endografts: The Procedures Work And Are Durable: Open Operations Are Procedures From The Past |
Presenter(s):Tara M. Mastracci, MD / Matthew J. Eagleton, MD / Roy K. Greenberg, MD | |
8:25 AM - 8:30 AM | DEBATE: Not So! Many Patients With TAAAs And Suprarenal AAAs Need Open Repair: Which Ones Do |
Presenter(s):Hazim J. Safi, MD | |
8:31 AM - 8:36 AM | Status Of Off-The-Shelf Devices For TAAAs: When Will They Be Available: What Proportion Of Patients Will Be Suitable |
Presenter(s):Timothy A.M. Chuter, DM | |
8:37 AM - 8:42 AM | Advantages And Limitations Of The Ventana Off-The-Shelf Fenestrated Device For Pararenal AAAs: Clinical Trial Results |
Presenter(s):Daniel G. Clair, MD | |
8:43 AM - 8:48 AM | Advantages And Limitations Of The Anaconda Fenestrated Graft For Juxta- And Pararenal AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
8:49 AM - 8:54 AM | Anaconda Fenestrated Graft: Short And Medium Term Results Of The First 100 UK Cases |
Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR | |
8:55 AM - 9:00 AM | Advantages And Limitations Of The Jotec Branched Endograft For TAAAs |
Presenter(s):Johannes Lammer, MD | |
9:01 AM - 9:06 AM | Innovative New Concept For A Versatile And Simple Branched Endograft Featuring Multiple Bifurcations To Repair TAAAs, Revascularize Hypogastrics, Etc. |
Presenter(s):Patrick W. Kelly, MD | |
9:07 AM - 9:12 AM | Advantages And Limitations Of The Lombard Aorfix Endograft, Now FDA Approved In The US |
Presenter(s):Mark F. Fillinger, MD | |
9:13 AM - 9:22 AM | Panel Discussion |
Moderator(s): Kenneth Ouriel, MD, MBA, FACS, FACC / Calogero Presti, MD | |
9:23 AM - 9:28 AM | Novel EVAR Devices That Seal Differently: Newer Polymer-Based Devices Make Traditional Concepts Of Neck Length Obsolete |
Presenter(s):Syed M. Hussain, MD | |
9:29 AM - 9:34 AM | Update On The Status Of The Nellix Device: A Different Concept For EVAR: Can It Be Used To Treat Ruptured AAAs |
Presenter(s):Andrew Holden, MBChB | |
9:35 AM - 9:40 AM | Clinical Experience With The TriVascular Ovation Endograft For EVAR: Post Trial And Multicenter Experience Show Continued Good Results In The Real World |
Presenter(s):Sean P. Lyden, MD / Michael D. Dake, MD | |
9:41 AM - 9:46 AM | The Horizon Endograft: A New Concept In Endografting That Can Be Applied To Situations Requiring Branched Grafts |
Presenter(s):Ralf R. Kolvenbach, MD / Mario Lachat, MD | |
View Abstract | |
9:47 AM - 9:52 AM | Two-Year Results Of The ENGAGE Global Registry With The Endurant Graft For EVAR |
Presenter(s):Dittmar Boeckler, MD | |
9:53 AM - 9:58 AM | Why Totally Infrarenal Devices With Repositioning Capability Are Best For EVAR With AAAs That Have Hostile Necks |
Presenter(s):Carlos H. Timaran, MD | |
9:59 AM - 10:04 AM | Better Graft Apposition To The Aortic Neck Correlates With Sealing And Sac Regression After EVAR: An Advantage Of The Endologix AFX Endograft: Why Is This Endograft Different In This Regard |
Presenter(s):Mell B. Welborn III, MD / Jean-Paul de Vries, MD, PhD | |
10:05 AM - 10:10 AM | The US Experience With The Incraft Endograft For EVAR: The INSPIRATION Trial |
Presenter(s):Michel Makaroun, MD | |
10:11 AM - 10:16 AM | One-Year Results With The Cordis Incraft: The INNOVATION Trial |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
10:17 AM - 10:22 AM | A New Better Off-The-Shelf Endograft With Internal Branches To Treat Most Pararenal AAAs |
Presenter(s):Marcelo Ferreira, MD | |
10:23 AM - 10:30 AM | Panel Discussion |
10:31 AM - 10:50 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 70 | |
SESSION 71 SCHEDULE | |
Friday
SESSION 71:
EXCITING NEW DEVELOPMENTS WITH ENDOGRAFT DEVICES FOR TEVAR AND AORTIC FIXATION WITH STAPLES
Moderators:Julie Ann Freischlag, MD / Gregg S. Landis, MD
|
|
x | |
10:50 AM - 10:55 AM | Challenges With TEVAR In The Aortic Arch: How Does The Gore C-TAG Device Help To Meet Them |
Presenter(s):Dittmar Boeckler, MD | |
10:56 AM - 11:01 AM | Advantages Of The Medtronic Valiant Captiva Device For TEVAR In Or Near The Arch |
Presenter(s):Giovanni Torsello, MD | |
View Abstract | |
11:02 AM - 11:07 AM | Advantages Of The Cook TX2 Pro-Form Low Profile Device For TEVAR In Or Near The Arch |
Presenter(s):Tilo Koelbel, MD, PhD | |
11:08 AM - 11:13 AM | Advantages Of The Bolton Relay Device For TEVAR In Or Near The Arch |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
11:14 AM - 11:19 AM | Status Of And Clinical Experience With The Embrella Cerebral Embolic Protection Device For Use During TEVAR And TAVR Procedures |
Presenter(s):Jeffrey P. Carpenter, MD | |
AORTIC FIXATION (STAPLING) DEVICES | |
11:20 AM - 11:25 AM | Heli-FX EndoAnchor System: When Should It Be Used And How Effective Is It In Stopping Migration And Endoleaks: How Durable Is It |
Presenter(s):David H. Deaton, MD | |
11:26 AM - 11:31 AM | Can The Heli-FX EndoAnchor Be Used To Treat Type I Endoleaks: An Overview Of The European Experience |
Presenter(s):Jean-Paul de Vries, MD, PhD / Dittmar Boeckler, MD | |
11:32 AM - 11:37 AM | Heli-FX EndoAnchors To Improve Fixation Of Aortic Endografts: When Are They Needed And Do They Decrease Secondary Interventions: Worldwide Experience With 200 Patients From The ANCHOR Registry |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
11:38 AM - 11:43 AM | The Lombard Stapling Device For Endograft Fixation: When Will It Become Available |
Presenter(s):Brian R. Hopkinson, ChM, FRCS | |
11:44 AM - 11:49 AM | Use Of The Heli-FX EndoAnchors In TEVAR: How To Resolve Problems In Complex Or Failing Cases |
Presenter(s):Luis A. Sanchez, MD | |
11:50 AM - 12:00 PM | Panel Discussion End Of Program K |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Friday
SESSION 72:
MORE LOWER EXTREMITY HOT TOPICS AND THE MULTILAYER STENT
Moderators:Keith D. Calligaro, MD / William D. Suggs, MD
|
|
x | |
7:00 AM - 7:05 AM | When Is Distal Embolic Protection Needed In Infrainguinal Interventions: How To Do It |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
7:06 AM - 7:11 AM | When Is Distal Embolic Protection Needed For SFA Interventional Procedures: How Should It Be Done |
Presenter(s):Nicholas J. Morrissey, MD | |
7:12 AM - 7:17 AM | Multicenter Analysis Of Early Tibial Bypass Patency: Comparison Of Different Conduits And Configurations |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
7:18 AM - 7:23 AM | DEBATE: Some CLI Patients Do Better With A Bypass First Strategy: Which Ones |
Presenter(s):Michael S. Conte, MD | |
7:24 AM - 7:29 AM | DEBATE: An Endo First Strategy Is Better For All CLI Patients: However, PTA Is Not Perfect But Will Be With Improvements That Are On The Horizon: What Is The Relevance Of Gap Analysis |
Presenter(s):Krishna J. Rocha-Singh, MD | |
7:30 AM - 7:35 AM | Infrapopliteal PTA Works Well Up To 5 Years For CLI If Lesions Are Short But Not For Long Lesions In Poor Bypass Candidates: Nature Of Disease Not Open vs. Endo Determines Outcome |
Presenter(s):Marc L. Schermerhorn, MD | |
7:36 AM - 7:41 AM | Panel Discussion |
Moderator(s): Giorgio M. Biasi, MD / Givi A. Tsitsuashvili, MD, PhD | |
7:42 AM - 7:47 AM | DEBs And DESs In Infrapopliteal Arteries: With DEBs Is There Still A Role For Stenting |
Presenter(s):Fabrizio Fanelli, MD | |
7:48 AM - 7:53 AM | A New Better Device For Continuous Mechanical/Aspiration Thrombectomy For Lower Extremity Arteries And With Less Blood Loss And Hemolysis: The Penumbra Indigo System |
Presenter(s):Richard R. Saxon, MD | |
7:54 AM - 7:59 AM | Can Direct Puncture Of Occluded Stents Facilitate Retrograde Crossing And Recanalization Of Long Occlusions That Cannot Be Crossed Antegrade: How To Do It |
Presenter(s):Giancarlo Biamino, MD, PhD | |
8:00 AM - 8:05 AM | RC Trial Comparing Standard Thrombolysis With Ultrasound Enhanced Thrombolysis In Lower Extremity Ischemia: The DUET Trial |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
8:06 AM - 8:11 AM | Updated Strategies To Treat Acute Arterial Complications Of Total Knee And Hip Replacements: Should The Treatment Be Endovascular |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
8:12 AM - 8:17 AM | How Well Does Current Non-Operative And Non-Interventional Treatment Work For Intermittent Claudication: In What Proportion Of Patients Is Intervention/Operation Justified |
Presenter(s):Peter Henke, MD | |
8:18 AM - 8:23 AM | How To Do Interventional Procedures In Patients With Ehlers-Danlos Syndrome |
Presenter(s):James H. Black III, MD | |
8:24 AM - 8:29 AM | How To Make Office Based Interventions Economically Favorable: Is IVUS Helpful And Cost Effective |
Presenter(s):Paul J. Gagne, MD | |
8:30 AM - 8:37 AM | Panel Discussion |
MORE ABOUT THE MULTILAYER FLOW MODULATING (MLFM) STENT FOR ANEURYSM TREATMENT | |
Moderator(s): Kenneth Ouriel, MD, MBA, FACS, FACC / Frans L. Moll, MD, PhD | |
8:38 AM - 8:43 AM | Peripheral And Visceral Artery Aneurysms: Cardiatis Multilayer Flow Modulating (MLFM) Uncovered Stent Provides Effective Treatment |
Presenter(s):Claudio Rabbia, MD, PhD / Maria Antonella Ruffino, MD | |
8:44 AM - 8:49 AM | German Registry Experience With The MLFM Stent In The Treatment Of Aortic Aneurysms |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:50 AM - 8:55 AM | Two-Year Single Center Experience With MLFM Stents For Treatment Of Challenging Complex Aortic Aneurysms: Are These Uncovered Stents An Effective Treatment Based On Sac Size And Pressure Measurements: What Is Their Role |
Presenter(s):Thomas Larzon, MD, PhD | |
8:56 AM - 9:01 AM | Mechanisms Involved In The Way MLFM Stents Treat Aortic Aneurysms: How The Induced Sac Thrombosis Could Prevent Rupture |
Presenter(s):Jean-Marc Alsac, MD, PhD / Jean-Baptiste Michel, MD, PhD | |
View Abstract | |
9:02 AM - 9:07 AM | MLFM Uncovered Stents Will Never Replace Branched And Fenestrated Grafts For The Treatment Of Complex Aortic Aneurysms: A Skeptic’s View |
Presenter(s):Timothy A.M. Chuter, DM | |
9:08 AM - 9:13 AM | A Positive 2-Year Experience With Use Of the Multilayer Flow Modulating Stent To Treat Complex Aortic Aneurysms With Follow-Up Data On Aneurysm Size Changes And Rupture Risk |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC / Niamh Hynes, MD | |
9:14 AM - 9:22 AM | Panel Discussion |
9:23 AM - 9:40 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
Friday
SESSION 73:
MORE HOT TOPICS RELATED TO THE AORTA, ITS BRANCHES AND ANEURYSMS
Moderators:James C. Stanley, MD / John H. Furtek, BS, RT(r)
|
|
x | |
9:40 AM - 9:45 AM | Duodenal De-Rotation For SMA Compression Of The Duodenum: When And How To Do It |
Presenter(s):William J. Quinones-Baldrich, MD | |
9:46 AM - 9:51 AM | The Worst Patients For EVAR Are The Best For Minimally Invasive Open Repair Which Is Better Than FEVAR: Tips And Tricks For Minilap Open Repair |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
9:52 AM - 9:57 AM | How Do Infrarenal Neck Morphology Changes Compare After EVAR And Open Repair: OR Was Pretty Good: From The DREAM Trial |
Presenter(s):Jan D. Blankensteijn, MD | |
9:58 AM - 10:03 AM | Tips And Tricks For Explanting Failed EVAR Endografts Safely |
Presenter(s):Afshin Assadian, MD | |
10:04 AM - 10:09 AM | Why Is Limb Thrombosis More Frequent With Low Profile EVAR Devices: How To Prevent And Treat It |
Presenter(s):Ronald M. Fairman, MD | |
10:10 AM - 10:15 AM | Profile vs. Durability In Aortic Endografts: What Is The Best Tradeoff |
Presenter(s):Scott L. Stevens, MD | |
10:16 AM - 10:21 AM | Effective Post-EVAR Surveillance Saves Lives: What Are The Best Reasonable Strategies Now And Moving Forward |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
10:22 AM - 10:27 AM | EVAR With Lower Profile: What Is The Future And What Concerns Should We Have |
Presenter(s):Michel Makaroun, MD | |
10:28 AM - 10:38 AM | Panel Discussion |
Moderator(s): Krassi Ivancev, MD, PhD / Jonathan S. Deitch, MD | |
10:39 AM - 10:44 AM | Effect Of Experience And Learning Curve On FEVAR: Are More Fenestrations Good Or Bad |
Presenter(s):Timothy A. Resch, MD, PhD | |
10:45 AM - 10:50 AM | A Progressively Compliant Endograft: Theoretical Advantages For Aortic Dissections And Other Conditions |
Presenter(s):Juan C. Parodi, MD | |
10:51 AM - 10:56 AM | The Optimal 3D Imaging And Planning For Complex AAA Repair By EVAR: It Is Getting Better |
Presenter(s):Lieven F. Maene, MD | |
10:57 AM - 11:02 AM | Benefits Of Innova Vision Technology With The GE Discovery System Makes Complex AAA Repair Simpler And Requires Less Radiation And Contrast |
Presenter(s):Stephan Haulon, MD | |
11:03 AM - 11:08 AM | DEBATE: Most Coarctations, Re-Coarctations, And Related Aneurysms Should Be Treated Endovascularly |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
11:09 AM - 11:14 AM | DEBATE: Not So! Some Of These Complex Coarctation Patients Require Open Repair |
Presenter(s):Joseph S. Coselli, MD | |
11:15 AM - 11:20 AM | How Does The Turn-Down Rate For Definitive Treatment Affect Overall And Procedural Mortality Rates For Ruptured AAAs In The US: How Can These Rates Be Improved |
Presenter(s):John J. Ricotta, MD | |
11:21 AM - 11:26 AM | Asymptomatic Renal Artery Aneurysms: When Should They Be Treated: Do We Really Know: What Is The Best Data |
Presenter(s):Peter F. Lawrence, MD | |
11:27 AM - 11:32 AM | Final Results Of The PEVAR (Percutaneous EVAR) Trial: PEVAR Is Best Except In What Circumstances: What Is Missing From The PEVAR Trial |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
11:33 AM - 11:45 AM | Panel Discussion End Of Program L |
11:45 AM - 1:00 PM | Lunch Break – Rhinelander Gallery (2nd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floor) |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
ISSUES RELATED TO TRAINING, CERTIFICATION, SPECIALIZATION, SIMULATION, RANDOMIZED CONTROLLED TRIALS (RCTs)
Moderators:John F. Eidt, MD / Karl A. Illig, MD
|
|
x | |
1:00 PM - 1:05 PM | Update On 0+5 Vascular Surgical Residencies: How Well Are They Working |
Presenter(s):Peter Henke, MD | |
1:06 PM - 1:11 PM | Comparison Of Vascular Surgery, Interventional Radiology And Interventional Cardiology Training Positions And Those Filling Them: Work Force Issues And Is Vascular Surgery Vulnerable |
Presenter(s):John F. Eidt, MD | |
1:12 PM - 1:17 PM | What Specialists Performs EVAR In The United States: From The Entire Medicare Database Since 2002: Which Specialty Does It Best: The Results Are Surprising |
Presenter(s):Ramon Berguer, MD, PhD / Jordan Knepper, MD | |
1:18 PM - 1:23 PM | Effect Of Surgeon Specialty And Volume On The Outcomes Of CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
1:24 PM - 1:29 PM | How To Shift The Learning Curve From The Patient To The Model Or Simulator: Rationale And Scope Of The International Vascular Training Courses |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:30 PM - 1:35 PM | Improving Endovascular Ruptured AAA Treatment By Simulation: Is Patient Specific Simulation Using Their CTA On The Horizon |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
1:36 PM - 1:41 PM | DEBATE: Randomized Controlled Trials (RCTs) And Level I Evidence Is The Best Guide To Good Medical Practice |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
1:42 PM - 1:47 PM | DEBATE: Nonsense, RCTs And Level I Evidence May Be Misleading And Not Lead To Best Medical Practice |
Presenter(s):Michael D. Dake, MD | |
1:48 PM - 1:53 PM | Why Are So Many Important Clinical Trials Falling Short Of Their Goals: What Are Their Flaws And How May They Be Prevented |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
1:54 PM - 1:59 PM | Why Can RCTs Be Misleading And Misinterpreted: Is Bias Ever A Consideration |
Presenter(s):Timothy M. Sullivan, MD | |
2:00 PM - 2:05 PM | Why Randomization And RCT Data Is Over-Rated And Over-Valued As A Measure Of Evidence Quality |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
2:06 PM - 2:11 PM | RCTs: Are They A Quest For The Truth Or A Means To An End |
Presenter(s):Francesco Liistro, MD | |
2:12 PM - 2:17 PM | The Impact Of Evidence On Current Practice |
Presenter(s):Roger M. Greenhalgh, MD | |
2:18 PM - 2:35 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floor) |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
FDA, REGISTRIES, HEALTH CARE REFORM, CONFLICT OF INTEREST, COST ISSUES, IMPROVING VASCULAR CARE
Moderators:Bruce A. Perler, MD, MBA / Frank J. Veith, MD
|
|
x | |
2:35 PM - 2:40 PM | What Is Off-Label Use: New Verdict, And New Rules And What They Mean For Vascular Surgeons And Vascular Specialists |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
2:41 PM - 2:46 PM | What Is The FDA Doing To Help With Vascular Device Innovation |
Presenter(s):Dorothy B. Abel, BSBME | |
2:47 PM - 2:52 PM | The Rise And Demise Of Medical Technology In The US: Why I Am Working With The FDA And Will It Do Any Good |
Presenter(s):Thomas J. Fogarty, MD | |
2:53 PM - 2:58 PM | How To Get An Investigator Sponsored IDE From The FDA In 2013 |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
2:59 PM - 3:04 PM | SVS VQI Update: Benefits, Challenges, Downsides |
Presenter(s):Jack L. Cronenwett, MD | |
3:05 PM - 3:10 PM | Identifying And Attacking The Top 5 Economic Challenges Of Obamacare (ACA) |
Presenter(s):Michael R. Jaff, DO | |
3:11 PM - 3:16 PM | Why Current Conflict Of Interest (COI) Policy Is A Farce |
Presenter(s):David H. Deaton, MD | |
3:17 PM - 3:22 PM | Calculating Total Cost For Vascular Procedures In The ACO Era |
Presenter(s):Timothy M. Sullivan, MD | |
3:23 PM - 3:28 PM | The Disconnect Between The Value To Patients And The Value To Hospitals For Complex Vascular Care: What Can Be Done To Fix The Problem |
Presenter(s):Michael C. Stoner, MD | |
3:29 PM - 3:34 PM | Cost Analysis Of Different Treatment Strategies For Non-Embolic Acute Limb Ischemia |
Presenter(s):Fedor Lurie, MD, PhD | |
3:35 PM - 3:41 PM | What VASCULAR SPECIALIST – Our SVS Newspaper – Has Meant To US Vascular Surgeons And What Is Its Future |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
3:42 PM - 3:47 PM | New Readmission Policies And Their Impact On Vascular Patients: Will Their Care Be Compromised |
Presenter(s):K. Craig Kent, MD | |
3:48 PM - 3:53 PM | All Vascular Surgery Should Be Centralized In High Volume Centers: Who Will Be Unhappy And Will It Happen |
Presenter(s):Ian Loftus, MD | |
View Abstract | |
3:54 PM - 3:59 PM | How Does Porter’s 5 Forces Model Impact On Vascular Surgery And What Should Individual Vascular Surgeons Do About It |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
4:00 PM - 4:07 PM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
NATURAL HISTORY OF VASCULAR DISEASE, ADVANCES IN MEDICAL TREATMENT AND PREVENTION
Moderators:Ronald L. Dalman, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
4:07 PM - 4:12 PM | What’s New With Endovascular Ablation Procedures For Atrial And Ventricular Arrhythmias: Why They Are Important To All Vascular Specialists |
Presenter(s):Larry Chinitz, MD | |
4:13 PM - 4:18 PM | Will Ezetimibe Have Increased Value When Added To Statins (Lipitor, Etc.) Over Statins Alone: What Does Ezetimibe Do |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
4:19 PM - 4:24 PM | All Vascular Surgery Patients Should Have Perioperative Troponin Measurements: Why And How Do They Help In Patient Management |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
4:25 PM - 4:30 PM | Increased Troponins And MIs In Vascular Surgical Patients Indicates Decreased 5-Year Survival: What Can Be Done To Improve This Poor Survival |
Presenter(s):Andres Schanzer, MD | |
4:31 PM - 4:36 PM | Genome Based Antiplatelet Treatment Will Improve Patient Outcomes In Patients With CAD And PAD |
Presenter(s):Karthikeshwar Kasirajan, MD | |
4:37 PM - 4:42 PM | How To Decrease Cardiac Mortality In Diabetic Patients With CLI |
Presenter(s):Francesco Liistro, MD | |
4:43 PM - 4:48 PM | DEBATE: Does Doxycline Treatment Help Keep Small AAAs Small: A RCT Shows That It Doesn’t Help |
Presenter(s):Jan H.N. Lindeman, MD, PhD | |
4:49 PM - 4:54 PM | DEBATE: The Doxycline Story Is Not Over: Another Trial Is Needed: Are There Other Drugs That Will Keep Small AAAs Small |
Presenter(s):John A. Curci, MD | |
4:55 PM - 5:00 PM | DEBATE: Screening Is Worthwhile In PVD Patients For Carotid Disease, Etc. |
Presenter(s):Glenn Jacobowitz, MD | |
5:01 PM - 5:06 PM | DEBATE: Screening Is Not Worthwhile: We Should ONLY Look For Atherosclerotic Disease When Symptoms Arise |
Presenter(s):Erich Minar, MD | |
5:07 PM - 5:12 PM | Initial Findings, Costs And Surgical Consequences Of Screening For AAA, PAD And Hypertension: Danish Population-Based RCT (VIVA) Of 50,000 65-74 Year Old Men: Is It Worthwhile |
Presenter(s):Jes S. Lindholt, MD | |
5:13 PM - 5:18 PM | What Is Happening With Cardiomems For AAA And PA Pressure Monitoring: Does It Have A Future |
Presenter(s):Ross Milner, MD | |
5:19 PM - 5:24 PM | Upper Extremity BP Differential Is A Marker For PAD, Carotid Disease And CAD: Is It Better Than ABIs |
Presenter(s):Caron B. Rockman, MD | |
5:25 PM - 5:35 PM | Panel Discussion End Of Program M |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
NEW TECHNIQUES, CONCEPTS AND UPDATES
Moderators:Ali F. AbuRahma, MD / A. Ross Naylor, MD, FRCS
|
|
x | |
1:00 PM - 1:05 PM | The Statin-Iron Nexus: Iron Reduction As An Alternative To Statins; Its Basis And How To Do It |
Presenter(s):Ralph G. DePalma, MD | |
View Abstract | |
1:06 PM - 1:11 PM | Microbubbles Can Facilitate Local Catheter Directed Thrombolysis And Decrease Systemic Side Effects: How Does The Technology Work |
Presenter(s):Kak Khee Yeung, MD, PhD / Willem Wisselink, MD | |
View Abstract | |
1:12 PM - 1:17 PM | Update On New Medications For Treating Lipid Abnormalities |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
1:18 PM - 1:23 PM | Do We Need To Stop Plavix Before Open Vascular Surgery |
Presenter(s):Jack L. Cronenwett, MD | |
1:24 PM - 1:29 PM | Tips And Tricks For Successful PEVAR 100% Of The Time |
Presenter(s):Firas F. Mussa, MD | |
1:30 PM - 1:35 PM | Long-Term Survival With Thoracic Aneurysms Is Worse After TEVAR Than Open Repair: This Does Not Mean We Should Abandon TEVAR |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
1:36 PM - 1:41 PM | Stem Cell Mobilization Improves Amputation Rates In CLI: What Is the Mechanism; How Can It Be Done Simply And Is It Better Than Stem Cell Transplantation |
Presenter(s):Eric T. Choi, MD | |
1:42 PM - 1:47 PM | CTO Crossing Techniques Using Only Catheters And Wires: How Often Are Special Devices Needed For Bailout: What Should Be In Your Toolbox |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Abstract | |
1:48 PM - 1:53 PM | DEBATE: How Bad Is A Minor MI After CAS Or CEA: It Is Equivalent To A Stroke |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
1:54 PM - 1:59 PM | DEBATE: Not So! In CREST A Minor Stroke Had A Worse Effect On Quality Of Life And As Bad An Effect On 4-Year Mortality As An MI |
Presenter(s):Thomas G. Brott, MD | |
2:00 PM - 2:05 PM | Updated Gender Differences In CAS vs. CEA Outcomes From CREST And The SVS Registry Indicate That CAS Is Rarely Justified In Women |
Presenter(s):Kosmas I. Paraskevas, MD / Dimitri P. Mikhailidis, MD / Christos D. Liapis, MD / Frank J. Veith, MD | |
View Abstract | |
2:06 PM - 2:30 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
NEW TECHNOLOOGY, TECHNIQUES, CONCEPTS AND UPDATES RELATED TO LOWER EXTREMITY, CAROTID AND VISCERAL ARTERY DISEASE
Moderators:Patrick J. Lamparello, MD / Lucien D. Castellani, MD
|
|
x | |
2:30 PM - 2:35 PM | Tips And Tricks For Doing Most Peripheral Interventions Via The Radial Artery |
Presenter(s):Ivo Petrov, MD, PhD | |
LOWER EXTREMITY TOPICS | |
2:36 PM - 2:41 PM | Open vs. Endovascular For Peripheral Aneurysms Including Popliteals: Outcomes Of Stent-Graft Exclusion Can Be Equivalent Or Better Than Open Repair (OR) If Certain Patients Are Excluded: Who Should Get OR |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
2:42 PM - 2:47 PM | Interventional Strategy For Large Popliteal Aneurysms With Tortuous Anatomy |
Presenter(s):Jacques Busquet, MD | |
2:48 PM - 2:53 PM | The Multispecialty BEST CLI Trial: What It Will Tell Us About The Treatment Of Lower Extremity CLI And Why It Is Unique |
Presenter(s):Matthew T. Menard, MD / Kenneth Rosenfield, MD / Alik Farber, MD / Michael D. Dake, MD / Michael S. Conte, MD | |
2:54 PM - 2:59 PM | Tips And Tricks For Sartorius Muscle Flaps For Groin Complications After Vascular Procedures: How To Make Them Work |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
3:00 PM - 3:05 PM | DEBATE: Subintimal PTA Is Superior To SilverHawk Atherectomy For Lower Extremity Occlusive Lesions |
Presenter(s):Jeffrey Indes, MD | |
3:06 PM - 3:11 PM | DEBATE: Not So! The SilverHawk Atherectomy Device Is A Valuable Tool If Used Correctly |
Presenter(s):James F. McKinsey, MD | |
3:12 PM - 3:17 PM | How Can OCT (Optical Coherence Tomography) Help In The Treatment Of Peripheral Arterial Lesions |
Presenter(s):Vikram S. Kashyap, MD | |
3:18 PM - 3:23 PM | How To Perform A To Z Revascularization Of Tibial Arteries Quickly And With High Success: How To Make Them Durable |
Presenter(s):Craig M. Walker, MD | |
3:24 PM - 3:29 PM | Toe And Foot Osteomyelitis: How To Diagnose And Treat It: Medical vs. Surgical |
Presenter(s):Wayne J. Caputo, DPM | |
3:30 PM - 3:35 PM | Restoring The Reputation Of Spliced Arm Veins For Lower Extremity Bypasses |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
3:36 PM - 3:43 PM | Panel Discussion |
CAROTID, VISCERAL, RENAL TOPICS | |
Moderator(s): Michel Makaroun, MD / Christos D. Liapis, MD | |
3:43 PM - 3:48 PM | Urgent CAS For Acutely Symptomatic Carotid Stenosis Works Fine And Has Good Outcomes If Certain Tips, Techniques And Strategies Are Followed |
Presenter(s):Gioacchino Coppi, MD | |
3:49 PM - 3:54 PM | A RC Trial Comparing Acuseal (PTFE) With Bovine Pericardium For Patching During CEA: Which Is Best And Why |
Presenter(s):Patrick A. Stone, MD | |
3:55 PM - 4:00 PM | DEBATE: Completion Imaging Should Be Performed After CEA |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
4:01 PM - 4:06 PM | DEBATE: Completion Imaging Is Not Needed After CEA |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
4:07 PM - 4:12 PM | How Does Routine Completion Angioscopy Decrease The Stroke Rate After CEA |
Presenter(s):A. Ross Naylor, MD, FRCS | |
4:13 PM - 4:18 PM | Retrograde Mesenteric PTA And Stent For Mesenteric Ischemia: Chronic And Acute |
Presenter(s):Edward Y. Woo, MD | |
4:19 PM - 4:24 PM | Stenting Of Renal Artery Stenosis Is Better Than Medical Treatment: Results Of The RADAR Trial |
Presenter(s):Thomas Zeller, MD | |
4:25 PM - 4:31 PM | Panel Discussion |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
NEW TECHNOLOGY, TECHNIQUES, CONCEPTS AND UPDATES RELATED TO AORTIC DISEASE
Moderators:Peter F. Lawrence, MD / Julie Ann Freischlag, MD
|
|
x | |
4:32 PM - 4:37 PM | All Acute Type B Aortic Dissections Are Complicated And Should Be Treated Interventionally |
Presenter(s):Frank R. Arko, MD | |
4:38 PM - 4:43 PM | Natural History Of Untreated Large AAAs In Patients Too Sick To Treat In The Modern Era: Is Prognosis Better Than We Thought |
Presenter(s):Katariina M. Noronen, MD / Maarit Venermo, MD / Mauri J.A. Lepantalo, MD | |
View Abstract | |
4:44 PM - 4:49 PM | Results Of The ECAR RCT Comparing EVAR And Open Repair For Ruptured AAAs: Why It Is Not Definitive Or Is It |
Presenter(s):Pascal Desgranges, MD, PhD | |
4:50 PM - 4:55 PM | What Is The Importance Of Biomarkers In Patients With AAA Disease |
Presenter(s):Ronald L. Dalman, MD | |
4:56 PM - 5:01 PM | Alternate Approaches To Hypogastric Revascularization During EVAR: Is There Still A Role For Open Revascularization Or Occlusion Without Revascularization |
Presenter(s):Arno von Ristow, MD | |
View Abstract | |
5:02 PM - 5:07 PM | Fate Of The Distal Aorta In Marfan’s Patients: How To Follow Them And Manage Them |
Presenter(s):Joseph S. Coselli, MD | |
View Abstract | |
5:08 PM - 5:13 PM | Wrapping Of Dilated Ascending Aorta To Facilitate Clamping, And Debranching That Is Otherwise Not Possible |
Presenter(s):Mario Lachat, MD | |
5:14 PM - 5:19 PM | How To Prevent Strokes During And After TEVAR |
Presenter(s):Bart E. Muhs, MD, PhD | |
5:20 PM - 5:30 PM | Panel Discussion End Of Program N |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
NEW DEVELOPMENTS IN EVAR, TEVAR, COMPLEX EVAR, LAPAROSCOPY AND RENAL DENERVATION
Moderators:Jean-Pierre Becquemin, MD, FRCS / Ronald M. Fairman, MD
|
|
x | |
1:00 PM - 1:05 PM | How To Decrease The Cost Of EVAR |
Presenter(s):Richard J. Powell, MD | |
1:06 PM - 1:11 PM | EVAR Is Better Than Open Repair: The Danish Registry Clearly Shows It In Comparable Patient Cohorts |
Presenter(s):Torben V. Schroeder, MD, DMSc | |
View Abstract | |
1:12 PM - 1:17 PM | Tips And Tricks On How To Place Palmaz Stents In Challenging EVAR Necks Accurately And Safely |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
1:18 PM - 1:23 PM | In Situ Fenestration To Revascularize Covered Hypogastric Arteries: Equipment And Technical Steps |
Presenter(s):Grayson H. Wheatley, MD | |
1:24 PM - 1:29 PM | Preoperative IMA Embolization Before EVAR: Is It Worthwhile And When |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
1:30 PM - 1:35 PM | Complex Iatrogenic Dissection Complicating TEVAR For (Degenerative) Aneurysm Of The Descending Aorta: Recognition And Management |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
1:36 PM - 1:41 PM | For Infected Paravisceral Aortic Grafts Cryopreserved Allografts Are A Good Treatment Option: How Should They Be Used |
Presenter(s):Mark D. Morasch, MD, FACS, RPVI | |
1:42 PM - 1:47 PM | Laparoscopic Aortofemoral Bypass Using A Clampless Sutureless Aortic Anastomotic Technique |
Presenter(s):Bernard J. Segers, MD | |
View Abstract | |
1:48 PM - 1:53 PM | Are There Potential Downsides To Renal Artery Denervation By Radiofrequency: What Damage To The Renal Artery Does It Cause And Are All Nerves Around The Artery Destroyed |
Presenter(s):Clemens Jilek, MD | |
1:54 PM - 2:02 PM | Panel Discussion |
TEVAR RELATED TOPICS | |
2:02 PM - 2:07 PM | Which Chronic Type B Aortic Dissection Should Be Treated With Fenestrated And Branched Endografts: Tips And Tricks For Doing This |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
2:08 PM - 2:13 PM | Fenestrated And Branched TEVAR Is Good Treatment For Some Chronic Type B Aortic Dissections: But At What Price |
Presenter(s):Marcelo Ferreira, MD | |
2:14 PM - 2:19 PM | When Should Aortic Branches Be Stented In The Treatment Of Complicated Acute Type B Aortic Dissections |
Presenter(s):Tara M. Mastracci, MD / Matthew J. Eagleton, MD / Roy K. Greenberg, MD | |
2:20 PM - 2:25 PM | Temporary Perfusion Branches Are The Way To Go To Decrease Spinal Cord Ischemia With Endovascular Repair Of TAAAs: Clinical Experience |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
2:26 PM - 2:31 PM | Branches With A Removable Plug To Decrease SCI After TAAA Endovascular Repair: Mechanism And Technique |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
2:32 PM - 2:37 PM | 3 Possible Techniques For Aortic Arch Repair Which Will Win Out |
Presenter(s):Eric E. Roselli, MD | |
2:38 PM - 2:51 PM | Panel Discussion |
2:51 PM - 3:10 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
NEW DEVELOPMENTS IN INNOVATION AND LOWER EXTREMITY AND CAROTID DISEASE
Moderators:Thomas J. Fogarty, MD / Albrecht H. Kramer, MD
|
|
x | |
3:10 PM - 3:15 PM | Advances In Interactive Telephone Technologies That Monitor And Improve Vascular Care Compliance |
Presenter(s):John (Jeb) W. Hallett, MD | |
3:16 PM - 3:21 PM | Nano And Microparticle Drug Delivery: How Will It Play A Role In Peripheral Arterial Interventions |
Presenter(s):Subhash Banerjee, MD | |
3:22 PM - 3:27 PM | Thrombosuction For Acute Limb Ischemia: Equipment, Technical Tips And Results |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
3:28 PM - 3:33 PM | External Iliac Arteriopathy (Endofibrosis) In Cyclists And Other Athletes: Recognition And Treatment |
Presenter(s):Kenneth J. Cherry, MD | |
3:34 PM - 3:39 PM | Life-Threatening Rupture In Vascular Ehlers-Danlos Syndrome: Is Endovascular Therapy Safe And Effective: Tips And Tricks That Help |
Presenter(s):Kyung Cho, MD | |
3:40 PM - 3:45 PM | Tips And Tricks For SFA Recanalization: Can Radiofrequency Help: Pitfalls |
Presenter(s):Marcelo S. Guimaraes, MD | |
3:46 PM - 3:51 PM | Endovascular Salvage Of Occluded Vascular Grafts: Tips And Tricks |
Presenter(s):Craig M. Walker, MD | |
3:52 PM - 3:57 PM | Novel Endovascular Technique To Administer Dexamethasone Into The Adventitia With Intent To Reduce Restenosis: 12-Month Results From The DANCE Pilot |
Presenter(s):Christopher D. Owens, MD | |
3:58 PM - 4:08 PM | Panel Discussion |
CAROTID RELATED TOPICS | |
Moderator(s): Giancarlo Biamino, MD, PhD / Richard M. Green, MD | |
4:09 PM - 4:14 PM | If CAS Experience Matters So Much, Why Are CAS Enthusiasts Pushing Everyone To Do CAS: Shouldn’t The Procedure Be Centralized |
Presenter(s):Klaus D. Mathias, MD | |
4:15 PM - 4:20 PM | What The Timing Of Strokes With CAS Tells Us About Their Pathogenesis: What Can Be Done To Decrease Stroke Rates |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
4:21 PM - 4:26 PM | Is There A Role For CAS With A Carotid String Sign |
Presenter(s):Carlos H. Timaran, MD | |
4:27 PM - 4:32 PM | Myths In The Interpretation Of The CREST Trial: Does An MI Have A Worse Effect On Late Mortality Than A Stroke: Is A Cranial Nerve Deficit Equivalent To A Stroke: Gender Has No Effect On Outcomes |
Presenter(s):Thomas G. Brott, MD | |
4:33 PM - 4:38 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: CAS – A Surgeon Interventionalist’s View |
Presenter(s):Kim J. Hodgson, MD | |
4:39 PM - 4:44 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: CAS – An Interventional Cardiologist’s View |
Presenter(s):Sriram S. Iyer, MD | |
4:45 PM - 4:50 PM | DEBATE: What Is The Best Treatment For Most Patients With Asymptomatic High Grade Carotid Stenosis: Best Medical Treatment: Another Surgeon’s View |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
4:51 PM - 4:56 PM | How To Perform CAS With Difficult Arch Anatomy Using Radial And Brachial Approaches: Tips And Tricks |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
4:57 PM - 5:07 PM | Panel Discussion End Of Program O |
END OF SESSION 81 | |
Saturday, November 23, 2013
Print Entire 2013 Program:
|
|
SESSION 82 SCHEDULE | |
Saturday
SESSION 82:
NEW TECHNOLOGIES, TECHNIQUES AND CONCEPTS: SOME HOT CAROTID TOPICS
Moderators:A. Ross Naylor, MD, FRCS / Ali Khoynezhad, MD, PhD
|
|
x | |
7:00 AM - 7:05 AM | Indications For Lower Extremity Bypasses In The Endovascular Era |
Presenter(s):R. Clement Darling III, MD | |
7:06 AM - 7:11 AM | Tibial Stents With Coronary Devices Are Effective In Achieving Foot Healing In Diabetics With CLI And Ulcers Or Gangrene |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
7:12 AM - 7:17 AM | Spiral Laminar Flow Grafts Show Encouraging Mid-Term Patency Results |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
7:18 AM - 7:23 AM | Endo-First vs. Bypass-First: Endo-First Has Some Negative Consequences In CLI Patients: Who Should Get Bypass-First Treatment |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
7:24 AM - 7:29 AM | Home Exercise Program With Nordic Walking Poles Are An Effective Treatment For Intermittent Claudication: Proof From A RC Trial |
Presenter(s):Jonathan D. Beard, MD | |
7:30 AM - 7:35 AM | In Infants Non-Operative Treatment Of Acute Limb Ischemia Is Best: The Evidence |
Presenter(s):Michael C. Dalsing, MD | |
View Abstract | |
7:36 AM - 7:41 AM | The ROX Device For Creating Endovascularly An A-V Fistula Is An Effective Treatment For Resistant Hypertension: What Is Its Effect On The Heart |
Presenter(s):David H. Deaton, MD | |
7:42 AM - 7:47 AM | Latin American Consensus For Best Modern Diagnosis And Treatment For Carotid Body Tumors |
Presenter(s):Oscar L. Ojeda, MD | |
View Abstract | |
CAROTID TOPICS | |
7:48 AM - 7:53 AM | Can Genetic Or Other Variables Predict Cognitive Changes After Carotid Interventions |
Presenter(s):Wei Zhou, MD | |
7:54 AM - 7:59 AM | Value Of MRI In Predicting The Behavior Of Carotid Plaques |
Presenter(s):Peter L. Faries, MD, FACS | |
8:00 AM - 8:05 AM | Institutional Differences In Carotid Duplex Criteria Produce Great Variability In Classification Of Carotid Stenosis And Disparities In Care And Cost |
Presenter(s):Andres Schanzer, MD | |
8:06 AM - 8:11 AM | Advantages And Limitations Of IVUS Guided CAS |
Presenter(s):Martin R. Back, MD | |
8:12 AM - 8:17 AM | Defining The High Risk Patients For Carotid Surgery; It’s Not As Simple As You Think: You Can’t Tell A Book By Its Cover |
Presenter(s):Laura Capoccia, MD, PhD | |
8:18 AM - 8:23 AM | The Higher Reimbursements For CAS Do Not Offset The Higher Costs |
Presenter(s):W. Charles Sternbergh III, MD | |
8:24 AM - 8:30 AM | Panel Discussion |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Saturday
SESSION 83:
MORE ABOUT THORACIC AND ABDOMINAL AORTIC DISEASE; ANEURYSMS AND DISSECTIONS; RENAL STENTING
Moderators:Vicente Riambau, MD, PhD / Mark A. Farber, MD
|
|
x | |
8:30 AM - 8:35 AM | Importance And Pitfalls In The Proper Endograft Sizing For TEVAR Treatment Of Traumatic Aortic Transections |
Presenter(s):Mark A. Farber, MD | |
8:36 AM - 8:41 AM | An Off-The-Shelf Fenestrated Stent-Graft For Juxta And Pararenal AAAs: One-Year Results With The Pivot Branch Device |
Presenter(s):James F. McKinsey, MD | |
8:42 AM - 8:47 AM | 10 Top Highlights Of The ESVS (European) Guidelines For The Treatment Of Descending Thoracic Aortic Disease |
Presenter(s):Vicente Riambau, MD, PhD | |
8:48 AM - 8:53 AM | Treatment Of Post-Surgery Pseudoaneurysms In The Ascending Aorta With Endovascular Devices |
Presenter(s):Luigi Inglese, MD | |
8:54 AM - 8:59 AM | 5-Year Results Of The TX 2 Trial For TEVAR: The Procedures Are Durable With Few Late Complications |
Presenter(s):Jon S. Matsumura, MD | |
9:00 AM - 9:05 AM | Do Thrombi In The Aortic Arch Need To Be Removed Or Covered: What Is Their Natural History |
Presenter(s):Samy S. Nitecki, MD | |
View Abstract | |
9:06 AM - 9:12 AM | Panel Discussion |
Moderator(s): Wesley S. Moore, MD / Jean-Pierre Becquemin, MD, FRCS | |
9:12 AM - 9:17 AM | First Case Of Endovascular Treatment Of A Complicated Acute Type B Aortic Dissection (TBAD) Treated With An Endograft: 15-Year Follow-Up |
Presenter(s):Juan C. Parodi, MD | |
9:18 AM - 9:23 AM | DEBATE: Emerging Evidence Continues To Support The Endograft Treatment Of All TBADs |
Presenter(s):Rodney A. White, MD | |
9:24 AM - 9:29 AM | DEBATE: Outcome Of TEVAR For TBADs Depends On The Indication For Treatment: They Do Not All Need to Be Treated |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
9:30 AM - 9:35 AM | Role Of Size And Location Of Intimal-Medial Tears In Predicting The Behavior Of Acute TBADs |
Presenter(s):Ali Khoynezhad, MD, PhD | |
9:36 AM - 9:41 AM | A New Method To Quantify Aortic Biomechanics In Vivo Using Four-Dimensional Magnetic Resonance Imaging (4D MRI): Implications For Ascending Aortic Endografts |
Presenter(s):Rachel Clough, MD, PhD / Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
9:42 AM - 9:47 AM | Treating Type B Aortic Dissections With A Dissection Specific Endovascular System: Does It Lead To Better Remodeling Than With Other Systems Based On Updated Results Of The STABLE Trial |
Presenter(s):Joseph V. Lombardi, MD | |
9:48 AM - 9:53 AM | Value Of Open Rescue After Failed TEVAR And EVAR Procedures: Tips And Tricks |
Presenter(s):Yamume Tshomba, MD / Roberto Chiesa, MD | |
View Abstract | |
9:54 AM - 9:59 AM | Renal Stenting With EVAR: When And How To Do It |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
10:00 AM - 10:05 AM | Renal Artery Stenting Failure May Require Complex Surgical Revascularization: Tips And Tricks |
Presenter(s):Thomas C. Bower, MD | |
View Abstract | |
10:06 AM - 10:30 AM | Panel Discuss and Break Visit Exhibits and Pavilions (3rd Floor Foyer and Promenade) |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Saturday
SESSION 84:
CAROTID AND SUPRA-AORTIC BRANCH ISSUES
Moderators:Ali F. AbuRahma, MD / Christos D. Liapis, MD
|
|
x | |
10:30 AM - 10:35 AM | Risk Of Intracerebral Aneurysm Rupture During CEA Or CAS |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
10:36 AM - 10:41 AM | Current Optimal Management Of Concomitant Carotid Stenosis And Intracranial Aneurysm |
Presenter(s):Thomas S. Maldonado, MD | |
10:42 AM - 10:47 AM | Extracranial Carotid Aneurysms: Indications For Aggressive Treatment And Optimal Methods |
Presenter(s):Samuel R. Money, MD, MBA | |
10:48 AM - 10:53 AM | Solutions For Known Access Issues To Aortic Arch Branches For CAS And Other Procedures |
Presenter(s):Gioacchino Coppi, MD | |
10:54 AM - 10:59 AM | Should Patients With Chronic Renal Disease Undergo CEA: What If They Are On Dialysis |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
11:00 AM - 11:05 AM | DEBATE: CEA With Patch Closure Is Better Than CEA Without: CREST Data Confirms Patches Results In Fewer Recurrent Strokes |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
11:06 AM - 11:11 AM | DEBATE: Not Necessarily So! With CEA Patching Doesn’t Matter If You Close The Arteriotomy Right With Small Bites: And Patching Can Cause Problems |
Presenter(s):Glenn M. LaMuraglia, MD | |
11:12 AM - 11:17 AM | To Balloon Or Not To Balloon: Avoidance Of Post-Stent Deployment Ballooning Reduces CAS Complications In A Single Center Study: In CREST Ballooning Was Associated With A Higher Stroke Rate And A Slight Decrease In The Restenosis Rate |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
11:18 AM - 11:23 AM | DEBATE: Screening Is A Waste Of Time And Dangerous |
Presenter(s):J. David Spence, MD | |
View Abstract | |
11:24 AM - 11:29 AM | DEBATE: Not True, Screening Is Not A Waste Of Time And Should Be Done Selectively: On Which Patients And Why |
Presenter(s):Caron B. Rockman, MD | |
11:30 AM - 11:35 AM | What Is The Cost For Screening And Treating Patients With High Grade Carotid Stenosis: How Effective Is It In Preventing Strokes |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:36 AM - 11:41 AM | Aggressive Treatment Of Post CEA Hypertension Decrease Intracranial Hemorrhage: Value Of A Written Guidance System |
Presenter(s):A. Ross Naylor, MD, FRCS | |
11:42 AM - 11:47 AM | The Obesity Paradox With CEA: Thin May Be In, But Fat Is Where It’s At |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
11:48 AM - 11:53 AM | How Can We Improve The Less Than Optimal Current Results With CAS: What Potential Improvements Are On The Horizon: The Rationale For Direct Cervical Access With Flow Reversal |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
11:54 AM - 11:59 AM | Basis For Errors In Carotid Duplex Exams: How Wrong Can They Be |
Presenter(s):K. Wayne Johnston, MD, FRCS | |
12:00 PM - 12:10 PM | Panel Discussion |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Saturday
SESSION 85:
CAROTID STENTING AND CAROTID ENDARTERECTOMY: WHERE DO THINGS STAND: THERE IS A FUTURE FOR CAS
Moderators:Hans-Henning Eckstein, MD, PhD / Frank J. Veith, MD
|
|
x | |
12:10 PM - 12:15 PM | Predictors For Successful Recanalization Of Totally Occluded Internal Carotid Arteries: It Can Be Beneficial |
Presenter(s):Paul H.L. Kao, MD | |
12:16 PM - 12:21 PM | Ignorance About Crucial Information That Can Be Obtained By Transcranial Doppler (TCD) And Its Relevance To CAS And CEA And Patient Selection For Each |
Presenter(s):Zsolt Garami, MD | |
12:22 PM - 12:27 PM | Will Results Of CEA Improve If Perioperative Medical (Drug) Treatment Is Equal To That Used For CAS: Implications For CREST Results And Interpretation |
Presenter(s):Timothy M. Sullivan, MD | |
12:28 PM - 12:33 PM | Comparative Negative Effects Of Perioperative Stroke And Perioperative MI After CEA And CAS: How Should Late Decreased Survival After Stroke Impact On Composite End Points In RCTs Like CREST |
Presenter(s):Andres Schanzer, MD | |
12:34 PM - 12:39 PM | How To Pick Asymptomatic Carotid Stenosis Patients Who Need CEA Or CAS |
Presenter(s):Frans L. Moll, MD, PhD | |
12:40 PM - 12:45 PM | What Proportions Of CAS And CEA In The US Are Done On Asymptomatic Patients |
Presenter(s):Caron B. Rockman, MD | |
12:46 PM - 12:51 PM | For Asymptomatic Carotid Stenosis We Simply Do Not Know What Is The Best Treatment So Bias Rules Until We Have Good RCTs |
Presenter(s):Alison Halliday, MS, FRCS | |
12:52 PM - 12:57 PM | Status Of The SPACE II Trial: Is The New Protocol Working And Will There Ever Be An Answer To The CAS vs. CEA vs. Best Medical Treatment (BMT) In Asymptomatic Carotid Stenosis Patients |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
12:58 PM - 1:03 PM | Status Of CREST II Comparing CAS, CEA And BMT: Will It Happen And When Will We Have An Answer |
Presenter(s):Thomas G. Brott, MD | |
1:04 PM - 1:09 PM | DEBATE: CEA Is The Best Current Treatment For Recently Symptomatic Carotid Stenosis Patients |
Presenter(s):Gustav Fraedrich, MD | |
1:10 PM - 1:15 PM | DEBATE: CAS Is A Good Treatment For Recently Symptomatic Carotid Stenosis Patients If Certain Precautions Are Followed |
Presenter(s):Mark H. Wholey, MD | |
1:16 PM - 1:21 PM | The Cervical Approach To CAS: A Game Changer |
Presenter(s):Patrice F. Bergeron, MD | |
1:22 PM - 1:27 AM | Which High Risk Carotid Stenosis Patients Should Not Undergo CAS Even By Expert Operators |
Presenter(s):Peter A. Schneider, MD | |
1:28 PM - 1:38 PM | Panel Discussion |
1:38 PM - 2:00 PM | Closing Reception – Meet and Greet Our Industry Partners 3rd Floor Foyer and Promenade |
2:00 PM - 2:00 PM | Symposium Ends Save The Date:Tuesday - Saturday, November 18 - 22, 2014 |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Saturday
SESSION 86:
LATE BREAKING INFORMATION, CAROTID TOPICS
|
|
x | |
7:10 AM - 7:15 AM | Neck Angulation Is Not A Bad Prognostic Indicator With EVAR In The Current Era |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
7:16 AM - 7:21 AM | Sheer Stress Induced Platelet Aggregation: What Is It And What Role Does It Play In Vascular Thrombosis: Does It Apply To Pinhole Carotid Stenoses |
Presenter(s):David H. Deaton, MD | |
7:22 AM - 7:27 AM | Why Not To Use Coronary Drug Eluting Stents In Tibial Arteries |
Presenter(s):Florian Dick, MD / Nicolas A. Diehm, MD | |
View Abstract | |
7:28 AM - 7:33 AM | Why Registry Findings May Be Misleading And Not Representative Of Real World Experience |
Presenter(s):Thomas S. Maldonado, MD | |
CAROTID TOPICS | |
7:34 AM - 7:39 AM | CREST Still Leaves Me An Agnostic And Uncertain About The Role And Value Of CAS |
Presenter(s):Frans L. Moll, MD, PhD | |
7:40 AM - 7:45 AM | Maximization Of Good Clinical Outcomes For Interventional Treatment Of Acute Strokes: What We Have Learned From The Recent IMS-3, SYNTHESIS And MR RESCUE Trials |
Presenter(s):Don Frei, MD | |
7:46 AM - 7:51 AM | Rescue Procedures For Embolic Complications Of CAS: How Well Do They Work |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
7:52 AM - 7:57 AM | Update On ACST 2: What Will It Tell Us And When |
Presenter(s):Alison Halliday, MS, FRCS | |
7:58 AM - 8:03 AM | Best Medical Optimization Of CEA Patients Reduces Stroke And Death Rates: What Are The Essential Elements |
Presenter(s):Michael C. Stoner, MD | |
8:04 AM - 8:09 AM | Transcervical CAS With Flow Reversal Can Reduce Stroke Risk But Not To Zero |
Presenter(s):Enrique Criado, MD, FACS | |
8:10 AM - 8:15 AM | Contralateral Internal Carotid Occlusion Is Not An Indication For CAS Or Mandatory Shunting With CEA |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
8:16 AM - 8:25 AM | Panel Discussion |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Saturday
SESSION 87:
MORE LATE BREAKING INFORMATION ON CCSVI, EVAR, AORTA, LOWER EXTREMITY PROBLEMS
Moderators:Enrico Ascher, MD / Daniel G. Clair, MD
|
|
x | |
8:25 AM - 8:30 AM | Observations Of Chronic Cerebrospinal Venous Insufficiency (CCSVI) In Multiple Sclerosis Patients Using Multimodality Imaging: Venographic Obstruction Is Not The Key Factor |
Presenter(s):Richard F. Neville, MD | |
View Abstract | |
8:31 AM - 8:36 AM | The CCSVI Controversy In Canada: Where Is Interventional Therapy Heading And Can It Go Wrong |
Presenter(s):Thomas L. Forbes, MD | |
8:37 AM - 8:42 AM | With Multiple Saccular Aneurysms Of The Aortic Arch And Other Lesions, Branched Grafts, Chimneys, Snorkels And Sandwich Grafts Won’t Work And Why |
Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
8:43 AM - 8:48 AM | DEBATE:Enough Is Enough: In Favor Of Open Surgical Reinterventions Rather Than Complex Endovascular Solutions For Some Patients With Failed EVARs |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
8:49 AM - 8:54 AM | DEBATE: Endovascular Treatment Is Usually Better For Serious Complications Of Aortic Surgery |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:55 AM - 9:00 AM | Endovascular Treatment Of Acute Mesenteric Ischemia |
Presenter(s):James H. Black III, MD | |
9:01 AM - 9:06 AM | How To Diagnose And Manage Infected Endografts After EVAR |
Presenter(s):Carlo Setacci, MD | |
9:07 AM - 9:12 AM | Tips And Tricks On Safely Crossing Aortic And Iliac CTOs Using The Avinger Wildcat Catheter |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
9:13 AM - 9:20 AM | Panel Discussion |
LOWER EXTREMITY TOPICS | |
Moderator(s): Gustavo S. Oderich, MD, FACS / Ignacio Escotto, MD | |
9:21 AM - 9:26 AM | RCT Comparing DEBs vs. Standard Balloons For SUPERA Stenting Of Long SFA Lesions: The RAPID Trial |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
9:27 AM - 9:32 AM | Importance Of Recoil In Plain Old Balloon Angioplasty Of BTK Arteries: Will DEBs Be Enough To Prevent Restenosis |
Presenter(s):Florian Dick, MD / Nicolas A. Diehm, MD | |
View Abstract | |
9:33 AM - 9:38 AM | Restenosis After Endo And Open Treatments For CLI Is An Epidemic: How Should This Influence How We Treat Patients |
Presenter(s):Philip P. Goodney, MD, MS | |
View Abstract | |
9:39 AM - 9:44 AM | PTFE Bypasses To BTK Target Arteries Are A Valuable Option To Save Threatened Limbs When Good Autologous Saphenous Vein Is Not Available: Despite A Bias Against Them |
Presenter(s):Hisham Rashid, FRCS, FRCS (Gen) | |
9:45 AM - 9:50 AM | New Technique To Treat Popliteal Aneurysm With Distal Embolization: Place A Stent-Graft First To Exclude The Aneurysm And Then Thrombolyse Through The Endograft |
Presenter(s):Mark W. Mewissen, MD | |
9:51 AM - 9:56 AM | Hybrid Approaches To CLI: They Still Have A Role |
Presenter(s):Francesco Setacci, MD | |
9:57 AM - 10:02 AM | A Shockwave Lithoplasty Catheter System For Cracking Heavily Calcified Plaques And Facilitating PTA |
Presenter(s):Andrew Holden, MBChB | |
10:03 AM - 10:11 AM | Panel Discussion |
MISCELLANEOUS IMPORTANT LATE BREAKING TOPICS | |
Moderator(s): Enrico Ascher, MD / Rajiv Parakh, MBBS, MS, FRCS | |
10:11 AM - 10:16 AM | Current Optimal Treatment Of Visceral And Renal Artery Aneurysms: When Endo And When Open |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
10:17 AM - 10:22 AM | Device Based Renal Denervation By Neurotropic Agents |
Presenter(s):Mark H. Wholey, MD | |
10:23 AM - 10:28 AM | An Improved Model For Assessing Operative Risk For Elective AAA Repair: Endo And Open |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
10:29 AM - 10:34 AM | Hydrogel Coated Coils For A More Dependable Arterial Occlusion: Why They Work Better |
Presenter(s):Jos C. van den Berg, MD, PhD | |
10:35 AM - 10:40 AM | Improved Management And Outcomes Of Battle Casualties With Traumatic Bilateral Lower Extremity Amputations |
Presenter(s):Charles J. Fox, MD, FACS | |
View Abstract | |
10:41 AM - 10:46 AM | How OR Nurses And Technicians Should Set Up The Back Table For EVAR Treatment Of Ruptured AAAs (Video): It Makes A Difference |
Presenter(s):Benjamin W. Starnes, MD / Niten Singh, MD | |
10:47 AM - 10:52 AM | Improved Technology For Videoscopic Vein Harvesting: It Is A Game Changer In Making Bypasses Less Invasive |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
10:53 AM - 10:58 AM | Antibiotic Coated Gloves Will Be The Standard Of Care For Vascular Surgeons And Endovascular Specialists |
Presenter(s):Afshin Assadian, MD | |
10:59 AM - 11:04 AM | Lessons Learned From Assessment Of AAA Mural Thrombus By MRI: It Makes A Difference |
Presenter(s):Lars Lonn, MD, PhD | |
View Abstract | |
11:05 AM - 11:12 AM | Panel Discussion Although Session 87 in the Grand Ballroom West ends, the Meeting continues in the Grand Ballroom East (See Sessions 84 and 85). |
END OF SESSION 87 | |